Terapias

Katharine A. Phillips, M.D.
Curriculum Vitae February 25, 2019
CURRICULUM VITAE
KATHARINE A. PHILLIPS, M.D.
CONTACT INFORMATION
Address: Weill Cornell Psychiatry Specialty Center

315 East 62nd Street
New York, New York 10065
Tel: 646-962-2820
Fax: 646-962-0175
E-mail: kap9161@med.cornell.edu
EDUCATION AND TRAINING
Dartmouth College, Hanover, N.H.

A.B., Psychology, 1977
Dartmouth Medical School, Hanover, N.H.

M.D., 1987
Dartmouth-Hitchcock Medical Center, Hanover, N.H.

Intern in Internal Medicine, 1987-1988
McLean Hospital/Harvard Medical School, Belmont, M.A.

Resident in General Psychiatry, 1988-1991
Chief Resident in Psychopharmacology, 1990-1991
Clinical and Research Fellow, Laboratories for Psychiatric Research, 1990-1991
Research Fellow in Psychiatry, 1991-1994
Brown University, Providence, RI

Master of Arts, ad eundem (honorary degree), 1998
ACADEMIC APPOINTMENTS
Professor of Psychiatry, Weill Cornell Medical College, Cornell University, 2017-present
DeWitt Wallace Senior Scholar, Weill Cornell Medical College, Cornell University, 2018-present
Adjunct Professor of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown
University, 2018-present
1
Katharine A. Phillips, M.D. Curriculum Vitae February 25, 2019
Professor of Psychiatry and Human Behavior (Research Scholar Track), Warren Alpert Medical
School of Brown University, 2003-2018
Associate Professor of Psychiatry and Human Behavior (Research Scholar Track), Warren
Alpert Medical School of Brown University, 1997-2003
Assistant Professor of Psychiatry and Human Behavior (Research Scholar Track), Warren
Instructor in Psychiatry, Harvard Medical School, 1991-1994
Clinical Fellow in Psychiatry, Harvard Medical School, 1988-1991
HOSPITAL AND DEPARTMENTAL APPOINTMENTS
Residency Research Director, Department of Psychiatry, Weill Cornell Medical College, Cornell
University, New York, New York, 2018-
Attending Psychiatrist, New York-Presbyterian Hospital, New York, New York, 2017-present
Senior Research Scientist, Rhode Island Hospital, Providence, RI, 2010-2017
Director of Research for Adult Psychiatry, Rhode Island Hospital, Providence, RI, 2010-2017
Director, Body Dysmorphic Disorder Program, Rhode Island Hospital, Providence, RI, 2010-
2017
Director of Research Training, General Psychiatry Residency Training Program, Department of

Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University,
Providence, RI, 2006-2017
Director, Body Dysmorphic Disorder Program, Butler Hospital, Providence, RI, 1994-2009
Associate Medical Director, Ambulatory Services, Butler Hospital, Providence, RI, 1998-2001
Chief, Outpatient Services, Butler Hospital, Providence, RI, 1994-1999
Research Affiliate in Psychiatry, McLean Hospital, Belmont, MA, 1994-1998
Director, Body Dysmorphic Disorder Clinic, McLean Hospital, Belmont, MA, 1992-1994
Assistant Psychiatrist, McLean Hospital, Belmont, MA, 1992-1994
Assistant in Psychiatry, McLean Hospital, Belmont, MA, 1991-1992
CERTIFICATION AND LICENSURE (CURRENT)
2
Licensed physician in New York state
Board Certified in Psychiatry, American Board of Psychiatry and Neurology, 1992 (lifetime
certification)
HONORS AND AWARDS
Summa Cum Laude, Dartmouth College, 1977
Phi Beta Kappa National Honor Society, Dartmouth College, 1977
Rufus Choate Scholar, Dartmouth College, 1977
Rolf C. Syvertsen Fellow (for outstanding academic performance), Dartmouth Medical School,
1986
Alpha Omega Alpha Honor Medical Society, Dartmouth Medical School, 1987
The Dean's Medal (awarded for highest academic achievement), Dartmouth Medical School,
1987
Outstanding Resident Award, National Institute of Mental Health, 1989
American Psychiatric Association/Burroughs-Wellcome Fellow, American Psychiatric

Association, 1989-1991
Honorable Mention, Psychiatric Research Fellowship, American Psychiatric Association, 1991
Resident Research Award, American Psychiatric Association, 1991
The Paul M. Howard Prize, McLean Hospital, 1991
Marquis Who’s Who Among Human Services Professionals, 1991
NCDEU New Investigators' Award, National Institute of Mental Health, 1993
Outstanding Psychiatrist Award for Clinical Psychiatry, Massachusetts Psychiatric Society, 1994
Travel Award, American College of Neuropsychopharmacology, 1995
Honorable Mention, Gerald L. Klerman Award for outstanding research, National Alliance for
Research on Schizophrenia and Depression, 1997
Literary Award (for “The Broken Mirror: Understanding and Treating Body Dysmorphic
Disorder”), Rhode Island Medical Women’s Association, 1998
Research Mentor Award, Department of Psychiatry and Human Behavior, Warren Alpert
Medical School of Brown University, 2001, 2007, and 2015
3
Best Doctors in America (National Edition), 2001-2003, 2005-2006, 2007-2008, 2009-2010,

2011-2014, 2015-2016, 2017-2018, Best Doctors, Inc., Aiken, SC
Dorfman Journal Paper Award, Academy of Psychosomatic Medicine, 2002
Distinguished Fellow, American Psychiatric Association, 2003-present
Special Presidential Commendation (for research on body dysmorphic disorder), American

Psychiatric Association, 2004
America’s Top Doctors (National Edition), Castle Connolly, 2006-2019
American Men and Women of Science, 26th Edition, 2009
Marquis Who’s Who in America, 2009-2016
Marquis Who’s Who of American Women, 2010
Fellow, American College of Neuropsychopharmacology, 2010-present
Marquis Who’s Who in Medicine and Healthcare, 2011
US News and World Report Best Doctors, 2011-2013
Marquis Who’s Who in Science and Engineering, 2011-2012 and 2016-2017
Author Commendation (one of best authors in Psychiatry), UpToDate, 2017
Exceptional Women in Medicine (National Edition), Castle Connolly, 2017, 2018
Marquis Who’s Who Lifetime Achievement Award, 2017, 2018
Who’s Who Top Doctors Honors Edition, 2017-present
Regional Top Doctor, Castle Connolly, 2017
Marquis Who’s Who in the World, 2017, 2018, 2019
GRANTS
1. Livingston Research Fellowship

Harvard Medical School
Principal Investigator, 1991-1992
2. Development of Diagnostic Instruments and Prevalence of Body Dysmorphic Disorder in

Psychiatric, Medical, and Surgical Populations
Young Investigator Award, National Alliance for Research on Schizophrenia and
4
Depression (NARSAD)
3. An Open-Label Flexible Dose Study of Fluvoxamine in Body Dysmorphic Disorder

Upjohn/Solvay Pharmaceuticals (Investigator Initiated)
Co-Principal Investigator, 1994-1995
4. A Prospective, Multicenter, Open-Label Study of Serzone (Nefazodone) in the

Management of Patients with Symptoms of Depression in General Psychiatric
Practices
Bristol-Myers Squibb Company
Co-Investigator, 1995
5. Pharmacotherapy of Body Dysmorphic Disorder

National Institute of Mental Health (R29-MH54841 [FIRST Award])
6. Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder

Young Investigator Award, National Alliance for Research on Schizophrenia and
Depression (NARSAD)
7. Retrospective Follow-up Study of Body Dysmorphic Disorder

Department of Psychiatry, Alpert Medical School of Brown University
8. Weekly Enteric-Coated Fluoxetine Hydrochloride Versus Daily Fluoxetine or Placebo in

the Continuation Treatment of Major Depressive Disorder
Eli Lilly and Company
Co-Investigator, 1997-1998
9. Phenomenology of Body Dysmorphic Disorder in Children and Adolescents

Solvay Pharmaceuticals (Investigator Initiated)
10. Harvard/Brown Anxiety Research Program

National Institute of Mental Health (5 R01 MH51415)
11. Citalopram Treatment of Body Dysmorphic Disorder

Forest Laboratories (Investigator Initiated)
12. Pharmacotherapy of Adolescent Body Dysmorphic Disorder

National Institute of Mental Health (R01 MH58750)
13. Pilot Study of the Genetics of Body Dysmorphic Disorder

5
14. Olanzapine Augmentation of Fluoxetine in Body Dysmorphic Disorder

Eli Lilly and Company (Investigator Initiated)
15. Visual Processing in Body Dysmorphic Disorder

16. Prospective Study of Body Dysmorphic Disorder

17. Treatment and Psychopathology of Body Dysmorphic Disorder/Interventions for Body

Dysmorphic Disorder
National Institute of Mental Health: Mid-Career Investigator Award in Patient-Oriented
Research (5 K24MH063975)
18. Escitalopram Treatment of Body Dysmorphic Disorder

Forest Laboratories (Investigator Initiated)
19. Open-Label Study of Levetiracetam in Body Dysmorphic Disorder

UCB Pharma (Investigator Initiated)
20. CBT Treatment Development in Body Dysmorphic Disorder

21. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder

22. Fluoxetine in Pediatric Body Dysmorphic Disorder

Food and Drug Administration (FD-R-002613)
23. A Prospective Study of Suicidal Ideation, Suicide Attempts, and Completed Suicide in
Body Dysmorphic Disorder
American Foundation for Suicide Prevention
24. A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to

Evaluate the Efficacy and Safety of Low-Dose Ondansetron for Adjunctive Therapy
in Adult Patients with Obsessive Compulsive Disorder Who Have Not Adequately
Responded to Treatment with a Selective Serotonin Reuptake Inhibitor
6
Transcept Pharmaceuticals
25. Cognitive-Behavioral Therapy Versus Supportive Psychotherapy for Body Dysmorphic

Disorder
26. Visual Processing in Body Dysmorphic Disorder

Brown Institute for Brain Science and Norman Prince Neurosciences Institute
27. Promoting Research Training During Psychiatry Residency

National Institute of Mental Health (1R25 MH101076)
28. Modification of Perception in Body Dysmorphic Disorder and Its Neural Correlates
Dean’s Emerging Areas of New Science (DEANS) Award, Brown University Division of
Biology and Medicine
29. Pathological Grooming in the Gabrg2 KO Mouse Model of Body Dysmorphic Disorder
National Institute of General Medical Sciences (Rhode Island Idea Network for
Excellence in Biomedical Research) (2P20GM103430)
Collaborative Mentor, 2014-2017
GRANT REVIEWER
Reviewer, B/START grants, National Institute of Mental Health, 1994
Member, Interventions Research Review Committee (Scientific Review Group), National

Institute of Mental Health, 2000-2006
Chair, Special Emphasis Panel (ZMH1-NRB-G-03) (Scientific Review Group), National Institute
of Mental Health, 2001
Chair, Interventions Research Review Committee (Scientific Review Group), National Institute
of Mental Health, 2002-2006
Ad hoc reviewer, Neural Basis of Psychopathology, Addictions, and Sleep Disorders Study
Section (Scientific Review Group), National Institute of Mental Health, 2005
Ad hoc reviewer, Adult Psychopathology and Disorders of Aging Study Section (Scientific
Review Group), National Institute of Mental Health, 2010 and 2011
Reviewer, International OCD Foundation grants, 2011-2016, 2018
Reviewer, Netherlands Organisation for Scientific Research, 2012
7
Chair, Special Emphasis Panel (ZMH1-ERB-X(02)) (Scientific Review Group), Pre-Doctoral and
Post-Doctoral Fellowships, National Institute of Mental Health, 2012
Reviewer/External Scientific Advisory Panel member, Institute for Mental Health Research,
2013
Chair, Early Phase Clinical Trials Review Committee (ZMH1 ERB-D (01) R) (Scientific Review
Group), National Institute of Mental Health, 2014
Chair, Early Phase Clinical Trials Review Committee (2015/05 ZMH1 ERB-D (02) R) (Scientific
Review Group), National Institute of Mental Health, 2015
EDITORIAL BOARDS
Deputy Editor, Harvard Review of Psychiatry, 1991-1994
Editorial Board, Journal of Personality Disorders, 1992-present
Column Editor (Psychopathology column) and Editorial Board, Harvard Review of Psychiatry,
1994-present
Editorial Board, CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 1997-
present
Associate Editor and Editorial Board, American Psychiatric Publishing, Inc. (books division),
2001-2004
Associate Editor and Editorial Board, Current Psychiatry, 2001-2006
Editorial Board, Psychiatric Glossary (Eighth Edition), American Psychiatric Publishing, Inc.,
2002
Editorial Board, Neuropsychopharmacology, 2003-2007
Editorial Board, Body Image: An International Journal of Research, 2003-present
Editorial Board, Primary Psychiatry, 2003-2008
Editorial Board, Comprehensive Psychiatry, 2003-present
Deputy Editor and Editorial Board, American Psychiatric Publishing, Inc. (Books Division), 2004-
2013
International Editorial Advisory Board, American Psychiatric Publishing, Inc. (Books Division),
2007-2013
Editorial Board, Journal of Obsessive-Compulsive and Related Disorders, 2011-present
8
Editorial Board, American Psychiatric Publishing Textbook of Psychiatry, 6th Edition, 2013
Editorial Board, American Psychiatric Publishing Textbook of Psychiatry, 7th Edition, 2017-
present
Editorial Board, Psychiatric Research and Clinical Practice, 2017-present
Editorial Board, Psychiatric Times, 2017-2019
OTHER APPOINTMENTS
Council on Medical Education and Career Development (as an APA/Burroughs-Wellcome

Fellow), American Psychiatric Association, 1989-1991
President, Burroughs-Wellcome Fellowship, American Psychiatric Association, 1990-1991
Burroughs-Wellcome Fellowship Representative to the American Psychiatric Association Board

of Trustees, 1990-1991
DSM-IV Workgroup on Psychiatric Systems Interface Disorders (somatoform, dissociative,

impulse control, adjustment, and other disorders), American Psychiatric Association, 1991-1994
Advisor, DSM-IV Workgroup on Personality Disorders, American Psychiatric Association, 1991-

1994
Committee on Psychiatric Diagnosis and Assessment, American Psychiatric Association

(Member or Corresponding Member, 1991-1992, 1994-1999, 2002-2007; Consultant, 1992-
1993, 2000-2001; Chair, 2006)
Participant, ICD-10 Clinical Field Trial for Mental and Behavioral Disorders, World Health
Organization, 1992
Site Coordinator and Expert-Phase Participant, MacArthur General Reliability Field Trial for
DSM-IV, American Psychiatric Association, 1994
Advisor, DSM-IV PC (primary care version), American Psychiatric Association, 1994-1995
Task Force, Handbook of Psychiatric Measures, American Psychiatric Association, 1995-1998
Board of Directors, Association for Research on Personality Disorders, 1995-2006
Consensus Panel, National Depressive and Manic Depressive Association Consensus

Conference on Depression, 1996
Ad Hoc Task Force on Managed Care System Standards, American Psychiatric Association,
1996
9
Expert Consensus Panel on Obsessive Compulsive Disorder, Expert Consensus Consortium,

1996
Reviewer, Practice Parameters for the Assessment and Treatment of Children and Adolescents
with Obsessive Compulsive Disorder, American Academy of Child and Adolescent Psychiatry,
1997
DSM-IV Text Revision Work Group on Psychiatric Systems Interface Disorders (somatoform,
dissociative, impulse control, adjustment, and other disorders), American Psychiatric
Scientific Planning Committee, NCDEU Annual Meeting, National Institute of Mental Health,
1997, 1998, 2002, 2003
Distinguished Lecturer in Psychiatry for the American Society of Clinical Psychopharmacology

Model Curriculum in Psychopharmacology for Psychiatry Residency Training, 1997, 2000, 2004,
2006, 2008, 2010, 2012, 2015, 2016
Consultant, Practice Guideline on Borderline Personality Disorder, American Psychiatric

Expert Consensus Panel on Depressive Disorders in Women, Expert Consensus Consortium,

1999
Vestermark Award Committee, American Psychiatric Association and National Institute of

Mental Health, 2001
Chair, Gender White Paper Committee, A Research Agenda for DSM-V, American Psychiatric
Council on Research Awards Subcommittee, American Psychiatric Association, 2003-2006
Co-Chair, Public Information Committee, American College of Neuropsychopharmacology, 2005
Council on Research, American Psychiatric Association, 2005-2006
Member, Public Information Committee, American College of Neuropsychopharmacology, 2005-

2012
Chair, Public Information Committee, American College of Neuropsychopharmacology, 2006-

2007
Secretary, Board of Directors, American Psychiatric Publishing, Inc., 2006-2008
Member, Board of Directors, American Psychiatric Publishing, Inc., 2006-2010
Strategic Planning Committee, American College of Neuropsychopharmacology, 2007
DSM-5 Task Force, American Psychiatric Association, 2007-2012
10
Chair, DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic, and Dissociative

Disorders Workgroup, American Psychiatric Association, 2007-2012
DSM-5 Diagnostic Spectra and DSM/ICD Harmonization Study Group, American Psychiatric
Ad Hoc Work Group on Disclosures and Interests Policies, American Psychiatric Association,
2008
President, Board of Directors, American Psychiatric Publishing, Inc., 2008-2009
Committee on Scientific Programs, American College of Psychiatrists, 2008-2011
50th Anniversary Committee for the NCDEU Annual Meeting, National Institute of Mental Health
and American Society of Clinical Psychopharmacology, 2009-2010
Scientific Council, Anxiety and Depression Association of America, 2009-present
Program Committee, ASCP/NCDEU Annual Meeting, American Society of Clinical

Psychopharmacology, 2010-2017
Scientific and Clinical Advisory Board, International OCD Foundation, 2010-present
Scientific Advisory Committee, The Canadian Institute for Obsessive Compulsive Disorders,
2011-present
New Investigator Award Committee, ASCP/NCDEU Annual Meeting, American Society of

Clinical Psychopharmacology, 2012-2019
Body Dysmorphic Disorder Special Interest Group (Facilitator), International OCD Foundation,
2012-present
Accreditation Task Force, The Canadian Institute for Obsessive Compulsive Disorders, 2012-
present
Conference Planning Committee, International OCD Foundation, 2014-2019
Patron, Body Dysmorphic Disorder Foundation, London, England, 2014-present
Awards Committee, American College of Psychiatrists, 2014-2020
Director, Board of Directors, The Canadian Institute for Obsessive Compulsive Disorders, 2014-
2020
Board of Directors, American Society of Clinical Psychopharmacology, 2015-2023
Reviewer, Clinical Practice Guideline Update: Improving Nasal Form and Function After
Rhinoplasty, American Academy of Otolaryngology – Head and Neck Surgery, 2016
11
Member, DSM Review Committee for Internalizing Disorders (Depressive, Anxiety, Trauma,
Obsessive-Compulsive, Dissociative, and Somatic Symptom Disorders), American Psychiatric
Association, 2016-present
Inclusivity Committee, American Society of Clinical Psychopharmacology, 2018-present
Chair, Awards Committee, American College of Psychiatrists, 2019-2020
AD HOC REVIEWER
Acta Dermato-Venereologica
American Journal of Psychiatry
Archives of Dermatology
Archives of General Psychiatry (now JAMA Psychiatry)
Behavior Therapy
Behaviour Research and Therapy
Behavioural and Cognitive Psychotherapy
Biological Psychiatry
Bipolar Disorders
BMJ Case Reports
Body Image: An International Journal of Research
British Journal of Clinical Psychology
Cleveland Clinic Journal of Medicine
Clinical Drug Investigation
Clinical Psychology and Psychotherapy
Clinical Schizophrenia & Related Psychoses
CNS Spectrums
Cognitive Therapy and Research
Cognition and Emotion
Comprehensive Psychiatry
Consultant: Consultations in Primary Care
Current Psychiatry
Depression and Anxiety
Drugs
European Journal of Psychological Assessment
European Psychiatry
General Hospital Psychiatry
Harvard Review of Psychiatry
Health Psychology
International Journal of Psychiatry in Clinical Practice
JAMA Psychiatry
Journal of Abnormal Psychology
Journal of Affective Disorders
Journal of the American Academy of Dermatology
Journal of Behavior Therapy and Experimental Psychiatry
Journal of Clinical Psychiatry
Journal of Clinical Psychology
12
Journal of Clinical Psychopharmacology

Journal of Nervous and Mental Disease
Journal of Neuropsychiatry and Clinical Neurosciences
Journal of Personality Disorders
Journal of Psychopathology and Behavioral Assessment
Journal of Psychosomatic Research
Journal of Traumatic Stress
Neural Plasticity
Neuropsychopharmacology
Nigerian Journal of Clinical Practice
Progress in Neuropsychopharmacology & Biological Psychiatry
Psychiatric Research and Clinical Practice
Psychiatric Services
Psychiatry Research
Psychological Assessment
Psychological Medicine
Psychopathology
Psychosomatic Medicine
Psychosomatics
Psychotherapy and Psychosomatics
Schizophrenia Bulletin
School Psychology Review
Social Psychiatry and Psychiatric Epidemiology
Southern Medical Journal
The Lancet
TEACHING AND TRAINING ROLES
Course Lecturer, Introduction to Clinical Psychopharmacology (course for PGY-I and PGY-II
residents), McLean Hospital/Harvard Medical School, 1989; Course Director and Lecturer, 1990
Tutorial Group Instructor, Human Nervous System and Behavior Course (course for second-
year medical students), Harvard Medical School, 1990
Psychopharmacology supervisor for PGY-II residents, McLean Hospital/Harvard Medical

School, 1990-1994
Lecturer, Psychopathology and Introduction to Clinical Psychiatry (course for third-year medical
students), Harvard Medical School, 1990-1994
Lecturer, various courses for PGY-II and PGY-III residents, McLean Hospital/Harvard Medical
School, 1990-1994
Seminar Director and Lecturer, Body Dysmorphic Disorder (seminar for faculty, residents, and
fellows), McLean Hospital/Harvard Medical School, 1992
Lecturer, Board review course, McLean Hospital/Harvard Medical School, 1992-1994
13
Course Co-Director and Lecturer, Personality Disorders (course for PGY-I and PGY-II
residents), McLean Hospital/Harvard Medical School, 1992-1994
Course Co-Director and Lecturer, Anxiety and Other Disorders (course for PGY-I and PGY-II
residents), McLean Hospital/Harvard Medical School, 1993; Course Director and Lecturer, 1994
Course Director, Understanding and Managing Complex Problems in Depression, McLean

Hospital/Harvard Medical School, 1994
Visiting Faculty (examiner), Mock Board Examination, Dartmouth Medical School, 1994
Director, PGY-III general outpatient psychiatry rotation, Butler Hospital/Alpert Medical School of
Brown University, 1994-1999
Outpatient clinical supervisor for psychiatry residents, Warren Alpert Medical School of Brown
University, 1994-2009
Research supervision of junior faculty, post-doctoral psychology fellows, psychology interns,

residents, medical students, and/or undergraduate students, Warren Alpert Medical School of
Brown University, 1994-2017
Lecturer for general psychiatry residents, psychology interns, and/or medical students, Warren
Tutor-advisor, General Psychiatry Residency Training Program, Warren Alpert Medical School
of Brown University, 1996-2005 (selected years)
Course Director and Lecturer, Psychopharmacology Track (courses for PGY-I, PGY-II, and
PGY-III general psychiatry residents), Warren Alpert Medical School of Brown University, 1996-
2017
Faculty Member, NIMH T-32 Training Grant in Treatment Research, Department of Psychiatry
and Human Behavior, Warren Alpert Medical School of Brown University, 1998-2013
Mentor, Research Colloquium for Junior Investigators (sponsored by the American Psychiatric
Association Committee on Research Training), American Psychiatric Association Annual
Meeting, 2000, 2005, 2007, 2009, 2010, 2014-2016
Mentor, Early Research Career Breakfast (sponsored by the American Psychiatric Council on
Research), American Psychiatric Association Annual Meeting, 2000-2010, 2012-2016, 2018
Supervising faculty for independent study (e.g., Biology 1060 course) for undergraduate
students, Brown University, 2003 – 2015 (selected years)
Mentor for Early Career Investigators, American College of Neuropsychopharmacology Annual

Meeting, 2005, 2007, 2009, 2010, 2011, 2013, 2014
Module Coordinator, Curriculum for PGY-I and PGY-II general psychiatry residents, Warren
14
Mentor, Brown Diversity Mentoring Program, Department of Psychiatry and Human Behavior,
Warren Alpert Medical School of Brown University, 2010-2013
Director, Research Seminar, Department of Psychiatry, Rhode Island Hospital/Warren Alpert

Medical School of Brown University, 2010-2017
Co-Director, Post-Doctoral Research Training Fellowship in Translational Neuroscience;

Sponsored by the Brown Institute for Brain Science, the Norman Prince Neurosciences Institute,
and the Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown
University (previously also sponsored by Rhode Island Hospital and Lifespan Hospitals), 2012-
2014
Mentor, New Investigator Award Program (sponsored by the American Society of Clinical
Psychopharmacology), American Society of Clinical Psychopharmacology/NCDEU Annual
Meeting, 2013, 2014, 2016, 2018
Faculty, New Investigator Workshop (sponsored by the American Society of Clinical

Psychopharmacology), American Society of Clinical Psychopharmacology/NCDEU Annual
Meeting, 2013-2016
Director, Research seminar for research track residents, Department of Psychiatry and Human
Behavior, Warren Alpert Medical School of Brown University, 2014-2017
Lecturer on various topics for psychiatry residents and medical students, Department of
Psychiatry, Weill Cornell Medical College, Cornell University, 2017-present
Faculty, Brain and Behavior Mental Status Exam and Psychiatric Diagnostic Interviewing
Course (for medical students), Weill Cornell Medical College, Cornell University, 2018
Table Leader, Networking Lunch, Women’s Task Force, American College of

Neuropsychopharmacology 57th Annual Meeting, 2018
Clinical Supervisor (for PGY-2 or PGY-3 residents), Department of Psychiatry, Weill Cornell
Medical College, Cornell University, 2018-present
Research Mentor/Advisor (for residents and junior faculty), Department of Psychiatry, Weill
Cornell Medical College, Cornell University, 2018-present
Faculty Leader, Clinical Scholars’ Institute Writing Seminar (for PGY-3 residents), Department
of Psychiatry, Weill Cornell Medical College, Cornell University, 2018-present
Journal Club Facilitator (for residents), Department of Psychiatry, Weill Cornell Medical College,
Cornell University, 2018-present
Faculty Mentor for Writing Seminar, Clinical Scholars Institute (mentoring of junior faculty),
Department of Psychiatry, Weill Cornell Medical College, Cornell University, 2019-
15
Faculty Mentor for Career Development Seminar, Clinical Scholars Institute (mentoring of junior
faculty), Department of Psychiatry, Weill Cornell Medical College, Cornell University, 2019-
MEMBERSHIP IN SOCIETIES
American Psychiatric Association, 1986-present; Distinguished Fellow, 2003-present
American Medical Association, 1986-2018
International Society for the Study of Personality Disorders, 1991-present
Association for Research on Personality Disorders, 1992-
Rhode Island Psychiatric Society, 1994-2017
Rhode Island Medical Society, 1995-2013
International Obsessive-Compulsive Disorder Foundation, 1998-present
American College of Neuropsychopharmacology; Fellow: 2010-present; Member: 2005-2010;

Associate Member, 2000-2004
Association of Women Psychiatrists, 2005-2014
American College of Psychiatrists, 2007-present
Anxiety and Depression Association of America, 2008-present
American Society of Clinical Psychopharmacology, 2014-present
New York County Psychiatric Society, 2017-present
New York State Psychiatric Association, 2017-present
The New York Psychiatric Society, 2018-present
UNIVERSITY/DEPARTMENT COMMITTEES
Institutional Self-Study Task Force, Liaison Committee on Medical Education, Dartmouth

Medical School, 1985-1986
President, Alpha Omega Alpha, Dartmouth Medical School chapter, 1986-1987
Coordinator of General Resident Recruitment, Department of Psychiatry, Alpert Medical School

of Brown University, 1994-1995
16
Selection Committee, General Psychiatry Residency, Alpert Medical School of Brown

University, 1994-2000, 2006-2017
Institutional Self-Study Task Force, Liaison Committee on Medical Education, Alpert Medical
Universal Treatment Program Committee, General Psychiatry Residency Training Program,

Curriculum Committee, General Psychiatry Residency Training Program, Alpert Medical School
of Brown University, 1996-2005, 2007
Research Track Committee, General Psychiatry Residency Training Program, Alpert Medical
Associate Training Director Search Committee, General Psychiatry Residency Training

Program, Alpert Medical School of Brown University, 2003
Dean Search Committee, Alpert Medical School of Brown University, 2003-2004
Full-Time Faculty Appointments, Reappointments, and Promotions Committee, Department of

Psychiatry, Alpert Medical School of Brown University, 2004-2017
Progressions Committee, General Psychiatry Residency Training Program, Alpert Medical

Clinical Competency Committee, General Psychiatry Residency Training Program, Alpert

Medical School of Brown University, 2014-2017
Education Committee, Department of Psychiatry, Weill Cornell Medical College, Cornell

University, 2018-present
Residency Selection Committee, Department of Psychiatry, Weill Cornell Medical College,

Cornell University, 2018-present
HOSPITAL COMMITTEES
Committee on Continuing Medical Education, McLean Hospital, 1990-1994
Ambulatory Care Committee, McLean Hospital, 1992-1994
Library Committee, McLean Hospital, 1993-1994
Residency Training Curriculum Committee, McLean Hospital/Harvard Medical School, 1993-

1994
Library Fund Development Committee, McLean Hospital, 1994
17
Transfer of Information Task Force (Chair), Butler Hospital, 1995-1996
Library Committee, Butler Hospital, 1995-2006
Continuing Medical Education Committee, Butler Hospital, 1995-2009
Risk Management Committee, Butler Hospital, 1998-2001
Behavioral Health Executive Committee, Rhode Island Hospital, 2010-2013
Research Advisory Committee, Lifespan Hospital System, 2010-2017
PUBLICATIONS
1. Phillips KA, Vaillant GE, Schnurr P. Some physiologic antecedents of adult mental
health. American Journal of Psychiatry 1987;144:1009-1013
2. Phillips KA, Gunderson JG, Hirschfeld RMA, Smith LE. A review of the depressive
personality. American Journal of Psychiatry 1990;147:830-837
3. Gunderson JG, Phillips KA. A current view of the interface between borderline
personality disorder and depression. American Journal of Psychiatry 1991;148:967-975
4. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. American
Journal of Psychiatry 1991;148:1138-1149
5. Phillips KA. The role of pimozide in clinical psychiatry (letter). Journal of Clinical
Psychiatry 1991;52:514
6. Nakao K, Gunderson JG, Phillips KA, Tanaka N, Yorifuji K, Takaishi J, Nishimura T.

Functional impairment in personality disorders. Journal of Personality Disorders
1992;6:24-33
7. Phillips KA. Reply to: Body dysmorphic disorder: a controlled study of patients
requesting cosmetic rhinoplasty (letter). American Journal of Psychiatry 1992;149:577
8. Gunderson JG, Phillips KA. Borderline personality disorder and depression (letter).
American Journal of Psychiatry 1992;149:581
9. Phillips KA. Body dysmorphic disorder (letter). American Journal of Psychiatry

1992;149:719
10. Phillips KA, McElroy SL. Obsessive-compulsive disorder in relation to body dysmorphic
disorder (letter). American Journal of Psychiatry 1992;149:1284
11. Phillips KA, McElroy SL, Lion JR. Plastic surgery and psychotherapy in the
treatment of psychologically disturbed patients (letter). Plastic and Reconstructive
Surgery 1992;90:333-334
18
12. Hollander E, Phillips KA. Body image and experience disorders: body dysmorphic and
depersonalization disorders. In: Obsessive Compulsive-Related Disorders. Hollander E,
editor. Washington, DC: American Psychiatric Press Inc, 1992
13. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic
disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 1993;150:302-
308
14. Phillips KA, Hirschfeld RMA, Shea TM, Gunderson JG. Depressive personality
disorder: perspectives for DSM-IV. Journal of Personality Disorders 1993;7:30-42
15. McElroy SL, Hudson JI, Phillips KA, Keck PE Jr, Pope HG Jr. Clinical and theoretical
implications of a possible link between obsessive-compulsive and impulse control
disorders. Depression 1993;1:121-132
16. McElroy SL, Phillips KA, Keck PE Jr, Hudson JI, Pope HG Jr. Body dysmorphic
disorder: does it have a psychotic subtype? Journal of Clinical Psychiatry 1993;54:389-
395
17. Phillips KA, McElroy SL. Insight, overvalued ideation, and delusional thinking in body
dysmorphic disorder: theoretical and treatment implications. Journal of Nervous and
Mental Disease 1993;181:699-702
18. Phillips KA. Troubles dysmorphiques du schéma corporel: le tourment de s'imaginer

laid (Body dysmorphic disorder: the torment of imagined ugliness). Médecine et Hygiène
1993;51:1934-1937
19. Phillips KA, Nierenberg AA. The assessment and treatment of refractory depression.
Journal of Clinical Psychiatry 1994;55(S):20-26
20. Phillips KA, Pope HG Jr, McElroy SL, Hudson JI, Keck PE Jr. Body dysmorphic
disorder: symptom or syndrome? (letter). American Journal of Psychiatry 1994;151:461
462
21. Phillips KA, Gunderson JG. Personality disorders. In: American Psychiatric Press
Textbook of Psychiatry, Second Edition. Hales RE, Yudofsky SC, Talbott JA, editors.
Washington, DC: American Psychiatric Press Inc, 1994
22. Phillips KA. Body dysmorphic disorder. In: DSM-IV Case Book. Spitzer RL, Gibbon M,
Skodol AE, Williams JBW, First MB, editors. Washington, DC: American Psychiatric
Press Inc, 1994
23. Gunderson JG, Phillips KA, Triebwasser JT, Hirschfeld RMA. The diagnostic interview
for depressive personality. American Journal of Psychiatry 1994;151:1300-1304
24. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. A comparison of
delusional and nondelusional body dysmorphic disorder in 100 cases.
Psychopharmacology Bulletin 1994;30:179-186
19
25. Suppes T, Phillips KA, Judd C. Clozapine treatment of nonpsychotic rapid-cycling

bipolar disorder: a report of three cases. Biological Psychiatry 1994;36:338-340
26. Kramlinger KG, Phillips KA, Post RM. Rash complicating carbamazepine treatment.
Journal of Clinical Psychopharmacology 1994;14:408-413
27. McElroy SL, Phillips KA, Keck PE Jr. Obsessive-compulsive spectrum disorders.
28. Phillips KA. Body dysmorphic disorder: clinical features and drug treatment. CNS Drugs
1995;3:30-40
29. Phillips KA, McElroy SL, Hudson JI, Pope HG Jr. Body dysmorphic disorder: an
obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both?
30. McElroy SL, Keck PE Jr, Phillips KA. Kleptomania, compulsive buying, and binge
eating disorder. Journal of Clinical Psychiatry 1995;56(S):14-26
31. Phillips KA, Hirschfeld RMA, Shea MT, Gunderson JG. Depressive personality
disorder: perspectives for DSM-IV. In: DSM-IV Personality Disorders. Livesley WJ,
editor. New York, NY: Guilford Publications, 1995
32. Gunderson JG, Phillips KA. Personality disorders. In: Comprehensive Textbook of
Psychiatry, Sixth Edition. Kaplan HI, Sadock BJ, editors. Baltimore, MD: Williams and
Wilkins, 1995
33. Phillips KA, Gunderson JG. Personality disorders. In: Core Readings in Psychiatry: An
Annotated Guide to the Literature, Second Edition. Sacks MH, Sledge WH, Warren C,
editors. Washington, DC: American Psychiatric Press Inc, 1995
34. Phillips KA, Kim JM, Hudson JI. Body image disturbance in body dysmorphic disorder
and eating disorders: obsessions or delusions? Psychiatric Clinics of North America
1995;18:317-334
35. Phillips KA, Atala KD, Albertini RS. Body dysmorphic disorder in adolescents. Journal
of the American Academy of Child and Adolescent Psychiatry 1995;34:1216-1220
36. Phillips KA, Taub SL. Skin picking as a symptom of body dysmorphic disorder.
37. Brawman-Mintzer O, Lydiard RB, Phillips KA, Morton A, Czepowicz V, Emmanuel N,

Villareal G, Johnson M, Ballenger JC. Body dysmorphic disorder in patients with anxiety
disorders and major depression: a comorbidity study. American Journal of Psychiatry
1995;152:1665-1667
38. Miguel EC, Coffey BJ, Shavitt RG, Biederman J, Baer L, Rauch S, O’Sullivan RJ,
Savage C, Phillips KA, Brotman A, Jenike M. Obsessive-compulsive spectrum
20
disorders in patients with obsessive-compulsive disorder and Tourette’s syndrome.

Psiquiatria Biologica 1995;3:9-15
39. Phillips KA, Hollander E. Body dysmorphic disorder. In: DSM-IV Sourcebook, Volume
2. Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW, editors.
Washington, DC: American Psychiatric Association, 1996
40. Phillips KA, Hirschfeld RMA, Shea MT, Gunderson J. Depressive personality disorder.
In: DSM-IV Sourcebook, Volume 2. Widiger TA, Frances AJ, Pincus HA, Ross R, First
MB, Davis WW, editors. Washington, DC: American Psychiatric Association, 1996
41. Phillips KA. Body dysmorphic disorder. In: DSM-IV Case Studies: A Clinical Guide to
Differential Diagnosis. Frances A, Ross R, editors. Washington, DC: American
Psychiatric Press Inc, 1996
42. Soriano JL, O'Sullivan RL, Baer L, Phillips KA, McNally RJ, Jenike MA. Trichotillomania
and self-esteem: a survey of 62 female hair pullers. Journal of Clinical Psychiatry
1996;57:77-82
43. Phillips KA, Gunderson JG. Personality disorders. In: Synopsis of Psychiatry. Hales
RE and Yudofsky SC, editors. Washington DC, American Psychiatric Press, 1996
44. Phillips KA, Nierenberg AA, Brendel G, Fava M. Prevalence and clinical features of
body dysmorphic disorder in atypical major depression. Journal of Nervous and Mental
Disease 1996;184:125-129
45. Phillips KA. An open study of buspirone augmentation of serotonin-reuptake inhibitors

in body dysmorphic disorder. Psychopharmacology Bulletin 1996;32:175-180
46. Phillips KA. Spectrum models (letter). Journal of Clinical Psychiatry 1996;57:311
47. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are
impulse control disorders related to bipolar disorder? Comprehensive Psychiatry
1996;37:229-240
48. Phillips KA, Hirschfeld RMA, Gunderson JG. Depressive personality disorder. In:
Psychiatry. Michels R, Oldham J, editors. Philadelphia, PA: JB Lippincott Co, 1996
49. Phillips KA. Body dysmorphic disorder: diagnosis and treatment of imagined ugliness.
50. Pato MT, Eisen JL, Phillips KA. Obsessive compulsive disorders. In: Psychiatry.
Tasman A, Kay J, Lieberman JA, editors. Philadelphia, PA: W.B. Saunders Co, 1996
51. Albertini R, Phillips KA, Guvremont D. Body dysmorphic disorder in a young child
(letter). Journal of the American Academy of Child and Adolescent Psychiatry
1996;35:1425-1426
21
52. Phillips KA. Pharmacologic treatment of body dysmorphic disorder.

53. Hirschfeld RMA, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J,
Froom J, Goldstein M, Gorman JM, Guthrie D, Marek RG, Maurer TA, Meyer R, Phillips
KA, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ. The National Depressive
and Manic-Depressive Association statement on the undertreatment of depression.
Journal of the American Medical Association 1997;277:333-340
54. Phillips KA, Atala KD, Albertini RA. Body dysmorphic disorder in adolescents.
Psychiatry Review Series, Issue 1, 1997
55. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A
severity rating scale for body dysmorphic disorder: development, reliability, and validity
of a modified version of the Yale-Brown Obsessive Compulsive Scale.
56. Phillips KA. Connection between obsessive compulsive disorder and body dysmorphic
disorder. In: Focus on Obsessive Compulsive Spectrum Disorders. den Boer JA,
Westenberg HGM, editors. Amsterdam, Netherlands: Synthesis, 1997
57. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, Phillips KA,
Moretti C, Leckman JF, Jenike MA. Phenomenological differences appearing with
repetitive behaviors in obsessive-compulsive disorder and Gilles de la Tourette's
syndrome. British Journal of Psychiatry 1997;170:140-145
58. Phillips KA, O’Sullivan RL, Pope HG Jr. “Muscle dysmorphia” (letter). Journal of Clinical
Psychiatry 1997;58:361
59. Phillips KA, Diaz S. Gender differences in body dysmorphic disorder. Journal of
Nervous and Mental Disease 1997;185:570-577
60. Vittorio CC, Phillips KA. Treatment of habit-tic deformity with fluoxetine. Archives of
Dermatology 1997;133:1203-1204
61. Pope HG Jr, Gruber AJ, Choi P, Olivardia R, Phillips KA. Muscle dysmorphia: an
underrecognized form of body dysmorphic disorder. Psychosomatics 1997;38:548-557
62. Phillips KA. Body dysmorphic disorder. In: OCD-Spectrum Disorders Casebook. Greist
J, Jefferson J, eds. Cocensys, Inc., 1997
63. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown
Assessment of Beliefs Scale: reliability and validity. American Journal of Psychiatry
1998;155:102-108
64. Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O’Sullivan RL, Savage CR,
Phillips KA, Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike M. Tourette’s
disorder with and without obsessive-compulsive disorder in adults: are they different?
Journal of Nervous and Mental Disease 1998;186:201-206
22
65. Lyoo IK, Gunderson JG, Phillips KA. Personality dimensions associated with
depressive personality disorder. Journal of Personality Disorders 1998;12:46-55
66. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body
dysmorphic disorder. Journal of Clinical Psychiatry 1998;59:165-171
67. Goldsmith T, Shapira NA, Phillips KA, McElroy SL. Conceptual foundations of
obsessive-compulsive spectrum disorders. In: Obsessive Compulsive Disorder: Theory,
Research, and Treatment. Swinson RP, Antony MM, Rachman S, Richter MA, editors.
New York, NY: Guilford Publications, 1998
68. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies. In:
Obsessive-Compulsive Disorders: Practical Management, Third Edition. Jenike MA,
Baer L, Minichiello WE, editors. Philadelphia, PA: Mosby-Yearbook Inc, 1998
69. Phillips KA, Gunderson JG, Triebwasser J, Kimble CR, Faedda G, Lyoo IK, Renn J.
Reliability and validity of depressive personality disorder. American Journal of Psychiatry
1998;155:1044-1048
70. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies.
Bulletin of the Menninger Clinic 1998;62:33-48
71. Phillips KA, Gunderson JG. Personality disorders. In: The American Psychiatric Press
Textbook of Psychiatry, Third Edition. Hales RE, Yudofsky SC, Talbott JA, editors.
72. Phillips KA, Gunderson JG. Personality disorders. In: Essentials of Clinical Psychiatry.
Hales RE, Yudofsky SC, editors. Washington, DC: American Psychiatric Press Inc, 1998
73. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of
body dysmorphic disorder and obsessive compulsive disorder. Journal of Clinical
Psychiatry 1998;59:568-575
74. DeMarco LM, Li LC, Phillips KA, McElroy SL. Perceived stress in body dysmorphic
disorder. Journal of Nervous and Mental Disease 1998;186:724-726
75. Albertini RS, Phillips KA. 33 cases of body dysmorphic disorder in children and
adolescents. Journal of the American Academy of Child and Adolescent Psychiatry
1999;38:453-459
76. Gunderson JG, Triebwasser J, Phillips KA, Sullivan CN. Personality and vulnerability to
affective disorders. In: Personality and Psychopathology. Cloninger CR, editor.
77. Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional
depression (letter). American Journal of Psychiatry 1999;156:977-978
23
78. Phillips KA, Gunderson JG. Depressive personality disorder: fact or fiction? Journal of
Personality Disorders 1999;13:128-134
79. O’Sullivan RL, Phillips KA, Keuthen NJ, Wilhelm S. Near fatal skin picking from
delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics
1999;40:79-81
80. Eisen JL, Phillips KA, Rasmussen SA. Obsessions and delusions: the relationship
between obsessive compulsive disorder and the psychotic disorders. Psychiatric Annals
1999;29:515-522
81. Phillips KA, Rasmussen SA, Price LH. Treating imagined ugliness (commentary).
Archives of General Psychiatry (now JAMA Psychiatry) 1999;56:1041-1042
82. Phillips KA. Body dysmorphic disorder and depression: theoretical considerations and
treatment strategies. Psychiatric Quarterly 1999;70:313-331
83. Phillips KA. Quality of life for patients with body dysmorphic disorder. Journal of
Nervous and Mental Disease 2000;188:170-175
84. Phillips KA. Body dysmorphic disorder: diagnostic controversies and treatment
challenges. Bulletin of the Menninger Clinic 2000;64:18-35
85. Phillips KA. Connection between obsessive compulsive disorder and body dysmorphic
disorder. In: Obsessive Compulsive Disorder: Contemporary Issues in Treatment.
Goodman WK, Rudorfer MV, Maser JD, editors. Mahwah, NJ: Lawrence Earlbaum &
Associates, 2000
86. Phillips KA, Dufresne RG Jr, Wilkel C, Vittorio C. Rate of body dysmorphic disorder in
dermatology patients. Journal of the American Academy of Dermatology 2000;42:436-
441
87. Phillips KA. Pharmacotherapy of body dysmorphic disorder: a review of empirical

evidence and a proposed treatment algorithm. Psychiatric Clinics of North America
2000;7:59-82
88. Phillips KA, Fallon B. Somatoform and factitious disorders and malingering measures.
In: Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Press,
Inc, 2000
89. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies. In:
Advances in Preclinical and Clinical Psychiatry. Sacchetti E, Spano P, editors. Milan,
Italy: Excerpta Medica, 2000
90. Phillips KA. The obsessive-compulsive spectrum: promises and pitfalls. In: Obsessive-
Compulsive Disorder. World Psychiatric Association Series: Evidence and Experience in
Psychiatry, Vol 4. Maj M, Sartorius N, Okasha A, Zohar J, editors. New York, NY: John
Wiley and Sons, 2000
24
91. Phillips KA, McElroy SL. Personality disorders and traits in patients with body
dysmorphic disorder. Comprehensive Psychiatry 2000;41:229-236
92. Phillips KA, Dufresne RG Jr. Body dysmorphic disorder: a guide for dermatologists and
cosmetic surgeons. American Journal of Clinical Dermatology 2000;1:235-243
93. Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlman U, Rauch SL, Baer L,
Jenike MA. Characteristics of memory dysfunction in body dysmorphic disorder. Journal
of the International Neuropsychological Society 2000;6:673- 681
94. Shea MT, Zlotnick C, Dolan R, Warshaw MG, Phillips KA, Brown P, Keller MB.
Personality disorders, history of trauma, and posttraumatic stress disorder in subjects
with anxiety disorders. Comprehensive Psychiatry 2000;41:315-325
95. Phillips KA. Body dysmorphic disorder. In: The New Oxford Textbook of Psychiatry.
Gelder MG, Lopez-Ibor JJ, Andreasen NC, editors. Oxford, England: Oxford University
Press, 2000
96. Dyck IR, Phillips KA, Warshaw MG, Dolan RT, Shea MT, Stout RL, Massion AO,
Zlotnick C, Keller MB. Patterns of personality pathology in patients with generalized
anxiety disorder, panic disorder with and without agoraphobia, and social phobia.
Journal of Personality Disorders 2001;15:60-71
97. Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Delusionality and
response to open-label fluvoxamine in body dysmorphic disorder. Journal of Clinical
Psychiatry 2001;62:87-91
98. Atiullah N, Phillips KA. Fatal body dysmorphic disorder by proxy (letter). Journal of
Clinical Psychiatry 2001;62:204-205
99. Phillips KA. Body dysmorphic disorder. In: Somatoform and Factitious Disorders
(Review of Psychiatry Series, Volume 20, Number 3; Oldham JM and Riba MB, series
editors). Phillips KA, ed. Washington DC: American Psychiatric Publishing, 2001
100. Phillips KA. Forward: The somatoform and factitious disorders. In: Somatoform and
Factitious Disorders (Review of Psychiatry Series, Volume 20, Number 3; Oldham JM
and Riba MB, series editors). Phillips KA, ed. Washington DC: American Psychiatric
Publishing, 2001
101. Phillips KA, Crino RD. Body dysmorphic disorder. Current Opinion in Psychiatry
2001;14:113-118
102. Phillips KA, Shea MT, Warshaw M, Dyck I, Bruce S, Keller M. The relationship between
comorbid personality disorders and treatment received in patients with anxiety disorders.
Journal of Personality Disorders 2001;15:157-167
103. Pope HG Jr, Olivardia R, Phillips KA. Reply to: Review of the Adonis Complex (letter).
New England Journal of Medicine 2001;344:1557-1558
25
104. Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS. A screening questionnaire for body
dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatologic Surgery
2001;27:457-462
105. Phillips KA, Albertini RS, Siniscalchi JM, Khan A, Robinson M. Effectiveness of
pharmacotherapy for body dysmorphic disorder: a chart-review study. Journal of Clinical
Psychiatry 2001;62:721-727
106. Phillips KA, Castle DJ. Somatoform disorders: a topic for education (letter). British
Journal of Psychiatry 2001;179:465-466
107. Phillips KA, Castle DJ. Body dysmorphic disorder in men. British Medical Journal
2001;323:1015-1016
108. Phillips KA. Body image and body dysmorphic disorder. In: Eating Disorders and
Obesity: A Comprehensive Handbook, Second Edition. Fairburn CG, Brownell KD,
editors. New York, NY: The Guilford Press, 2001
109. Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, Ninan P,
Piggott T. Insight and treatment outcome in obsessive-compulsive disorder.
Comprehensive Psychiatry 2001;42:494-497
110. Castle DJ, Phillips KA. Body dysmorphic disorder in men. Society for the Psychological
Study of Men and Masculinity Bulletin 2001;6:8-9
111. Phillips KA, Grant J, Siniscalchi J, Albertini RS. Surgical and nonpsychiatric medical
treatment of patients with body dysmorphic disorder. Psychosomatics 2001;42:504-510
112. Olivardia R, Phillips KA. Body dysmorphic disorder in men: facing the man in the mirror.
Primary Psychiatry 2001;8:32-36
113. Phillips KA, Dufresne RG Jr. Body dysmorphic disorder: a guide for primary care
physicians. Primary Care 2002;29:99-111
114. Phillips KA, Castle DJ. Body dysmorphic disorder. In: Disorders of Body Image. Castle
DJ, Phillips KA, editors. Hampshire, England: Wrightson Biomedical, 2002
115. Castle DJ, Phillips KA. Disordered body image in psychiatric disorders. In: Disorders of
Body Image. Castle DJ, Phillips KA, editors. Hampshire, England: Wrightson
Biomedical, 2002
116. Phillips KA. "I'm as ugly as the elephant man": how to recognize and treat body
dysmorphic disorder. Current Psychiatry 2002;1:58-65
117. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of
fluoxetine in body dysmorphic disorder. Archives of General Psychiatry (now JAMA
Psychiatry) 2002;59:381-388
26
118. Carroll DH, Scahill L, Phillips KA. Current concepts in body dysmorphic disorder.
Archives of Psychiatric Nursing 2002;16:72-79
119. Phillips KA. Body dysmorphic disorder. In: Women's Mental Health: A Comprehensive
Textbook. Kornstein SG, Clayton AH, editors. New York, NY: The Guildford Press, 2002
120. Massion AO, Dyck IR, Shea MT, Phillips KA, Warshaw MG, Keller MB. Personality
disorders and time to remission in generalized anxiety disorder, social phobia, and panic
disorder. Archives of General Psychiatry (now JAMA Psychiatry) 2002;59:434-440
121. Castle DJ, Honigman RJ, Phillips KA. Does cosmetic surgery improve psychosocial
wellbeing? Medical Journal of Australia 2002;17;601-604
122. Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow
JR, Rosenbaum JF, Fava M. Body dysmorphic disorder in outpatients with major
depression. Journal of Affective Disorders 2002;69:141-148
123. Phillips KA. Body image and body dysmorphic disorder. In: Body Image: A Handbook of
Theory, Research, and Clinical Practice. Cash TF, Pruzinsky T, editors. New York, NY:
The Guilford Press, 2002
124. Phillips KA. Body dysmorphic disorder. In: Women's Health and Psychiatry. Pearson
KH, Sonawalla SB, Rosenbaum JF, editors. Baltimore, MD: Lippincott Williams &
Wilkins, 2002
125. Phillips KA. Pharmacologic treatment of body dysmorphic disorder: review of the
evidence and a recommended treatment approach. CNS Spectrums 2002;7:453-460
126. Horowitz K, Gorfinkle K, Lewis O, Phillips KA. Body dysmorphic disorder in an

adolescent girl. Journal of the American Academy of Child and Adolescent Psychiatry
2002;41:1503-1509
127. Phillips KA. The obsessive compulsive spectrums. Psychiatric Clinics of North America
2002;25:791-809
128. Phillips KA, Yen S, Gunderson JG. Personality disorders. In: The American Psychiatric
Press Textbook of Psychiatry, Fourth Edition. Hales RE, Yudofsky SC, editors.
Washington, DC: American Psychiatric Publishing Inc, 2003
129. Phillips KA, Price LH, Greenberg BD, Rasmussen SA. Should DSM’s diagnostic
groupings be changed? In: Advancing DSM: Dilemmas in Psychiatric Diagnosis. Phillips
KA, First MB, Pincus H, editors. Washington DC: American Psychiatric Association,
2003
130. Rauch SL, Phillips KA, Segal E, Makris N, Shin LM, Whalen PJ, Jenike MA, Caviness
VS Jr, Kennedy DN. A preliminary morphometric magnetic resonance imaging study of
regional brain volumes in body dysmorphic disorder. Psychiatry Research:
Neuroimaging 2003;20:13-19
27
131. Grant JE, Phillips KA. Body dysmorphic disorder. McGraw-Hill Yearbook of Science
and Technology. New York, NY: McGraw-Hill, 2003
132. Shader RI, Phillips KA. Dissociative, somatoform, and paranoid disorders. In: Manual of
Psychiatric Therapeutics, Third Edition. Shader RI, editor. Philadelphia, PA: Lippincott
Williams & Wilkins, 2003
133. Pato MT, Eisen JL, Phillips KA. Obsessive compulsive disorders. In: Psychiatry.
Tasman A, Kay J, Lieberman JA, editors. Philadelphia, PA: W.B. Saunders Co, 2003
134. Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder.
Journal of Clinical Psychiatry 2003;64:715-720
135. Holt DJ, Phillips KA, Shapiro ER, Becker AE. “My face is my fate”: biological and
psychosocial approaches to the treatment of a woman with obsessions and delusions.
Harvard Review of Psychiatry 2003;11:142-154
136. Phillips KA, Dufresne RG. Body dysmorphic disorder. In: Psychocutaneous Medicine.
Koo JYM, Lee CS, editors. New York, NY: Marcel Dekker, Inc, 2003
137. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Comprehensive
Psychiatry 2003;44:270-276
138. Phillips KA, Yen S, Gunderson JG. Personality disorders. In: Essentials of Clinical
Psychiatry, Second Edition. Hales RE, Yudofsky SC, editors. Washington, DC: American
Psychiatric Press Inc, 2003
139. Grant JE, Phillips KA. Captive of the mirror: “I pick at my face all day, every day.”
Current Psychiatry 2003;2:45-52
140. Pato MT, Phillips KA. Biological, pharmacological, and somatic treatments for
obsessive-compulsive disorder. Brief Treatment and Crisis Intervention 2003;3:275-290
141. Eisen JL, Phillips KA, Coles ME, Rasmussen SA. Insight in obsessive compulsive
disorder and body dysmorphic disorder. Comprehensive Psychiatry 2004;45:10-15
142. Phillips KA. Psychosis in body dysmorphic disorder. Journal of Psychiatric Research
2004;38:63-72
143. Phillips KA. Body dysmorphic disorder: recognizing and treating imagined ugliness.
World Psychiatry 2004;3:12-17
144. Phillips KA, Crino RD. Body dysmorphic disorder. In: Treatment Companion to the
DSM-IV-TR Case Book. Spitzer RL, First MA, Gibbon M, Williams JBW, editors.
Washington, DC: American Psychiatric Publishing, Inc, 2004
145. Honigman RJ, Phillips KA, Castle DJ. A review of psychosocial outcomes for patients
seeking cosmetic surgery. Plastic and Reconstructive Surgery 2004;113:1229-1137
28
146. Grant JE, Phillips KA. Is anorexia nervosa a subtype of body dysmorphic disorder?
Harvard Review of Psychiatry 2004;12:123-126
147. Phillips KA, Menard W. Body dysmorphic disorder and art background (letter).
American Journal of Psychiatry 2004;161:927-928
148. Castle DJ, Molton M, Hoffman K, Preston NJ, Phillips KA. Correlates of dysmorphic
concern in people seeking cosmetic enhancement. Australia and New Zealand Journal
of Psychiatry 2004;38:439-444
149. Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life of
patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled
study. Psychosomatics 2004;45:438-444
150. Phillips KA, Siniscalchi JM, McElroy SL. Depression, anxiety, anger, and somatic
symptoms in patients with body dysmorphic disorder. Psychiatric Quarterly 2004;75;309-
320
151. Phillips KA, Pinto A, Jain S. Self-esteem in body dysmorphic disorder. Body Image: An
International Journal of Research 2004;1:385-390
152. Phillips KA. Treating body dysmorphic disorder with medication. Psychiatric Annals
2004;34:945-953
153. Cash TF, Phillips KA, Santos MT, Hrabosky JI. Measuring “negative body image”:
validation of the Body Image Disturbance Questionnaire in a nonclinical population.
Body Image: An International Journal of Research 2004;1:363-372
154. Castle DJ, Phillips KA, Dufresne RG Jr. Body dysmorphic disorder and cosmetic
dermatology: more than skin deep. Journal of Cosmetic Dermatology 2004;3:99-103
155. Phillips KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body

dysmorphic disorder. American Journal of Psychiatry 2005;162:377-379
156. Eide MJ, Weinstock MA, Dufresne RG, Neelagaru S, Risica P, Burkholder GJ, Upegui D,
Phillips KA, Armstrong BK, Robinson-Bostom L. Relationship of treatment delay with
surgical defect size from keratinocyte carcinoma (basal cell and squamous cell
carcinoma of the skin). Journal of Investigative Dermatology 2005;124:308-314
157. Grant JE, Menard W, Pagano ME, Fay C, Phillips KA. Substance use disorders in
individuals with body dysmorphic disorder. Journal of Clinical Psychiatry 2005;66:309-
311
158. Phillips KA. Olanzapine augmentation of fluoxetine in body dysmorphic disorder (letter).
159. Phillips KA. Clinical features and treatment of body dysmorphic disorder. Focus: The
Journal of Lifelong Learning in Psychiatry 2005;3:179-183
29
160. Phillips KA, Coles M, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and
suicide attempts in body dysmorphic disorder. Journal of Clinical Psychiatry
2005;66:717-725
161. Phillips KA, Menard W, Fay C, Pagano M. Psychosocial functioning and quality of life in
body dysmorphic disorder. Comprehensive Psychiatry 2005;46:254-260
162. Phillips KA, Grant JE, Siniscalchi JM, Stout R, Price LH. A retrospective follow-up study
of body dysmorphic disorder. Comprehensive Psychiatry 2005;46:315-321
163. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics,

phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic
disorder. Psychosomatics 2005;46:317-332
164. Phillips KA, Pagano ME, Menard W, Fay C, Stout RL. Predictors of remission from
body dysmorphic disorder: a prospective study. Journal of Nervous and Mental Disease
2005;193;564-567
165. Crerand C, Phillips KA, Menard W, Fay C. Non-psychiatric medical treatment of body
dysmorphic disorder. Psychosomatics 2005;46:549-555
166. Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of
muscle dysmorphia among males with body dysmorphic disorder. Body Image: An
167. Pinto A, Phillips KA. Social anxiety in body dysmorphic disorder. Body Image: An
168. Grant JE, Phillips KA. Recognizing and treating body dysmorphic disorder. Annals of
Clinical Psychiatry 2005;17:205-210
169. Phillips KA, Stout RL. Associations in the longitudinal course of body dysmorphic
disorder with major depression, obsessive compulsive disorder, and social phobia.
Journal of Psychiatric Research 2006;40:360-369
170. Coles ME, Phillips KA, Menard W, Pagano ME, Fay C, Weisberg RB, Stout RL. Body
dysmorphic disorder and social phobia: cross-sectional and prospective data.
Depression and Anxiety 2006;23:26-33
171. Phillips KA, Menard W, Pagano M, Fay C, Stout RL. Delusional versus nondelusional
body dysmorphic disorder: clinical features and course of illness. Journal of Psychiatric
Research 2006;40:95-104
172. Kaplan GB, Phillips KA, Vaccaro A, Eisen JL, Posternak MA, MacAskill HS.
Assessment of insight into delusional beliefs in schizophrenia using the Brown
Assessment of Beliefs Scale (letter). Schizophrenia Research 2006;82:279-281
30
173. Ruffulo JS, Phillips KA, Menard W, Fay C, Weisberg RB. Comorbidity of body
dysmorphic disorder and eating disorders: severity of psychopathology and body image
disturbance. International Journal of Eating Disorders 2006;39:11-19
174. Castle D, Phillips KA. The OCD spectrum of disorders: a defensible construct?
Australia and New Zealand Journal of Psychiatry 2006;40;114-120
175. Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals
with body dysmorphic disorder. Comprehensive Psychiatry 2006;47:77-87
176. Phillips KA. An open-label study of escitalopram in body dysmorphic disorder.

International Clinical Psychopharmacology 2006;21:177-179
177. Phillips KA, Didie ER, Menard W, Pagano ME, Fay C, Weisberg RB. Clinical features of
body dysmorphic disorder in adolescents and adults. Psychiatry Research
2006;141:305-314
178. Phillips KA, Pagano ME, Menard W, Stout RL. A 12-month follow-up study of the
course of body dysmorphic disorder. American Journal of Psychiatry 2006;163:907-912
179. Phillips KA. What physicians need to know about body dysmorphic disorder. Medicine
and Health Rhode Island 2006;89:175-177
180. Phillips KA. “I look like a monster”: pharmacotherapy and cognitive-behavioral therapy
for body dysmorphic disorder. In: DSM-IV-TR Case Book, Volume 2: Experts Tell How
They Treated Their Own Patients. Spitzer RL, First MB, Williams JBW, Gibbon M,
editors. Washington, DC: American Psychiatric Publishing, Inc, 2006
181. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study.
182. Phillips KA. Body dysmorphic disorder: clinical features and treatment of an
underrecognized somatoform disorder. In: Psychosomatic Medicine in the 21st Century.
Blumenfield M, Strain JJ, editors. Baltimore, MD: Lippincott, Williams and Wilkins, 2006
183. Dyl J, Kittler J, Phillips KA, Hunt JI. Body dysmorphic disorder and other clinically
significant body image concerns in adolescent psychiatric inpatients: prevalence and
clinical characteristics. Child Psychiatry and Human Development 2006;36:369-382
184. Phillips KA, Conroy M, Dufresne RG, Menard W, Didie ER, Hunter-Yates J, Fay C,
Pagano M. Tanning in body dysmorphic disorder. Psychiatric Quarterly 2006;77:129-38
185. Phillips KA. The presentation of body dysmorphic disorder in medical settings. Primary
Psychiatry 2006;13:51-59
186. Didie ER, Tortolani C, Walters M, Menard W, Fay C, Phillips KA. Social functioning in
body dysmorphic disorder: assessment considerations. Psychiatric Quarterly
2006;77:223-229
31
187. Didie ER, Tortolani CC, Pope CG, Menard W, Fay C, Phillips KA. Childhood abuse
and neglect in body dysmorphic disorder. Child Abuse and Neglect 2006;30:1105-1115
188. Phillips KA. Body dysmorphic disorder. In: American Society of Clinical
Psychopharmacology Model Psychopharmacology Curriculum (ASCP) for Training
Directors and Teachers of Psychopharmacology in Psychiatric Residency Programs, 4th
Edition. Glen Oaks, NY: ASCP, 2006
189. Phillips KA, Gunderson C, Gruber U, Castle DJ. Delusions of body malodour: the
olfactory reference syndrome. In: Olfaction and the Brain. Brewer W, Castle D, Pantelis
C, editors. Cambridge, England: Cambridge University Press, 2006
190. Grant JE, Menard W, Phillips KA. Pathological skin picking in individuals with body
dysmorphic disorder. General Hospital Psychiatry 2006;28:487-493
191. Phillips KA, Pagano ME, Menard W. Pharmacotherapy for body dysmorphic disorder:
treatment received and illness severity. Annals of Clinical Psychiatry 2006;18:251-257
192. Phillips KA, Pinto A, Menard W, Eisen JL, Mancebo M, Rasmussen SA. Obsessive-
compulsive disorder versus body dysmorphic disorder: a comparison study of two
possibly related disorders. Depression and Anxiety 2007;24:399-409
193. Phillips KA, Menard W, Didie E. Clinical features and correlates of major depressive
disorder in individuals with body dysmorphic disorder. Journal of Affective Disorders
2007;97:129-135
194. Kittler JE, Menard W, Phillips KA. Weight concerns in individuals with body dysmorphic
disorder. Eating Behavior 2007;8:115-120
195. Pagano ME, Phillips KA, Stout RL, Menard W, Piliavin JA. Impact of helping behaviors
on the course of substance use disorders in individuals with body dysmorphic disorder.
Journal of Studies on Alcohol and Drugs 2007;68:291-295
196. Didie ER, Phillips KA. Mortality among Canadian women with cosmetic breast implants
(letter). American Journal of Epidemiology 2007;165:846
197. Phillips KA, Castle DJ. How to help patients with olfactory reference syndrome.
Current Psychiatry 2007;6:49-65 (reprinted in The Journal of Family Practice)
198. Phillips KA. Introduction: Somatoform and Factitious Disorders. In: Treatments of DSM-
IV-TR Psychiatric Disorders. Gabbard G, editor. Washington, DC: American Psychiatric
Publishing, Inc, 2007
199. Phillips KA. Body dysmorphic disorder. In: Treatments of DSM-IV-TR Psychiatric
Disorders. Gabbard G, editor. Washington, DC: American Psychiatric Publishing, Inc,
2007
200. Hunter-Yates J, Dufresne RG, Phillips KA. Tanning in body dysmorphic disorder.
Journal of the American Academy of Dermatology 2007;56:S107-109
32
201. Phillips KA, Kaye W. The relationship of body dysmorphic disorder and eating
disorders to obsessive compulsive disorder. CNS Spectrums 2007;12:347-358
202. Phillips KA, First MB. Sex/Gender: introduction. In: Age and Gender Considerations in
Psychiatric Diagnosis: A Research Agenda for DSM-V. Narrow WE, First MB, Sirovatka
PJ, Regier DA, editors. Washington, DC: American Psychiatric Association, 2007
203. Phillips KA, First MB. Sex/Gender: concluding thoughts. In: Age and Gender
Considerations in Psychiatric Diagnosis: A Research Agenda for DSM-V. Narrow WE,
First MB, Sirovatka PJ, Regier DA, editors. Washington, DC: American Psychiatric
Association, 2007
204. Didie ER, Walters MM, Pinto A, Menard W, Eisen JL, Mancebo M, Rasmussen SA,
Phillips KA. Comparison of quality of life and psychosocial functioning in obsessive-
compulsive disorder and body dysmorphic disorder. Annals of Clinical Psychiatry
2007;19:181-186
205. Phillips KA, Fallon BA, King S. Somatoform and factitious disorders and malingering
measures. In: Handbook of Psychiatric Measures, Second Edition. Rush AJ, First MB,
Blacker D, editors. Washington, DC: American Psychiatric Publishing, Inc, 2007
206. Phillips KA. Suicidality in body dysmorphic disorder. Primary Psychiatry 2007;14:58-66
207. Conroy M, Menard W, Fleming-Ives K, Modha P, Cerullo H, Phillips KA. Prevalence

and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.
General Hospital Psychiatry 2008;30:67-72
208. Phillips KA, Hollander E. Treating body dysmorphic disorder with medication:
evidence, misconceptions, and a suggested approach. Body Image: An International
Journal of Research 2008;5:13-27
209. Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a
prospective, follow-up study. Journal of Psychiatric Research 2008;42:701-707
210. Hales RE, McDuffie JJ, Gabbard GO, Phillips K, Oldham J, Stewart DE. Practical
strategies for becoming a successful medical book author. Academic Psychiatry
2008;32:183-187
211. Pato MT, Fanous A, Eisen JL, Phillips KA. Obsessive-compulsive disorder. In:
Psychiatry, Third Edition. Tasman A, Maj M, First MB, Kay J, Lieberman JA, editors.
Hoboken, NJ: John Wiley & Sons, Ltd., 2008
212. Phillips KA, Didie ER, Feusner J, Wilhelm S. Body dysmorphic disorder: treating an
underrecognized disorder. American Journal of Psychiatry 2008;165:1111-1118
213. Didie ER, Menard W, Stern AP, Phillips KA. Occupational functioning and impairment
in adults with body dysmorphic disorder. Comprehensive Psychiatry 2008;49:561-569
33
Psychopharmacology Model Psychopharmacology Curriculum (ASCP) for Training
Directors and Teachers of Psychopharmacology in Psychiatric Residency Programs,
Fifth Edition. Glen Oaks, NY: ASCP, 2008
215. Phillips KA, Kelly MM. Suicidality in a placebo-controlled fluoxetine study of body
dysmorphic disorder. International Clinical Psychopharmacology 2009;24:26-28
216. Phillips KA. Body dysmorphic disorder. In: The New Oxford Textbook of Psychiatry, 2nd
Edition. Gelder M, Andreasen N, Lopez-Ibor J, Geddes J, editors. Oxford, England:
Oxford University Press, 2009
217. Phillips KA, Menard W. A prospective pilot study of levetiracetam for body dysmorphic
disorder. CNS Spectrums 2009;14:252-260
218. Hrabosky JI, Cash TF, Veale D, Neziroglu F, Soll EA, Garner DM, Strachan-Kinser M,
Bakke B, Clauss LJ, Phillips KA. Multidimensional body image comparisons among
patients with eating disorders, body dysmorphic disorder, and clinical controls: a
multisite study. Body Image: An International Journal of Research 2009;6:155-163
219. Sherrill JT, Sommers DI, Nierenberg AA, Leon AC, Arndt S, Bandeen-Roche K,
Greenhouse J, Guthrie D, Normand SL, Phillips KA, Shear MK, Woolson R. Integrating
statistical and clinical research elements in intervention-related grant
applications: summary from an NIMH workshop. Academic Psychiatry 2009;33:221-228
220. Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA.
Obsessive-compulsive disorder: diagnostic and treatment issues. Psychiatric Clinics of
North America 2009;32:665-685
221. Feusner J, Hembacher E, Phillips KA. The mouse who couldn’t stop washing:
pathologic grooming in animals and humans. CNS Spectrums 2009;14:503-513
222. Didie ER, Kuniega-Pietrzac T, Phillips KA. Body image in patients with body
dysmorphic disorder: evaluations of and investment in appearance, health/illness, and
fitness. Body Image: An International Journal of Research 2010;7:66-69
223. Phillips KA, Friedman MJ, Stein DJ, Craske M. Special DSM-V issues on anxiety,
obsessive-compulsive spectrum, posttraumatic, and dissociative disorders (Editorial).
224. Kelly MM, Walters C, Phillips KA. Social anxiety and its relationship to functional
impairment in body dysmorphic disorder. Behavior Therapy 2010;41:143-153
225. Christopher PP, Boland RJ, Recupero PR, Phillips KA. Psychiatry residents’
experience conducting disability evaluations. Academic Psychiatry 2010;34:211-215
226. Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC,
Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a
34
review of the diagnostic criteria and possible subtypes and dimensional specifiers for
DSM-V. Depression and Anxiety 2010:27;507-527
227. Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, Leckman JF,
Rauch SL, Phillips KA. Should OCD be classified as an anxiety disorder in DSM-V?
228. Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-
Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ,
Farrow J, Leckman J. Should an obsessive-compulsive spectrum grouping of disorders
be included in DSM-V? Depression and Anxiety 2010;27:528-555
229. Feusner JD, Phillips KA, Stein DJ. Olfactory reference syndrome: Issues for DSM-V.
230. Phillips KA, Wilhelm S, Koran LM, Didie ER, Fallon BA, Feusner J, Stein DJ. Body
dysmorphic disorder: Some key issues for DSM-V. Depression and Anxiety
2010;27:573-591
231. Didie ER, Reinecke MA, Phillips KA. Case conceptualization and treatment of comorbid
body dysmorphic disorder and bulimia nervosa. Cognitive and Behavioral Practice
2010;17:259-269
232. Phillips KA, Kaye W. The relationship of body dysmorphic disorder and eating disorders
to obsessive compulsive disorder. In: Obsessive Compulsive Spectrum Disorders:
Refining the Research Agenda for DSM-V. Hollander E, Zohar J, Sirovatka PJ, Regier
DA, editors. Washington, DC: American Psychiatric Publishing, 2010
233. Crerand C, Menard W, Phillips KA. Surgical and minimally invasive cosmetic
procedures among persons with body dysmorphic disorder. Annals of Plastic Surgery
2010;65:11-16
234. Bjornsson AS, Didie ER, Phillips KA. Body dysmorphic disorder. Dialogues in Clinical
Neuroscience 2010;12:221-232
235. Stein DJ, Phillips KA, Bolton D, Fulford KW, Sadler JZ, Kendler KS. What is a
mental/psychiatric disorder? From DSM-IV to DSM-V. Psychological Medicine
2010;40:1759-1765
236. Stein DJ, Phillips KA, Bolton D, Fulford KW, Sadler JZ, Kendler KS. Response to the
commentaries on “What is a mental/psychiatric disorder?” (Letter to the Editor)
Psychological Medicine 2010;40:1931-1934
237. Phillips KA. Body dysmorphic disorder (Guest Editor Editorial). Psychiatric Annals
2010;40:306-307
238. Didie ER, Kelly MM, Phillips KA. Clinical features of body dysmorphic disorder.
Psychiatric Annals 2010;40:310-316
35
239. Phillips KA, Feusner JD. Assessment and differential diagnosis of body dysmorphic
disorder. Psychiatric Annals 2010;40:317-324
240. Phillips KA. Pharmacotherapy for body dysmorphic disorder. Psychiatric Annals
2010;40:325-332
Psychopharmacology Model Psychopharmacology Curriculum for Training Directors and
Teachers of Psychopharmacology in Psychiatric Residency Programs. Glick ID, Balon
R, Zisook S et al, editors. Glen Oaks, NY: American Society of Clinical
Psychopharmacology, 2010
242. Bjornsson AS, Dyck I, Moitra E, Stout RL, Weisberg R, Keller MB, Phillips KA. The
clinical course of body dysmorphic disorder in the Harvard/Brown Anxiety Research
Project (HARP). Journal of Nervous and Mental Disease 2011;199:55-57
243. Phillips KA. Body dysmorphic disorder. In: Clinical Obsessive-Compulsive Disorders in
Adults and Children. Hudak R and Dougherty DD, editors. New York, NY: Cambridge
University Press, 2011
244. Phillips KA, Rogers J. Cognitive-behavioral therapy for youth with body dysmorphic
disorder: current status and future directions. Child and Adolescent Psychiatric Clinics of
North America 2011;20:287-304
245. Black DW, Pfohl B, Blum N, McCormick B, Allen J, North C, Phillips KA, Robins C,
Siever L, Silk K, Williams JB, Zimmerman M. Attitudes toward borderline personality
disorder: a survey of 706 mental health clinicians. CNS Spectrums 2011;16:67-74
246. Stein DJ, Craske MG, Friedman MJ, Phillips KA. Meta-structure issues for the DSM-5:
How do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic
disorders, and dissociative disorders fit together? Current Psychiatry Reports
2011;13:248-250
247. Phillips KA. Body image and body dysmorphic disorder. In: Body Image: A Handbook
of Science, Practice, and Prevention, Second Edition. Cash TF and Smolak L, editors.
New York, NY: Guilford Publications, 2011
248. Phillips KA, Menard W. Olfactory reference syndrome: demographic and clinical
features of imagined body odor. General Hospital Psychiatry 2011;33:398-406
249. Kelly MM, Phillips KA. Phenomenology and epidemiology of body dysmorphic disorder.
In: The Oxford Handbook of Obsessive Compulsive and Spectrum Disorders. Steketee
G, editor. New York, NY: Oxford University Press, 2011
250. Wilhelm S, Phillips KA, Fama JM, Greenberg JL, Steketee G. Modular cognitive-
behavioral therapy for body dysmorphic disorder. Behavior Therapy 2011;42:624-633
36
251. Weingarden H, Marques L, Fang A, LeBlanc N, Buhlmann U, Phillips KA, Wilhelm S.

Culturally adapted cognitive-behavioral therapy for body dysmorphic disorder (BDD):
Case examples. International Journal of Cognitive Therapy 2011;4:381-396
252. Phillips KA. Body dysmorphic disorder. In: Ferri’s Clinical Advisor 2012. Ferri FF,
editor. Philadelphia, PA: Elsevier, 2012
253. Phillips KA. Body dysmorphic disorder. In: Encyclopedia of Body Image and Human
Appearance. Cash TF, editor. San Diego, CA: Academic Press, 2012
Teachers of Psychopharmacology in Psychiatric Residency Programs, Seventh Edition.
Brentwood, TN: ASCP, 2012
255. Dide ER, Loerke EH, Howes SE, Phillips KA. Severity of interpersonal problems in
individuals with body dysmorphic disorder. Journal of Personality Disorders
2012;26:345-356
256. Witte TK, Didie ER, Menard W, Phillips KA. The relationship between body dysmorphic
disorder behaviors and the acquired capability for suicide. Suicide and Life-Threatening
Behavior 2012;42:318-331
257. Phillips KA, Pinto A, Hart AS, Coles ME, Eisen JL, Menard W, Rasmussen SA. A
comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.
Journal of Psychiatric Research 2012;46:1293-1299
259. Phillips KA, Menard W, Quinn E, Didie ER, Stout RL. A four-year prospective
observational follow-up study of course and predictors of course in body dysmorphic
disorder. Psychological Medicine 2013;43:1109-1117
260. Kelly MM, Dalrymple K, Zimmerman M, Phillips KA. A comparison study of body
dysmorphic disorder versus social phobia. Psychiatry Research 2013;205:109-116
261. LeBeau RT, Mischel E, Simpson HB, Mataix-Cols D, Phillips KA, Stein DJ, Craske MG.
Preliminary assessment of obsessive-compulsive spectrum disorder scales for DSM-
5. Journal of Obsessive-Compulsive and Related Disorders 2013;2:114-118
262. Hart AS, Phillips KA. Symmetry concerns as a symptom of body dysmorphic disorder.
Journal of Obsessive-Compulsive and Related Disorders 2013;2:292-298
263. Bjornsson AS, Didie ER, Grant JE, Menard W, Stalker E, Phillips KA. Age at onset and
clinical correlates in body dysmorphic disorder. Comprehensive Psychiatry 2013;54:893-
903
264. Phillips KA, Menard W, Bjornsson AS. Cued panic attacks in body dysmorphic
37
disorder. Journal of Psychiatric Practice 2013;19:194-203
265. Stein DJ, Phillips KA. Patient advocacy and DSM-5. BMC Medicine 2013;11:133
267. Phillips KA, Hart A, Menard W, Eisen JL. Psychometric evaluation of the Brown
Assessment of Beliefs Scale in body dysmorphic disorder. Journal of Nervous and
268. Phillips KA. Appearance preoccupations (a case of body dysmorphic disorder). In:
DSM-5 Clinical Cases. Barnhill J, editor. Arlington, VA: American Psychiatric Publishing,
2013
269. Stein DJ, Simpson HB, Phillips KA. Germs (a case of obsessive-compulsive disorder).
In: DSM-5 Clinical Cases. Barnhill J, editor. Arlington, VA: American Psychiatric
Publishing, 2013
270. Phillips KA, Hart AS, Simpson HB, Stein DJ. Delusional versus nondelusional body
dysmorphic disorder: recommendations for DSM-5. CNS Spectrums 2014;19:10-20
271. Bjornsson AS, Phillips KA. Do obsessions and compulsions play a role in social anxiety
disorder? Harvard Review of Psychiatry 2014;22:55-58
272. Wilhelm S, Phillips KA, Didie E, Buhlmann U, Greenberg JL, Fama JM, Keshaviah A,
Steketee G. Modular cognitive-behavioral therapy for body dysmorphic disorder: a
randomized controlled trial. Behavior Therapy 2014:45:314-327
273. Phillips KA, Hart AS, Menard W. Psychometric evaluation of the Yale-Brown
Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS).
Journal of Obsessive-Compulsive and Related Disorders 2014;3:205-208
274. Phillips KA. Body dysmorphic disorder. In: Gabbard’s Treatment of Psychiatric
Disorders. Gabbard G, editor. Arlington, VA: American Psychiatric Publishing, 2014
275. Stein DJ, Craske MA, Friedman MJ, Phillips KA. Anxiety disorders, obsessive-
compulsive and related disorders, trauma- and stressor-related disorders, and
dissociative disorders in DSM-5. American Journal of Psychiatry 2014;171:611-613
276. Phillips KA. Body dysmorphic disorder. In: Ferri’s Clinical Advisor 2015. Ferri FF, editor.
Philadelphia, PA: Elsevier, 2014
277. Kelly MM, Didie ER, Phillips KA. Personal- and appearance-based rejection sensitivity
in body dysmorphic disorder. Body Image: An International Journal of Research
2014;11:260–265
38
278. Crerand CE, Phillips KA. Reply to: Patients with mild to moderate body dysmorphic
disorder may benefit from rhinoplasty (Letter to the Editor). Journal of Plastic,
Reconstructive & Aesthetic Surgery 2014;67:646-654
279. Phillips KA. Body dysmorphic disorder: Common, severe, and in need of treatment
research (Invited Editorial). Psychotherapy and Psychosomatics 2014;83:325-329
280. Stein DJ, Phillips KA. Pros and cons of the new DSM-5 chapter of obsessive-
compulsive and related disorders. Current Psychiatry Reviews 2014;10:325-329
281. Phillips KA. Obsessive-compulsive and related disorders: Introduction. In: Psychiatry.
Tasman A, Lieberman J, Kay J, First M, Riba M, editors. Hoboken, NJ: Wiley-Blackwell,
2015
282. Pato MT, Steketee G, Eisen JL, Yip AG, Phillips KA. Obsessive-compulsive disorder
and hoarding. In: Psychiatry. Tasman A, Lieberman J, Kay J, First M, Riba M, editors.
Hoboken, NJ: Wiley-Blackwell, 2015
283. Phillips KA, Stein DJ. Body dysmorphic disorder, trichotillomania (hair-pulling disorder),
and excoriation (skin-picking) disorder. In: Psychiatry. Tasman A, Lieberman J, Kay J,
First M, Riba M, editors. Hoboken, NJ: Wiley-Blackwell, 2015
284. Fineberg NA, Reghunandanan S, Simpson HB, Phillips KA, Richter MA, Matthews K,
Stein DJ, Sareen J, Brown A, Sookman D. Obsessive compulsive disorder (OCD):
Practical strategies for pharmacological and somatic treatment in adults. Psychiatry
Research 2015;227:114-125
Teachers of Psychopharmacology in Psychiatric Residency Programs, Eighth Edition.
286. Phillips KA. Body dysmorphic disorder: Clinical aspects and relationship to OCD.
Focus: The Journal of Lifelong Learning in Psychiatry 2015;13:162-174
287. Kelly MM, Zhang J, Phillips KA. The prevalence of body dysmorphic disorder and its
clinical correlates in a VA primary care behavioral health clinic. Psychiatry Research
2015:228:162-165
288. Phillips KA, Stein DJ. Introduction and major changes for the obsessive-compulsive
and related disorders in DSM-5. In: Handbook on Obsessive-Compulsive and Related
Disorders. Phillips KA, Stein DJ, editors. Arlington, VA: American Psychiatric
Publishing, 2015
289. Phillips KA. Body dysmorphic disorder. In: Handbook on Obsessive-Compulsive and
Related Disorders. Phillips KA, Stein DJ, editors. Arlington, VA: American Psychiatric
Publishing, 2015
39
290. Phillips KA, Stein DJ. Other obsessive-compulsive and related disorders in DSM-5. In:
Handbook on Obsessive-Compulsive and Related Disorders. Phillips KA, Stein DJ,
editors. Arlington, VA: American Psychiatric Publishing, 2015
291. Stein DJ, Phillips KA. Conclusions. In: Handbook on Obsessive-Compulsive and
Related Disorders. Phillips KA, Stein DJ, editors. Arlington, VA: American Psychiatric
Publishing, 2015
293. Phillips KA, Zai G, King NA, Menard W, Kennedy JL, Richter MA. A preliminary
candidate gene study in body dysmorphic disorder. Journal of Obsessive-Compulsive
and Related Disorders 2015:6:72-76
Psychopharmacology Model Psychopharmacology Curriculum, for Training Directors
and Teachers of Psychopharmacology in Psychiatric Residency Programs, 9th Edition.
296. Phillips KA, Keshaviah A, Dougherty DD, Stout RL, Menard W, Wilhelm S.
Pharmacotherapy relapse prevention in body dysmorphic disorder: A double-blind
placebo-controlled trial. American Journal of Psychiatry 2016;173:887-895
297. Phillips KA. Foreword. In: Reflections on Body Dysmorphic Disorder: Stories of
Courage, Determination, and Hope. Schnackenberg N and Petro S, editors. London,
England: The Body Dysmorphic Disorder Foundation, 2016
298. Kelly M, Simmons R, Wang S, Kraus S, Donahue J, Phillips KA. Motives to drink
alcohol among individuals with body dysmorphic disorder. Journal of Obsessive-
Compulsive and Related Disorders 2017;12:52-57
299. Phillips KA, Crerand CE. Psychological evaluation and body dysmorphic disorder. In:
Orthognathic Surgery: Principles, Planning and Practice. Naini FB and Gill DS, editors.
Oxford, England: Wiley-Blackwell, 2017
300. Phillips KA. Body dysmorphic disorder. In: Eating Disorders and Obesity: A
Comprehensive Handbook, 3rd Edition. Brownell KD, Walsh BT, editors. New York, NY:
Guilford Press, 2017
302. Philips KA. Introduction. In: Body Dysmorphic Disorder: Advances in Research and
Clinical Practice. Phillips KA, editor. New York, NY: Oxford University Press, 2017
40
303. Phillips KA, Simmons R, Donahue J. Three patients with body dysmorphic disorder:
cases and commentary. In: Body Dysmorphic Disorder: Advances in Research and
304. Phillips KA. Classification of body dysmorphic disorder and relevance for patient care.
In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice. Phillips
KA, editor. New York, NY: Oxford University Press, 2017
305. Simmons R, Phillips KA. Core clinical features of body dysmorphic disorder:
appearance preoccupations, negative emotions, core beliefs, and repetitive and
avoidance behaviors. In: Body Dysmorphic Disorder: Advances in Research and Clinical
Practice. Phillips KA, editor. New York, NY: Oxford University Press, 2017
306. Phillips KA. Insight and delusional beliefs in body dysmorphic disorder. In: Body
Dysmorphic Disorder: Research and Clinical Advances. Phillips KA, editor. New York,
NY: Oxford University Press, 2017
307. Phillips KA. Suicidality and aggressive behavior in body dysmorphic disorder. In: Body
Dysmorphic Disorder: Advances in Research and Clinical Practice. Phillips KA, editor.
New York, NY: Oxford University Press, 2017
308. Phillips KA. Body dysmorphic disorder in children and adolescents. In: Body
309. Phillips KA. Assessment of body dysmorphic disorder: screening, diagnosis, severity,
and insight. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice.
Phillips KA, editor. New York, NY: Oxford University Press, 2017
310. Phillips KA. Differentiating body dysmorphic disorder from normal appearance concerns
and other mental disorders. In: Body Dysmorphic Disorder: Advances in Research and
311. Veale D, Phillips KA, Neziroglu F. Challenges in assessing and treating patients with
body dysmorphic disorder and recommended approaches. In: Body Dysmorphic
Disorder: Advances in Research and Clinical Practice. Phillips KA, editor. New York,
312. Phillips KA. Pharmacotherapy and other somatic treatments for body dysmorphic
disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice.
Phillips KA, editor. New York, NY: Oxford University Press, 2017
313. Phillips KA, Simmons R. Treating a patient with body dysmorphic disorder using
medication and cognitive-behavioral therapy: an illustrative case example. In: Body
41
314. Phillips KA. Appendix: Measures and resources. In: Body Dysmorphic Disorder:
Advances in Research and Clinical Practice. Phillips KA, editor. New York, NY: Oxford
University Press, 2017
315. Phillips KA. New insights on the treatment of hypochondriasis (invited editorial).
316. Phillips KA. The obsessive-compulsive and related disorders: A new category in DSM-
5. In: Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and
Treatment. Pittenger C, editor. New York, NY: Oxford University Press, 2017
317. Kelly MM, Phillips KA. Update on body dysmorphic disorder: clinical features,
epidemiology, pathogenesis, assessment, and treatment. Psychiatric Annals
2017;47:552-558
318. Weingarden H, Shaw AM, Phillips KA, Wilhelm S. Shame and defectiveness beliefs in
treatment-seeking patients with body dysmorphic disorder. Journal of Nervous and
320. Phillips KA, Citrome L. Inaccurate prescribing warnings in electronic medical record
systems: results from an American Society of Clinical Psychopharmacology membership
survey. Journal of Clinical Psychiatry 2019;80:18ac12536
321. Phillips KA. Body dysmorphic disorder. In: Approach to the Psychiatric Patient: Case-
Based Essays, Second Edition. Barnhill JW, editor. Washington, DC: American
Psychiatric Association Publishing, 2019
322. Wilhelm S, Phillips KA, Greenberg JL, O’Keefe SM, Hoeppner SS, Keshaviah A,
Sarvode-Mothi S, Schoenfeld DA. Efficacy and posttreatment effects of therapist-
delivered cognitive behavioral therapy vs supportive psychotherapy for adults with body
dysmorphic disorder: A randomized clinical trial. JAMA Psychiatry epub February 20,
2019. doi:10.1001/jamapsychiatry.2018.4156
323. Phillips KA. Body dysmorphic disorder. American Society of Clinical

Psychopharmacology Model Psychopharmacology Curriculum, for Training Directors
and Teachers of Psychopharmacology in Psychiatric Residency Programs,
10th Edition. Brentwood, TN: ASCP, in press
324. Kelly MM, Phillips KA. Body dysmorphic disorder. In: The New Oxford Textbook of
Psychiatry, 3rd Edition. Geddes JR, Andreasen NC, Goodwin GM, editors. Oxford, UK:
Oxford University Press, in press
editor. Philadelphia, PA: Elsevier, in press
326. Greenberg JL, Phillips KA, Steketee G, Hoeppner SS, Wilhelm S. Predictors of
42
response to cognitive-behavioral therapy for body dysmorphic disorder. Behavior

Therapy, in press
327. Fang A, Porth R, Phillips KA, Wilhelm S. Personality as a predictor of treatment

response to escitalopram in adults with body dysmorphic disorder. Journal of Psychiatric
Practice, in press
328. Kelly MM, Houchins J, Phillips KA. Motives for illicit drug use among individuals with
body dysmorphic disorder. Journal of Psychiatric Practice, in press
BOOKS
1. Phillips KA. The Broken Mirror: Understanding and Treating Body Dysmorphic
Disorder. New York, NY: Oxford University Press, 1996
(Japanese Edition): Phillips KA. The Broken Mirror: Understanding and Treating Body
Dysmorphic Disorder. Tokyo, Japan: Kongo Shuppan Co., Ltd., 1999
2. Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex: The Secret Crisis of Male
Body Obsession. New York, New York: The Free Press, 2000 (Paperback edition: The
Adonis Complex: How to Identify, Treat, and Prevent Body Obsession in Men and Boys.
New York, NY: The Free Press, 2002)
(Portuguese Edition): Pope HG Jr, Phillips KA, Olivardia R. O Complexo de Adônis; A

Obsessão Masculina Pelo Corpo. Trans. Teixeira SA. Rio de Janeiro, Brazil: Editora
Campus Ltda., 2000
(German Edition): Pope HG Jr, Phillips KA, Olivardia R. Der Adonis-Komplex:

Schönheitswahn und Körperkult bei Männern. Münich, Germany: Deutscher
Taschenbuch Verlag GmbH & Co., 2000
(Greek Edition): Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex: The Secret
Crisis of Male Body Obsession. Athens, Greece: Editions Thymari, 2001
(Chinese Edition): Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex: The
Secret Crisis of Male Body Obsession. Taipei, Taiwan: Cité Publishing, 2001
(Latin American Edition): Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex:
The Secret Crisis of Male Body Obsession. Oceano, 2002
(Chinese Edition): Pope HG Jr, Phillips KA, Olivardia R. The Adonis Complex: The
Secret Crisis of Male Body Obsession. Chongqing, China: Chongqing Publishing House,
2005
3. Phillips KA (editor). Somatoform and Factitious Disorders (Review of Psychiatry Series,

Volume 20, Number 3; Oldham JM and Riba MB, series editors). Washington DC:
American Psychiatric Publishing, Inc, 2001
43
4. Castle DJ, Phillips KA (editors). Disorders of Body Image. London, England: Wrightson
Biomedical Publishing LTD, 2002
5. Phillips KA, First MB, Pincus HA (editors). Advancing DSM: Dilemmas in Psychiatric
Diagnosis. Washington DC: American Psychiatric Publishing Inc, 2003
(Spanish Edition): Phillips KA, First MB, Pincus HA (editors). Advancing DSM:
Dilemmas in Psychiatric Diagnosis. Washington DC: American Psychiatric Publishing
Inc, 2005
6. Phillips KA. The Broken Mirror: Understanding and Treating Body Dysmorphic
Disorder. Revised and Expanded Edition. New York, NY: Oxford University Press, 2005
(Chinese Edition): Phillips KA. The Broken Mirror: Understanding and Treating Body
Dysmorphic Disorder. Beijing, China: Beijing World Publishing Corp., 2018
7. Section Editor, Somatoform and factitious disorders. Gabbard’s Treatments of

Psychiatric Disorders, Fourth Edition. Washington DC: American Psychiatric Publishing
Inc, 2007
8. Associate Editor, Handbook of Psychiatric Measures. Washington DC: American

Psychiatric Publishing Inc, 2008
9. Phillips KA. Understanding Body Dysmorphic Disorder: An Essential Guide. New York,
(Chinese edition): Phillips KA. Understanding Body Dysmorphic Disorder: An Essential

Guide. Beijing, China: Posts and Telecommunications Press of Beijing, in press
10. Shahrokh NC, Hales RE, Phillips KA, Yudofsky SC. The Language of Mental Health: A
Glossary of Psychiatric Terms. Washington, DC: American Psychiatric Publishing Inc,
2011
(French Edition): Shahrokh NC, Hales RE, Phillips KA, Yudofsky SC. Dictionnaire de
Psychiatrie. Paris, France: Elsevier Masson, 2014
11. Wilhelm S, Phillips KA, Steketee G. Cognitive-Behavioral Therapy for Body Dysmorphic
Disorder: A Treatment Manual. New York, NY: Guilford Press, 2013
12. Phillips KA, Stein DJ (editors). Handbook on Obsessive-Compulsive and Related

Disorders. Arlington, VA: American Psychiatric Publishing, 2015
13. Phillips KA (editor). Body Dysmorphic Disorder: Advances in Research and Clinical
Practice. New York, NY: Oxford University Press, 2017
OTHER PUBLICATIONS
44
1. Phillips KA. What is body dysmorphic disorder? Harvard Mental Health Letter, March
1992
2. Phillips KA. Body dysmorphic disorder. In: Encyclopedia Britannica. McHenry R, ed.
Chicago, IL: Encyclopedia Britannica, Inc., 1992
3. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Treatment
Centers, December 1992
4. Phillips KA. Body dysmorphic disorder: the "ugliness problem." OCD Newsletter
1993;7:1-3
5. Phillips KA. Is body dysmorphic disorder a variant of obsessive compulsive disorder?

Masters in Psychiatry, 1994
6. Phillips KA. Body dysmorphic disorder: recognizing and treating imagined ugliness.
Psychiatric Times, November 1996
7. Phillips KA, Van Noppen B, Shapiro L. Learning to Live with Body Dysmorphic
Disorder. Milford, CT: Obsessive-Compulsive Foundation, 1997
8. Phillips KA. The broken mirror: recognizing and treating body dysmorphic disorder.
American Society of Clinical Psychopharmacology Progress Notes, 1998
9. Albertini RS, Phillips KA. Body dysmorphic disorder: when appearance becomes an
obsession. World College Health, www.worldcollege health.org, 1999
10. Albertini RS, Phillips KA. The broken mirror: recognizing and treating body dysmorphic
disorder. Lifescape, DrKoop.com, 1999
11. Regan L, Dufresne RG, Phillips K. Body dysmorphic disorder: a clinician's introduction.
Medicine and Health/Rhode Island. 2001;84:292-293
12. Phillips KA. Somatoform disorders. The Merck Manual of Medical Information--Home
Edition. West Point, PA: Merck and Co, Inc., 2003
13. Phillips KA. Body dysmorphic disorder. World Book Online Americas Edition,
http://www.worldbook online.com/ar?/na/ar/co/ar750243.htm, July 2003
14. Phillips KA. Somatoform and factitious disorders. The Merck Manual, Eighteenth
Edition. West Point, PA: Merck and Co, Inc., 2006
15. Phillips KA. Somatoform and factitious disorders. The Merck Manual of Medical
Information—Home Edition. West Point, PA: Merck and Co, Inc., 2008
http://www.merck.com/mmhe/sec07/ch099/ch099a.html
16. Phillips KA. Somatoform and factitious disorders. The Merck Manual of Medical
Information—Professional Edition. West Point, PA: Merck and Co, Inc., 2008
http://www.merck.com/mmpe/sec15/ch204/ch204a.html
45
17. Phillips KA. Somatoform disorders. The Merck Manual Home Health Handbook.
Whitehouse Station, NJ, Merck Research Laboratories, 2009
18. Didie ER, Kelly M, Hart A, Phillips KA. Body dysmorphic disorder and eating disorders.
Renfrew Perspectives, Winter 2012
19. Phillips KA, Stein D. Obsessive compulsive and related disorders. The Merck Manual,
Professional Edition, 2014
20. Phillips KA, Stein D. Obsessive compulsive and related disorders. The Merck Manual,
Home Edition, 2014
21. Phillips KA. How to recognize and treat body dysmorphic disorder. “From the Experts”
column. Psychiatric News, August 12, 2015
22. Phillips KA. Body dysmorphic disorder: Epidemiology, pathogenesis, and clinical
features. UpToDate, 2016
23. Phillips KA. Body dysmorphic disorder: Assessment, diagnosis, and differential
diagnosis. UpToDate, 2016
24. Phillips KA. Body dysmorphic disorder: Treatment and prognosis. UpToDate, 2016
25. Phillips KA, Stein D. Obsessive compulsive and related disorders. The Merck Manual
Professional Version, 2017
26. Schaefer J, Phillips KA. The body as a prison: BDD and eating disorders. International
OCD Foundation Newsletter, Winter 2017
27. Phillips KA. International OCD Foundation website (wrote portions of the website on
body dysmorphic disorder). IOCDF, 2018
Consumer Version, 2018
Professional Version, 2018
30. Phillips KA. Body dysmorphic disorder: Epidemiology, pathogenesis, and clinical
features. UpToDate, 2018
31. Phillips KA. Body dysmorphic disorder: Assessment, diagnosis, and differential
diagnosis. UpToDate, 2018
32. Phillips KA. Body dysmorphic disorder: Treatment and prognosis. UpToDate, 2018
33. Phillips KA. Olfactory reference syndrome: Problematic preoccupation with perceived
body odor. International OCD Foundation Newsletter 2018;32:14-19
46
ABSTRACTS AND POSTERS
1. Phillips KA, Gunderson JG, Hirschfeld RMA, Smith LE. The depressive personality: a
review. CME Syllabus and Scientific Proceedings, American Psychiatric Association
(APA) 143rd Annual Meeting. New York: APA, 1990:240
2. Phillips KA. Body dysmorphic disorder. CME Syllabus and Scientific Proceedings,
American Psychiatric Association 143rd Annual Meeting. New York: APA, 1990:304
disorder: a report of 20 cases. New Research Abstracts, American Psychiatric
Association 144th Annual Meeting. New Orleans: APA, 1991:70
4. Phillips KA, Gunderson JG, Hirschfeld RMA, Smith LE. A review of the depressive
personality. Focus on Depression 1991;2:18-20
5. Phillips KA, Gunderson JG. Controversies surrounding the diagnosis of depressive

personality. Programme and Abstracts, Second International Congress on the Disorders
of the Personality. Oslo, Norway: International Society for the Study of Personality
Disorders, 1991:95
6. Phillips KA, Gunderson JG, Kimble CR, Triebwasser J, Faedda G. An empirical study
of depressive personality. CME Syllabus and Proceedings Summary, American
Psychiatric Association 145th Annual Meeting. Washington, DC: APA, 1992:197
7. Gunderson JG, Phillips KA, Triebwasser J. Diagnostic interview for depressive

personality. CME Syllabus and Proceedings Summary, American Psychiatric
Association 145th Annual Meeting. Washington, DC: APA, 1992:197
8. Hirschfeld RMA, Shea MT, Phillips KA. Depressive personality disorder in DSM-IV.
CME Syllabus and Proceedings Summary, American Psychiatric Association 145th
Annual Meeting. Washington, DC: APA, 1992:198
disorder: 50 cases of imagined ugliness. New Research Program and Abstracts,
American Psychiatric Association 145th Annual Meeting. Washington, DC: APA,
1992:83
10. McElroy SL, Phillips KA, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic
disorder: can it be psychotic? New Research Program and Abstracts, American
Psychiatric Association 145th Annual Meeting. Washington, DC: APA, 1992:165
disorder: 74 cases of imagined ugliness. First International Obsessive Compulsive
Disorder Conference Abstracts. Weesp, The Netherlands: Solvay Duphar, 1993;85-86
47
disorder: 90 cases of imagined ugliness. New Research Program and Abstracts,

American Psychiatric Association 146th Annual Meeting. San Francisco: APA, 1993:6
disorder: can it be psychotic? New Research Program and Abstracts, American
Psychiatric Association 146th Annual Meeting. San Francisco: APA, 1993:59
14. Eisen JL, Phillips KA, Beer D, Rasmussen SA, Goodman WK. Assessment of insight in
obsessions and delusions. New Research Program and Abstracts, American Psychiatric
Association 146th Annual Meeting. San Francisco: APA, 1993:149
disorder: 100 cases of imagined ugliness. Syllabus, American Psychiatric Association
45th Institute on H&CP. Baltimore: APA, 1993:64
disorder: can it be delusional? Syllabus, American Psychiatric Association 45th Institute
on H&CP. Baltimore: APA, 1993:63
17. Eisen JL, Phillips KA, Beer D, Rasmussen SA, Goodman WK. Assessment of the
degree of delusionality in obsessions and delusions. Syllabus, American Psychiatric
Association 45th Institute on H&CP. Baltimore: APA, 1993:64
18. Phillips KA, Taub SL, Atala KD. Skin picking: a symptom of body dysmorphic disorder.
New Research Program and Abstracts, American Psychiatric Association 147th Annual
Meeting. Philadelphia: APA,1994:95
19. Phillips KA, Nierenberg AA, Fava M. Body dysmorphic disorder in atypical depression.
Meeting. Philadelphia: APA,1994:94
20. Miguel EC, Baer L, Coffey BJ, Rauch SL, O'Sullivan R, Moretti C, Savage CR, Phillips
KA, Leckman JF, Jenike MA. Phenomenology of obsessive compulsive disorder and
Tourette’s syndrome. New Research Program and Abstracts, American Psychiatric
Association 147th Annual Meeting. Philadelphia: APA, 1994:117
21. Eisen JL, Phillips KA, Rasmussen S, Pato MT. Insight in OCD. CME Syllabus and
Proceedings, American Psychiatric Association 147th Annual Meeting. Philadelphia:
APA, 1994:114
22. Phillips KA, Taub SL. Compulsive skin picking as a symptom of body dysmorphic
disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 34th Annual Meeting
Abstracts of Posters and Presentations. Marco Island, FL: National Institute of Mental
Health, 1994:32
23. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of
body dysmorphic disorder and obsessive compulsive disorder. Abstracts of Panels and
Posters, American College of Neuropsychopharmacology 33rd Annual Meeting (ACNP).
San Juan: ACNP, 1994:155
48
24. Nierenberg AA, Phillips KA, Kaji J, Alpert JE, Worthington JJ, Fava M. Body
dysmorphic disorder is comorbid with major depression. Society of Biological Psychiatry
50th Annual Meeting. Miami: Society for Biological Psychiatry, 1995
25. Phillips KA, Atala KD, Pope HG. Diagnostic instruments for body dysmorphic disorder.
Meeting. Miami: APA, 1995:157
26. Phillips KA, Gunderson CG, McElroy SL, Mallya G, Carter W. A comparison study of
body dysmorphic disorder and OCD. New Research Program and Abstracts, American
Psychiatric Association 148th Annual Meeting. Miami: APA, 1995:156
27. Nierenberg AA, Phillips KA, Kaji J, Alpert JE, Worthington JJ, Fava M. Body
dysmorphic disorder is comorbid with major depression. New Research Program and
Abstracts, American Psychiatric Association 148th Annual Meeting. Miami: APA,
1995:154
28. Diaz S, Phillips KA, Gunderson CG. Gender differences in body dysmorphic disorder.
29. Penn J, Phillips KA, Dimond K. Body dysmorphic disorder and social phobia. New
Research Program and Abstracts, American Psychiatric Association 148th Annual
30. Soriano JL, O'Sullivan RL, Baer L, Phillips KA, McNally JR, Jenike MA. Trichotillomania
and self- esteem: a survey of 62 female hair-pullers. New Research Program and
Abstracts, American Psychiatric Association 148th Annual Meeting. Miami: APA,
1995:145
31. Eisen JL, Rasmussen SA, Phillips KA, Lydiard RB, Pigott TA. Does degree of insight in
OCD predict improvement? New Research Program and Abstracts, American
Psychiatric Association 148th Annual Meeting. Miami: APA, 1995:154
32. Phillips KA. A preliminary open study of buspirone augmentation of SRIs in body
dysmorphic disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 35th Annual
Meeting Abstracts of Posters and Presentations. Orlando, FL: National Institute of
Mental Health, 1995:41
33. Phillips KA, McElroy SL. An open-label study of fluvoxamine in body dysmorphic
disorder. Scientific Abstracts, American College of Neuropsychopharmacology 34th
Annual Meeting. San Juan: ACNP, 1995:239
34. Phillips KA, McElroy SL. An open-label study of fluvoxamine in body dysmorphic
disorder. Society of Biological Psychiatry 51st Annual Meeting. New York: Biological
Psychiatry, 1996
35. Zimmerman M, Mattia JI, Phillips KA. Screening for body dysmorphic disorder in an
49
outpatient clinic. Syllabus and Proceedings Summary, American Psychiatric Association

149th Annual Meeting. New York: APA, 1996:4
36. Eisen JL, Phillips KA, Rasmussen SA. Delusionality in OCD, body dysmorphic disorder,
and mood disorders. Syllabus and Proceedings Summary, American Psychiatric
Association 149th Annual Meeting. New York: APA, 1996:165
37. Phillips KA, Steketee G, Shapiro L. Parental bonding in OCD and body dysmorphic
disorder. New Research Program and Abstracts, American Psychiatric Association
149th Annual Meeting. New York: APA, 1996:261
38. Phillips KA, Aronowitz BR, DeCaria C, Hollander E, Rasmussen SA. Reliability and
validity of the Body Dysmorphic Disorder Yale-Brown Obsessive-Compulsive Scale.
Meeting. New York: APA, 1996:261
39. Phillips KA, McElroy SL. Fluvoxamine in body dysmorphic disorder. New Research
Program and Abstracts, American Psychiatric Association 149th Annual Meeting. New
York: APA, 1996:262
40. Phillips KA, Aronowitz BR, DeCaria C, Hollander E, Rasmussen SA, Goodman W.
Reliability and validity of the BDD-YBOCS. New Clinical Drug Evaluation Unit Program
(NCDEU) 36th Annual Meeting Abstracts of Posters and Presentations. Boca Raton:
National Institute of Mental Health, 1996:117
41. Phillips KA, Eisen JL, Baer L, Beer D, Atala K, Rasmussen SA. The Brown Assessment
of Beliefs Scale: Reliability and validity. Scientific Abstracts, American College of
Neuropsychopharmacology 35th Annual Meeting. San Juan: ACNP, 1996:142
42. Phillips KA. Delusional vs nondelusional body dysmorphic disorder. Poster

Presentations and Abstracts, Brown Brain Science Research Day. Providence: Alpert
Medical School of Brown University, 1997
43. Phillips KA, McElroy SL. Personality traits and disorders in body dysmorphic disorder.
Meeting. San Diego: APA, 1997:198
44. Phillips KA, Dufresne R, Wilkel C, Vittorio C. Prevalence of body dysmorphic disorder in
dermatology patients. New Research Program and Abstracts, American Psychiatric
Association 150th Annual Meeting. San Diego: APA, 1997:198
45. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown
Assessment of Beliefs Scale: Reliability and validity. New Research Program and
Abstracts, American Psychiatric Association150th Annual Meeting. San Diego: APA,
1997:199
46. Eisen JL, Phillips KA, Rasmussen SA, Luce D. Insight in body dysmorphic disorder
versus OCD. New Research Program and Abstracts, American Psychiatric Association
150th Annual Meeting. San Diego: APA, 1997:199
50
47. Phillips KA, McElroy SL, Eisen JL, Rasmussen SA. Insight and treatment response in
body dysmorphic disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 37th
Annual Meeting Abstracts of Posters and Presentations. Boca Raton: National Institute
of Mental Health, 1997:88
body dysmorphic disorder. Poster Presentations and Abstracts, Second Annual
Research Symposium on Mental Health Sciences. Providence: Department of
Psychiatry and Human Behavior, Alpert Medical School of Brown University, 1997
49. Bidadi K, Phillips KA. The relationship between body dysmorphic disorder and
substance abuse. Poster Presentations and Abstracts, Second Annual Research
Symposium on Mental Health Sciences. Providence: Department of Psychiatry, Brown
Medical School, 1997
body dysmorphic disorder. Scientific Abstracts, American College of
Neuropsychopharmacology 36th Annual Meeting. Waikaloa, Hawaii: ACNP, 1997:183
51. Albertini RS, Phillips KA. Body dysmorphic disorder in children and adolescents. New
Research Program and Abstracts, American Psychiatric Association 151st Annual
Meeting. Toronto, Canada: APA,1998:229
52. Phillips KA, Grant J, DeMarco LM. Medical and surgical treatment received in body
dysmorphic disorder. New Research Program and Abstracts, American Psychiatric
Association 151st Annual Meeting. Toronto, Canada: APA, 1998:230
53. Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Insight and treatment
response in body dysmorphic disorder. New Research Program and Abstracts,
American Psychiatric Association 151st Annual Meeting. Toronto, Canada: APA,
1998:230
54. Phillips KA. Recognizing and treating body dysmorphic disorder in depressed patients.
Syllabus and Proceedings Summary, American Psychiatric Association 151st Annual
Meeting. Toronto, Canada: APA, 1998:304
55. Phillips KA, McElroy SL. Treatment response of depression in patients with body
dysmorphic disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 38th Annual
Meeting Abstracts of Poster Presentations. Boca Raton: National Institute of Mental
Health, 1998:146
56. Phillips KA. Quality of life for patients with body dysmorphic disorder. 3rd Annual
Research Symposium on Mental Health Sciences. Providence: Alpert Medical School of
Brown University, 1998:80
57. Grant J, Phillips KA, Price LH. Retrospective follow-up study of body dysmorphic
disorder. 3rd Annual Research Symposium on Mental Health Sciences. Providence:
Alpert Medical School of Brown University, 1998:36
51
58. Albertini RS, Phillips KA. 33 cases of body dysmorphic disorder in children and
adolescents. 3rd Annual Research Symposium on Mental Health Sciences. Providence:
59. Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlman U, Rauch SL, Baer L,
Jenike MA. Memory dysfunction in body dysmorphic disorder. Scientific Abstracts,
American College of Neuropsychopharmacology 37th Annual Meeting. Las Croabas,
Puerto Rico: ACNP, 1998:138
60. Phillips KA. Quality of life in body dysmorphic disorder. New Research Program and
Abstracts, American Psychiatric Association 152nd Annual Meeting. Washington, DC:
APA, 1999:152
61. Phillips KA, Grant J, Albertini RS, Stout R, Price LH. Retrospective follow-up study of
body dysmorphic disorder. New Research Program and Abstracts, American Psychiatric
Association 152nd Annual Meeting. Washington, DC: APA, 1999:151
62. Pfohl BM, Gunderson JG, Silk KR, Zimmerman M, Williams JBW, Phillips KA, Robins
C, Rush J. Survey of clinician attitudes towards borderline personality disorder. Syllabus
and Proceedings Summary, American Psychiatric Association 152nd Annual Meeting.
Washington, DC: APA, 1999:11
63. Phillips KA. Clinical features of body dysmorphic disorder: diagnosing an

underrecognized disorder. Syllabus and Proceedings Summary, American Psychiatric
Association 152nd Annual Meeting. Washington, DC: APA, 1999:118
64. Albertini RS, Phillips KA. Body dysmorphic disorder in children and adolescents.
Syllabus and Proceedings Summary, American Psychiatric Association 152nd Annual
Meeting. Washington, DC: APA, 1999:118
65. Phillips KA. Should the diagnostic groupings be reorganized? Syllabus and
Proceedings Summary, American Psychiatric Association 152nd Annual Meeting.
Washington, DC: APA, 1999:158
body dysmorphic disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 39th
Annual Meeting Abstracts of Poster Presentations. Boca Raton: National Institute of
67. Albertini RS, Phillips KA. Body dysmorphic disorder in children and adolescents: clinical
features and treatment response. New Clinical Drug Evaluation Unit Program (NCDEU)
39th Annual Meeting Abstracts of Poster Presentations. Boca Raton: National Institute of
68. Phillips KA. Quality of life for patients with body dysmorphic disorder. European
Neuropsychopharmacology: Abstracts of the 12th Congress of the European College of
Neuropsychopharmacology. London: ECNP, 1999:219
52
69. Phillips KA, Albertini RS, Khan AA, Robinson M. Effectiveness of pharmacotherapy for
body dysmorphic disorder: a chart review study. 4th Annual Research Symposium on
Mental Health Sciences. Providence: Alpert Medical School of Brown University,
1999:68
Neuropsychopharmacology 38th Annual Meeting. Acapulco, Mexico: ACNP, 1999:172
71. Phillips KA, Steketee G, Shapiro L, McElroy SL, Grant J. Temperament and parental
care: risk factors for BDD? Fourth International Obsessive Compulsive Disorder
Conference. St. Thomas, US Virgin Islands: IOCDC, 2000:28
72. Eisen JL, Phillips KA, Rasmussen SA. The continuum between obsessions and
delusions in OCD and BDD. Syllabus and Proceedings Summary, American Psychiatric
Association 2000 Annual Meeting. Chicago: APA, 2000:114
73. Phillips KA. Body dysmorphic disorder: new data on an old disorder. Syllabus and
Proceedings Summary, American Psychiatric Association 2000 Annual Meeting.
Chicago: APA, 2000:154
74. Phillips KA, McElroy SL, Siniscalchi JM. Depression, anxiety, anger, and somatic
symptoms in body dysmorphic disorder. New Research Program and Abstracts,
American Psychiatric Association 2000 Annual Meeting. Chicago: APA, 2000:122
75. Albertini RS, Phillips KA, Khan A, Robinson M. Pharmacotherapy of body dysmorphic
disorder: a chart-review study. New Research Program and Abstracts, American
Psychiatric Association 2000 Annual Meeting. Chicago: APA, 2000:122
76. Phillips KA, Albertini RS, Khan AA, Robinson M. Effectiveness of pharmacotherapy for
body dysmorphic disorder: a chart-review study. New Clinical Drug Evaluation Unit
Program (NCDEU) 40th Annual Meeting Abstracts of Posters and Presentations. Boca
Raton, FL: National Institute of Mental Health, 2000:180
77. Phillips KA, Rauch S, Deckersbach T, Rasmussen SA, Savage C, Albertini RS,
Wilhelm S, Grant J, Price L, Baer L, Jenike M. BDD: Phenomenology, course, treatment,
neuropsychology, and structural imaging. Scientific Abstracts, American College of
Neuropsychopharmacology 39th Annual Meeting. San Juan, Puerto Rico: ACNP,
2000:61
78. Phillips KA, Albertini RS, Rasmussen SA. A placebo-controlled trial of fluoxetine in
Neuropsychopharmacology 39th Annual Meeting. San Juan, Puerto Rico: ACNP,
2000:271
body dysmorphic disorder. 5th Annual Research Symposium on Mental Health Sciences.
Providence: Alpert Medical School of Brown University, 2001:52
53
80. Menard W, Siniscalchi JM, Phillips KA. Substance use disorders in patients with body
dysmorphic disorder. 5th Annual Research Symposium on Mental Health Sciences.
body dysmorphic disorder. New Research Program and Abstracts, American Psychiatric
Association 2001 Annual Meeting. New Orleans: APA, 2001:721
body dysmorphic disorder. New Clinical Drug Evaluation Unit (NCDEU) 41st Annual
Meeting Poster Presentations Abstracts. Phoenix, AZ: National Institute of Mental
Health, 2001:I-79
83. Phillips KA, Albertini RS, Eisen JL, Rasmussen SA. Response of delusional and
nondelusional body dysmorphic disorder to fluoxetine vs placebo. Scientific Abstracts,
American College of Neuropsychopharmacology 40th Annual Meeting. Waikaloa,
Hawaii: ACNP, 2001:261
84. Phillips KA, Najjar F. Efficacy and safety of citalopram for body dysmorphic disorder.
Scientific Abstracts, American College of Neuropsychopharmacology 40th Annual
Meeting. Waikoloa, Hawaii: ACNP, 2001:399
85. Gunstad J, Phillips KA. Comorbidity in body dysmorphic disorder. 6th Annual Research
Symposium on Mental Health Sciences. Providence: Alpert Medical School of Brown
University, 2002
86. Kuniega-Pietrzak T, Siniscalchi J, Phillips KA. Body image in patients with body
dysmorphic disorder. 6thAnnual Research Symposium on Mental Health Sciences.
Providence: Alpert Medical School of Brown University, 2002
87. Phillips KA, Albertini RS, Eisen JL, Rasmussen SA. Response of delusional and
nondelusional body dysmorphic disorder to fluoxetine vs placebo. 6th Annual Research
University, 2002
88. Kuniega-Pietrzak T, Siniscalchi J, Phillips KA. Body image in patients with body
dysmorphic disorder. New Research Abstracts, American Psychiatric Association 2002
Annual Meeting. Philadelphia: APA, 2002:24
89. Gunstad J, Phillips KA. Comorbidity in body dysmorphic disorder. New Research
Abstracts, American Psychiatric Association 2002 Annual Meeting. Philadelphia: APA,
2002:41
90. Phillips KA, Rasmussen SA, Albertini RS, Eisen JL. Response of delusional and
nondelusional body dysmorphic disorder to fluoxetine vs placebo. New Research
Abstracts, American Psychiatric Association 2002 Annual Meeting. Philadelphia: APA,
2002:40
54
91. Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life in
body dysmorphic disorder with fluoxetine vs. placebo. New Clinical Drug Evaluation Unit
(NCDEU) 42nd Annual Meeting Poster Presentations Abstracts. Boca Raton, FL:
National Institute of Mental Health, 2002:I-4
92. Phillips KA. A placebo-controlled trial of pimozide augmentation of fluoxetine in body

dysmorphic disorder. Scientific Abstracts, American College of
Neuropsychopharmacology 41st Annual Meeting. San Juan, Puerto Rico: ACNP,
2002:164
93. Phillips KA. Quality of life in body dysmorphic disorder. 7th Annual Research
University, 2003:40
94. Jain S, Phillips KA. Self-esteem in patients with body dysmorphic disorder. 7th Annual
95. Phillips KA. Body dysmorphic disorder. Dermatol Psychosom 2003;4:14
96. Jain S, Phillips KA. Self-esteem in patients with body dysmorphic disorder. New
Research Abstracts, American Psychiatric Association 2003 Annual Meeting. San
Francisco: APA, 2003:20
97. Phillips KA, Menard W. Quality of life in patients with body dysmorphic disorder. New
Research Abstracts, American Psychiatric Association 2003 Annual Meeting. San
Francisco: APA, 2003:127
98. Phillips KA. A placebo-controlled trial of pimozide augmentation of fluoxetine in body

dysmorphic disorder. NCDEU 43nd Annual Meeting Abstracts. Boca Raton, FL: National
Institute of Mental Health, 2003:I-73
99. Phillips KA, Richter MA, Tharmalingam S, King NA, Jeffers C, Menard W, Kennedy JL.
The 5HTTLPR and GABA-A gamma-2 genes may be implicated in body dysmorphic
disorder. World Congress of Psychiatric Genetics. Quebec City, Canada, 2003
100. Phillips KA, Menard W, Pagano M. Quality of life and psychosocial functioning in body
dysmorphic disorder. 6th International Obsessive Compulsive Disorder Conference
Abstracts. Lanzarote, Spain, 2003:22
A preliminary candidate gene study of body dysmorphic disorder. Scientific Abstracts,
American College of Neuropsychopharmacology 42nd Annual Meeting. San Juan,
Puerto Rico: ACNP, 2003:157
102. Phillips KA, Grant JE, Pagano M, Fay C, Menard W. Comorbid substance use
disorders in patients with body dysmorphic disorder. 8th Annual Research Symposium on
Mental Health Sciences. Providence: Alpert Medical School of Brown University,
2004:63
55
A preliminary candidate gene study of body dysmorphic disorder. 8th Annual Research
University, 2004:62
104. Pinto A, Phillips KA. Social anxiety in body dysmorphic disorder. 8th Annual Research
University, 2004:64
105. Ruffulo JS, Menard W, Fay C, Phillips KA. Comorbidity of body dysmorphic disorder
and eating disorders: severity of psychopathology and body image disturbance. 8th
Annual Research Symposium on Mental Health Sciences. Providence: Alpert Medical
School of Brown University, 2004:69
106. Jain S, Grant JE, Menard W, Cerasoli S, Phillips KA. A chart-review study of SRI
continuation treatment versus discontinuation in body dysmorphic disorder. 8th Annual
107. Tharmalingham S, Phillips KA, Richter MA, Burroughs E, King N, Menard W, Kennedy
JL. The serotonin transporter gene and response to SSRIs in body dysmorphic disorder.
Pharmacogenetics and Psychiatry 3rd Annual Meeting. New York, NY, 2004
108. Eide MJ, Weinstock M, Dufresne R, Neelagaru S, Risica P, Burkholder G, Upegui D,

Phillips KA, Armstrong B, Robinson-Bostom L. Relationship of treatment delay with
surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous
cell carcinoma). Journal of Investigative Dermatology, April, 2004
109. Phillips KA, Grant JE, Pagano M, Fay C, Menard W. Comorbid substance use
disorders in patients with body dysmorphic disorder. New Research Abstracts, American
Psychiatric Association 2004 Annual Meeting. New York, NY: APA, 2004:853
110. Richter MA, Tharmalingham S, Burroughs E, King NA, Kennedy JL, Phillips KA. A
preliminary genetics investigation of BDD and OCD. New Research Abstracts, American
Psychiatric Association 2004 Annual Meeting. New York, NY: APA, 2004:206
111. Phillips KA, Pagano ME, Fay C, Menard W. Pharmacotherapy received by individuals
with body dysmorphic disorder. Abstracts, National Institute of Mental Health NCDEU
44th Annual Meeting. Phoenix, AZ: 2004:229
112. Jain S, Grant JE, Menard W, Cerasoli S, Phillips KA. A chart-review study of SRI
continuation treatment versus discontinuation in body dysmorphic disorder. Abstracts,
National Institute of Mental Health NCDEU 44th Annual Meeting. Phoenix, AZ: 2004:231
113. Hunter-Yates J, Dufresne RJ, Phillips KA. Excessive tanning in body dysmorphic
disorder. Abstracts, American Academy of Dermatology 62nd Annual Meeting. New York,
NY:2004
56
114. Dyl J, Kittler J, Hunt J, Phillips KA. Body dysmorphic disorder in adolescent psychiatric
inpatients. Scientific Proceedings, American Academy of Child and Adolescent
Psychiatry 51st Annual Meeting. Washington, DC:2004:155
115. Pinto A, Phillips KA. Social anxiety in body dysmorphic disorder. Association for the
Advancement of Behavior Therapy Annual Meeting. New Orleans, LA:2004
116. Cash TF, Phillips KA, Santos MT, Hrabosky JI. Measuring negative body image:
validation of the body image disturbance questionnaire in a nonclinical population.
Association for the Advancement of Behavior Therapy Annual Meeting. New Orleans,
LA:2004
117. Phillips KA, Pagano ME, Menard WE, Fay C, Stout RL. A prospective longitudinal
investigation of the course of body dysmorphic disorder and pharmacotherapy received.
Scientific Abstracts, Neuropsychopharmacology 2004:29:S200
118. Richter MA, Tharmalingam S, Burroughs E, King NA, Menard WE, Kennedy JL, Phillips
KA. A preliminary genetic investigation of the relationship between body dysmorphic
disorder and OCD. Scientific Abstracts, Neuropsychopharmacology 2004:29:S200
119. Phillips KA, Pagano M, Menard WE, Fay C, Stout RL. A prospective longitudinal
investigation of the course of BDD and pharmacotherapy received. 9th Annual Research
University, 2005:54
120. Phillips KA, Coles ME, Yen S, Menard W, Fay C. Suicidal ideation and suicide attempts
in BDD. 9th Annual Research Symposium on Mental Health Sciences. Providence: Alpert
Medical School of Brown University, 2005:55
121. Pope CG, Phillips KA, Pope HE, Menard WE, Fay C. Is muscle dysmorphia different
from other forms of BDD? 9th Annual Research Symposium on Mental Health Sciences.
122. Didie ER, Tortolani CC, Pope CG, Menard WE, Fay C, Phillips KA. Childhood abuse
and neglect in BDD. 9th Annual Research Symposium on Mental Health Sciences.
123. Conroy M, Phillips KA, Dufresne R, Menard W, Didie ER, Hunter J, Fay C, Pagano M.
Tanning in BDD. 9th Annual Research Symposium on Mental Health Sciences.
124. Coles ME, Menard W, Fay C, Weisberg RB, Phillips KA. Investigation of the
relationship between BDD and social phobia. New Research Abstracts, American
Psychiatric Association 2005 Annual Meeting. Atlanta, GA: APA, 2005:674
125. Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg R. Suicidal ideation and
suicide attempts in body dysmorphic disorder. New Research Abstracts, American
Psychiatric Association 2005 Annual Meeting. Atlanta, GA: APA, 2005:675
57
126. Phillips KA. An open-label trial of escitalopram in body dysmorphic disorder. New
Research Abstracts, American Psychiatric Association 2005 Annual Meeting. Atlanta,
GA: APA, 2005:676
127. Didie ER, Phillips KA, Pope C, Tortolani C, Menard W, Fay C. Childhood abuse and
neglect in BDD. New Research Abstracts, American Psychiatric Association 2005
Annual Meeting. Atlanta, GA: APA, 2005:11
128. Conroy M, Dufresne RG, Menard W, Didie ER, Hunter J, Fay C, Pagano M, Phillips KA.
Compulsive tanning in BDD. New Research Abstracts, American Psychiatric Association
2005 Annual Meeting. Atlanta, GA: APA, 2005:160
129. Phillips KA, Pagano ME, Menard WE, Fay C, Stout RL. A prospective longitudinal
investigation of the course of body dysmorphic disorder (BDD) and pharmacotherapy
received. NCDEU 45th Annual Meeting Abstracts. Boca Raton, FL: National Institute of
Mental Health, 2005:I-180
130. Dyl JL, Buchman A, Kittler J, Hunt J, Hollander B, Phillips KA. Prevalence and
comorbidity of body dysmorphic disorder in hospitalized adolescents. Scientific
Proceedings, American Academy of Child and Adolescent Psychiatry 52nd Annual
Meeting. Toronto, CA: AACAP, 2005:113
131. Kittler J, Hollander B, Dyl J, Hunt J, Buchman A, Phillips KA. Clinical correlates of body
dysmorphic disorder among adolescent psychiatric inpatients. Scientific Proceedings,
American Academy of Child and Adolescent Psychiatry 52nd Annual Meeting. Toronto,
CA: AACAP, 2005:113
132. Didie ER, Tortolani CC, Walters M, Menard W, Phillips KA. Social functioning in body
dysmorphic disorder. Annual Meeting of the Association for Behavioral and Cognitive
Therapies. Washington, DC: ABCT, 2005
133. Phillips KA, Stout RL. Associations in the longitudinal course of body dysmorphic
disorder with major depression, obsessive compulsive disorder, and social phobia.
Neuropsychopharmacology 2005:30:S231
compulsive disorder versus body dysmorphic disorder: A comparison study of two
possibly related disorders. 10th Annual Research Symposium on Mental Health
Sciences. Providence, RI: Alpert Medical School of Brown University, 2006
135. Didie ER, Menard W, Stern A, Phillips KA. Work and academic impairment in
individuals with body dysmorphic disorder. 10th Annual Research Symposium on Mental
Health Sciences. Providence, RI: Alpert Medical School of Brown University, 2006
136. Didie ER, Walters MM, Pinto A, Menard W, Eisen JL, Mancebo M, Rasmussen SA,
Phillips KA. A comparison of quality of life and psychosocial functioning in obsessive-
compulsive disorder versus body dysmorphic disorder. 10th Annual Research
Symposium on Mental Health Sciences. Providence, RI: Alpert Medical School of Brown
University, 2006
58
137. Phillips KA, Didie ER, Menard W. Clinical features and correlates of major depressive
disorder in individuals with body dysmorphic disorder. 10th Annual Research Symposium
on Mental Health Sciences. Providence, RI: Alpert Medical School of Brown University,
2006
138. Khezri R, Didie E, Menard W, Phillips KA. Sexual functioning and romantic intimacy in
body dysmorphic disorder. 10th Annual Research Symposium on Mental Health
Sciences. Providence, RI: Alpert Medical School of Brown University, 2006
139. Didie ER, Walters MM, Pinto A, Menard W, Eisen JL, Rasmussen SA, Phillips KA. A
comparison of quality of life and psychosocial functioning in obsessive-compulsive
disorder versus body dysmorphic disorder. New Research Abstracts, American
Psychiatric Association 2006 Annual Meeting. Toronto, Canada: APA, 2006:15
140. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: A prospective study.
New Research Abstracts, American Psychiatric Association 2006 Annual Meeting.
Toronto, Canada: APA, 2006:349
141. Kittler JE, Menard W, Phillips KA. Weight concerns in individuals with body dysmorphic
disorder. New Research Abstracts, American Psychiatric Association 2006 Annual
Meeting. Toronto, Canada: APA, 2006:391
142. Phillips KA, Pagano ME, Menard W, Stout RL. A prospective longitudinal study of the
course of BDD. New Research Abstracts, American Psychiatric Association 2006
Annual Meeting. Toronto, Canada: APA, 2006:404
143. Didie ER, Tortolani C, Walters MM, Menard W, Phillips KA. Social functioning in body
dysmorphic disorder: assessment considerations. NCDEU 46th Annual Meeting
Abstracts. Boca Raton, FL: National Institute of Mental Health, 2006:II-62
144. Phillips KA, Leon AC. Pharmacotherapy effectiveness for body dysmorphic disorder in
a prospective observational study: preliminary propensity-adjusted results. NCDEU 46th
Annual Meeting Abstracts. Boca Raton, FL: National Institute of Mental Health, 2006:II-
70
compulsive disorder versus body dysmorphic disorder: A comparison study of two
possibly related disorders. 2nd Annual Body Dysmorphic Disorder Conference.
Hempstead, NY, October 22, 2006
146. Didie ER, Stern A, Menard W, Phillips KA. Work and academic impairment in
individuals with body dysmorphic disorder. 2nd Annual Body Dysmorphic Disorder
Conference. Hempstead, NY, October 22, 2006
147. Phillips KA, Leon AC. Pharmacotherapy effectiveness for body dysmorphic disorder in
a prospective observational study: preliminary propensity-adjusted results.
Neuropsychopharmacology 2006:S219
59

and clinical characteristics of body dysmorphic disorder on a general inpatient adult
psychiatric unit. 11th Annual Research Symposium on Mental Health Sciences.
Providence, RI: The Warren Alpert Medical School of Brown University, 2007:17
149. Didie ER, Menard W, Phillips KA. Severity of interpersonal problems in individuals with
body dysmorphic disorder. 11th Annual Research Symposium on Mental Health
Sciences. Providence, RI: The Warren Alpert Medical School of Brown University,
2007:23
prospective, follow-up study. 11th Annual Research Symposium on Mental Health
Sciences. Providence, RI: The Warren Alpert Medical School of Brown University,
2007:61

and clinical characteristics of body dysmorphic disorder on a general inpatient adult
psychiatric unit. New Research Abstracts, American Psychiatric Association 2007
Annual Meeting. San Diego, CA: APA: 2007:NR96
prospective, follow-up study. New Research Abstracts, American Psychiatric Association
2007 Annual Meeting. San Diego, CA: 2007:NR812
153. Phillips KA. An open-label trial of levetiracetam for body dysmorphic disorder. NCDEU
47th Annual Meeting Poster Session Abstracts. Boca Raton, FL: National Institute of
Mental Health, 2007:I-11
154. Phillips KA. A pilot study of levetiracetam for body dysmorphic disorder. Scientific
Abstracts, American College of Neuropsychopharmacology 46th Annual Meeting. Boca
Raton, FL: ACNP, 2007
155. Phillips KA, Pinto A, Coles M, Eisen JL, Menard W, Rasmussen SA. A comparison of
insight in body dysmorphic disorder and obsessive compulsive disorder. 12th Annual
Research Symposium on Mental Health Sciences. Providence, RI: The Warren Alpert
156. Didie ER, Kurahara L, Menard W, Phillips KA. Adherence to cognitive-behavioral

therapy and pharmacotherapy recommendations among patients with body dysmorphic
disorder. 12th Annual Research Symposium on Mental Health Sciences. Providence, RI:
The Warren Alpert Medical School of Brown University, 2008:22
157. Pope CG, Pope HG, Menard W, Phillips KA. Substance abuse and dependence in
subjects with body dysmorphic disorder in a longitudinal study. 12th Annual Research
Symposium on Mental Health Sciences. Providence, RI: The Warren Alpert Medical
60
158. Kelly MM, Phillips KA. Features of social anxiety in body dysmorphic disorder. 12th
Annual Research Symposium on Mental Health Sciences. Providence, RI: The Warren
159. Christopher PP, Boland RJ, Recupero PR, Phillips KA. Teaching psychiatry residents
about performing disability evaluations: are we doing enough. Second Annual Teaching
160. Phillips KA, Pinto A, Coles M, Eisen JL, Menard W, Rasmussen SA. A comparison of
insight in body dysmorphic disorder and obsessive compulsive disorder. American
Psychiatric Association 2008 Annual Meeting. Washington, DC: APA, 2008:NR3-139
161. Crerand CE, Menard W, Phillips KA. Surgical and minimally invasive cosmetic
procedures among persons with body dysmorphic disorder. American Psychiatric
Association 2008 Annual Meeting. Washington, DC: APA, 2008:NR6-101
162. Didie ER, Loerke E, Menard W, Phillips KA. Severity of interpersonal problems in
individuals with body dysmorphic disorder. International Conference on Eating
Disorders. Seattle, WA: 2008
163. Phillips KA, Kelly MM, Menard W. Suicidality in a placebo-controlled fluoxetine study of
body dysmorphic disorder. NCDEU 48th Annual Meeting Poster Abstracts. Phoenix, AZ:
National Institute of Mental Health, 2008:I-56
164. Didie ER, Loerke E, Menard W, Phillips KA. Severity of interpersonal problems in
individuals with body dysmorphic disorder. NCDEU 48th Annual Meeting Poster
Abstracts. Phoenix, AZ: National Institute of Mental Health, 2008:II-46
165. Didie ER, Kurahara L, Menard W, Phillips KA. Adherence to cognitive behavioral
therapy and pharmacotherapy recommendations among patients with body dysmorphic
disorder. Annual Meeting of the Association for Behavioral and Cognitive Therapies.
Orlando, FL: ABCT, 2008
166. Phillips KA, Kelly MM. Suicidality in a placebo-controlled fluoxetine study of body
dysmorphic disorder. Scientific Abstracts, American College of
Neuropsychopharmacology 47th Annual Meeting. Phoenix, AZ: ACNP, 2008
167. Phillips KA, Kelly MM, Menard W. Physical functioning and physical health-related
quality of life in body dysmorphic disorder. 13th Annual Research Symposium on Mental
Health Sciences. Providence, RI: The Warren Alpert Medical School of Brown
University, 2009:57
168. Kelly MM, Dalrymple K, Zimmerman M, Phillips KA. A comparison study of body
dysmorphic disorder versus social phobia. 13th Annual Research Symposium on Mental
University, 2009:37
61
169. Christopher P, Menard W, Stuart G, Phillips KA. Aggressive and violent behavior in
individuals with body dysmorphic disorder. 13th Annual Research Symposium on Mental
University, 2009:14
170. Greenberg JL, Cannistraro PA, Dougherty DD, Renaud SR, Rauch L, Phillips KA,
Rauch SL, Wilhelm S. PET-FDG study of cerebral metabolic activity in body dysmorphic
disorder. 29th Annual Conference of the Anxiety Disorders Association of America.
Santa Ana Pueblo, NM: ADAA, 2009
171. Didie ER, Phillips KA. Interpersonal psychotherapy for body dysmorphic disorder: A
pilot study. Annual meeting of the International Society for Interpersonal Psychotherapy.
New York, NY; 2009
172. Kelly M, McLaughlin NC, Greenberg BD, Phillips KA. Comparison of personality
dimensions in body dysmorphic disorder and obsessive-compulsive disorder. American
Psychiatric Association 162nd Annual Meeting. San Francisco, CA:APA, 2009:NR6-087
173. Phillips KA, Kelly MM, Menard W. Physical functioning and physical health-related
quality of life in body dysmorphic disorder. American Psychiatric Association 2009
Annual Meeting. San Francisco, CA:APA, 2009:NR6-088
174. Greenberg JL, Cannistraro PA, Dougherty DD, Evans KC, Simon NM, Rauch L, Phillips
KA, Rauch SL, Wilhelm S. Preliminary evidence for aberrant prefrontal metabolic activity
in BDD. Massachusetts General Hospital Clinical Research Day. Boston, MA, 2009
175. Didie ER, Kurahara L, Menard W, Phillips KA. Adherence to pharmacotherapy and
cognitive behavioral therapy recommendations among patients with body dysmorphic
disorder. NCDEU 49th Annual Meeting Poster Abstracts. Hollywood, FL: National
Institute of Mental Health, 2009:I-49
176. Greenberg JL, Cannistraro PA, Dougherty DD, Evans KC, Simon NM, Rauch L, Phillips
KA, Rauch SL, Wilhelm S. Preliminary evidence for aberrant prefrontal metabolic activity
in BDD. 43rd Annual Conference of the Association for Behavioral and Cognitive
Therapies. New York, NY: ABCT, 2009
177. Didie ER, Phillips, KA. Interpersonal psychotherapy for body dysmorphic disorder.
Annual Meeting of the Association for Behavioral and Cognitive Therapies. New York,
NY: ABCT, 2009
178. Didie E, Howes S, Kurahara L, Phillips KA. Pharmacotherapy non-adherence in body

dysmorphic disorder: rates, reasons, and predictors. American College of
Neuropsychopharmacology 48th Annual Meeting. Hollywood, FL: ACNP, 2009
179. Phillips KA, Menard W. Clinical features of olfactory reference syndrome. American
Psychiatric Association 2010 Annual Meeting. New Orleans, LA: APA, 2010:NR4-87
62
180. Bjornsson AS, Stalker E, Menard W, Grant JE, Phillips KA. Age at onset and clinical
correlates in body dysmorphic disorder. American Psychiatric Association 163rd Annual
Meeting. New Orleans, LA: APA, 2010:NR4-88
181. Didie ER, Howes S, Phillips KA, Kelly M, Veale DM. Development and validation of the
Appearance Attitudes Scale in body dysmorphic disorder. 6th World Congress of
Behavioral and Cognitive Therapies. Boston, MA, 2010:92
182. Phillips KA, Kelly MM, Strong D. The relationship of components of delusionality to
treatment outcome in a placebo-controlled trial of fluoxetine for body dysmorphic
disorder. 18th Annual Research Celebration. Rhode Island Hospital. Providence, RI,
2010;115
183. Didie ER, Phillips KA. A pilot study for an interpersonally focused psychotherapy for
body dysmorphic disorder. 18th Annual Research Celebration. Rhode Island Hospital.
Providence, RI, 2010
184. Dyl J, Kittler J, Holland BLG, Hunt J, Spirito A, Seifer R, Phillips KA. Body dysmorphic
disorder in adolescents: prevalence and clinical characteristics in inpatients. Scientific
Proceedings, American Academy of Child and Adolescent Psychiatry 57th Annual
Meeting. New York, NY: 2010
185. Phillips KA, Kelly MM, Strong D. The relationship of components of delusionality to
treatment outcome in a placebo-controlled trial of fluoxetine for body dysmorphic
disorder. American College of Neuropsychopharmacology 49th Annual Meeting. Miami,
FL: ACNP, 2010
longitudinal study of the course of body dysmorphic disorder. 14th Annual Research
187. Dyl J, Kittler J, Holland BLG, Hunt J, Spirito A, Seifer R, Phillips KA. Body dysmorphic
disorder in adolescents: prevalence and clinical characteristics in inpatients. 14th Annual
observational follow-up study of remission and relapse of body dysmorphic disorder.
American Psychiatric Association 164th Annual Meeting. Honolulu, HI: APA, 2011
189. Bjornsson AS, Didie ER, Menard W, Grant JE, Stalker E, Phillips KA. Age at onset and
clinical correlates in two samples of individuals with body dysmorphic disorder. 41st
European Association for Behavioural and Cognitive Therapies Conference. Reykjavik,
Iceland: EABCT, 2011
190. Phillips KA, Kelly M. Gender differences in a placebo-controlled trial of fluoxetine for
body dysmorphic disorder. 19th Annual Hospital Research Celebration, Providence, RI:
Lifespan, 2011
63
191. Phillips KA, Kelly M. Gender differences in a placebo-controlled trial of fluoxetine for
body dysmorphic disorder. American College of Neuropsychopharmacology 50th Annual
Meeting. Waikoloa, HI: ACNP, 2011
15th Annual Research Symposium on Mental Health Sciences. Providence, RI: The
Warren Alpert Medical School of Brown University, 2012:33
193. Phillips KA, Hart AS, Menard W, Eisen JL. Psychometric evaluation of the Brown
Assessment of Beliefs Scale in body dysmorphic disorder. 15th Annual Research
194. Mischel ER, LeBeau R, Hanover L, Stein D, Phillips KA, Craske M. Preliminary
assessment of new obsessive-compulsive spectrum scales for the DSM-5. 32nd Anxiety
Disorders Association of America Annual Conference. Arlington, VA: ADAA, 2012
195. Phillips KA, Menard WE, Quinn E, Stout RL. Predictors of suicidal ideation in a
prospective study of body dysmorphic disorder. American Psychiatric Association 165th
Annual Meeting. Philadelphia, PA: APA, 2012:NR10-31
196. Phillips KA, Hart A, Menard W, Eisen J. Psychometric evaluation of the Brown
Assessment of Beliefs Scale. NCDEU 52nd Annual Meeting. Phoenix, AZ: American
Society of Clinical Psychopharmacology, 2012:88
197. Phillips KA, Hart AS, Menard W. Psychometric evaluation of the Yale-Brown
Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder. 19th Annual OCD
Conference. Chicago, IL: International Obsessive-Compulsive Disorder Foundation,
2012
19th Annual OCD Conference. Chicago, IL: International Obsessive-Compulsive Disorder
Foundation, 2012
199. Phillips KA, Menard WE, Quinn E, Stout RL. Predictors of suicidal ideation in a
prospective study of body dysmorphic disorder. Lifespan 20th Annual Hospital Research
Celebration, Providence, RI: Lifespan, 2012:132
200. Phillips KA, Hart AS, Eisen JL, Menard WE, Sibrava NJ, Rasmussen S. Psychometric
evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder and
obsessive-compulsive disorder. American College of Neuropsychopharmacology 51st
Annual Meeting. Hollywood, FL: ACNP, 2012
201. Phillips KA, Menard W, Hart A. Suicidality in body dysmorphic disorder. 16th Annual
202. Phillips KA, Menard W, Hart A. Suicidality in body dysmorphic disorder. New Research
64
Abstracts, American Psychiatric Association 166th Annual Meeting. San Francisco: APA,
2013:229
203. Phillips KA, Menard W, Hart A. Clinical characteristics and correlates of suicidality in
body dysmorphic disorder. 20th Annual OCD Conference. Atlanta, GA: International
Obsessive-Compulsive Disorder Foundation, 2013
204. Phillips KA, Kelly MM, Menard W, Zhang J. Associations between substance use
disorders and gender in the course of body dysmorphic disorder. Brown Mind Brain
Research Day 2014. Providence, RI: Brown University, 2014:113
205. Kelly MM, Phillips KA. The prevalence of body dysmorphic disorder and its clinical
correlates in a VA primary care behavioral health setting. Brown Mind Brain Research
Day 2014. Providence, RI: Brown University, 2014:66
206. Phillips KA, Eisen JL, Boland R. Brown’s new NIMH-funded R25 grant to support
resident research training. Brown Mind Brain Research Day 2014. Providence, RI:
207. Quinn E, Tardiff M, Phillips KA, Menard W, Stout RL. Investigation of multiple episodes
in the longitudinal course of body dysmorphic disorder. Brown Mind Brain Research Day
2014. Providence, RI: Brown University, 2014:118
208. Kelly MM, Phillips KA. Associations between substance use disorders and gender in
the course of body dysmorphic disorder. Anxiety Disorders Association of America
Annual Conference. Chicago, IL: ADAA, 2014
209. Phillips KA, Kelly MM. Associations between substance use disorders and gender in
the course of body dysmorphic disorder. American Psychiatric Association 167th Annual
Meeting. New York, NY: APA, 2014
clinical correlates in a VA primary care behavioral health setting. 21st Annual OCD
Conference. Los Angeles, CA: International Obsessive-Compulsive Disorder
Foundation, 2014
clinical correlates in a VA primary care behavioral health setting. Lifespan 22nd Annual
Hospital Research Celebration, Providence, RI: Lifespan, 2014
212. Phillips KA, Keshaviah A, Dougherty D, Stout RL, Menard W, Wilhelm S.

placebo-controlled trial. Mind Brain Research Day 2015. Providence, RI: Brown
University, 2015:87
213. Phillips KA, Eisen J, Vargas S. Brown’s NIMH-funded R-25 grant to support resident
research training: Overview and update. Mind Brain Research Day 2015. Providence,
RI: Brown University, 2015:86
65
214. Kelly MM, Simmons R, Donahue J, Phillips KA. Motives to drink alcohol in body
dysmorphic disorder. 2015 ADAA Annual Conference. Miami, FL: Anxiety and
Depression Association of America, 2015:64
215. Hollander E, Ferretti CJ, Taylor BP, Noone R, Simberlund J, McElroy S, Menard W,
Phillips KA. FDA/NIMH trial of fluoxetine vs placebo in pediatric body dysmorphic
disorder. American Psychiatric Association 168th Annual Meeting. Toronto, Canada:
APA, 2015
216. Phillips KA, Keshaviah A, Dougherty D, Stout RL, Menard W, Wilhelm S.

placebo-controlled trial. Annual Meeting of the American Society of Clinical
Psychopharmacology (NCDEU). Miami, FL: ASCP, 2015:55
217. Kelly MM, Simmons RA, Donahue J, Phillips KA. Motives to drink alcohol in body
dysmorphic disorder. 22nd Annual OCD Conference. Boston, MA: International
Obsessive-Compulsive Disorder Foundation, 2015:41
218. Kelly MM, Simmons RA, Donahue J, Phillips KA. Motives to drink alcohol in body
dysmorphic disorder. Lifespan 23rd Annual Hospital Research Celebration, Providence,
RI: Lifespan, 2015
219. Zai G, Cappi C, Phillips KA, Gonçalves V, Zai CC, Shavitt SG, Miguel EC, Richter MA,
Kennedy JL. Pharmacogenetics of antidepressant response in obsessive-compulsive
and related disorders. XXIIIrd World Congress of Psychiatric Genetics Annual Meeting.
Toronto, Canada, 2015
220. Zai G, Cappi C, Phillips KA, Gonçalves V, Zai CC, Shavitt SG, Miguel EC, Richter MA,
Kennedy J. Genetic markers of antidepressant response in a cross-cultural sample of
patients with obsessive-compulsive and related disorders. 14th Annual
Pharmacogenetics in Psychiatry Meeting. Toronto, Canada, 2015
221. Phillips KA, Keshaviah A, Dougherty D, Stout R, Menard W, Wilhelm S.

Pharmacotherapy relapse prevention with escitalopram in body dysmorphic disorder: a
double-blind placebo-controlled trial. American College of Neuropsychopharmacology
54th Annual Meeting. Hollywood, FL: ACNP, 2015:M21
222. Phillips KA, Tyrka AR, Philip NS, Vargas SE. Brown’s NIH-funded R25 grant to support
psychiatry resident research training: overview and 2015-2016 update. Mind Brain
223. Quinn GP, Phillips KA, Stout RL, Afeltra JK. Further results from the investigation of
multiple episodes in the longitudinal course of body dysmorphic disorder. Mind Brain
224. Kelly MM, Padilla-Martinez V, Simmons S, Donahue D, Phillips KA. Motives to use
drugs in body dysmorphic disorder. 2016 ADAA Annual Conference. Philadelphia, PA:
Anxiety and Depression Association of America, 2016
66
drugs in body dysmorphic disorder. 2016 ADAA Annual Conference. Philadelphia, PA:
Anxiety and Depression Association of America, 2016
drugs in body dysmorphic disorder. American Psychiatric Association Annual Meeting.
Atlanta, GA: APA, 2016
227. Quinn E, Phillips KA, Stout RL, Afeltra JK. Investigation of multiple episodes in the
longitudinal course of body dysmorphic disorder. 23rd Annual OCD Conference,
International OCD Foundation. Chicago, IL, 2016
228. Phillips KA, Tyrka AR, Philip NS, Guthrie T, Vargas SE. Brown’s NIMH-funded grant to
support psychiatry resident research training: overview and 2016-2017 update. Mind
Brain Research Day 2017. Providence, RI: Brown University 2017:81
229. Gallo M, Phillips KA, Bloom C, Bath K. Inhibiting inhibition: consequences of GABRG-2
on fear and anxiety. Mind Brain Research Day 2017. Providence, RI: Brown University
2017:34
230. Ritzert T, Brodt M, Kelly M, Menard W, Phillips KA. Social avoidance as a predictor of
psychosocial functioning in body dysmorphic disorder: a prospective longitudinal
analysis. Mind Brain Research Day 2017. Providence, RI: Brown University 2017:93
231. Phillips KA, Tyrka AR, Philip NS, Vargas SE, Morriss D, Guthrie T. Brown’s NIMH-
funded grant to support psychiatry resident research training: overview and 2016-2017
update. Medical Education Scholarship Workshop Poster Session, Alpert Medical
School of Brown University. Providence, RI, 2017
232. Porth R, Mothi SS, Fang A, Wilhelm S, Phillips KA. Maladaptive schemas in individuals
with body dysmorphic disorder. 51st annual convention of the Association for Behavioral
and Cognitive Therapies. San Diego, CA, 2017
233. Ritzert T, Brodt M, Kelly M, Menard W, Phillips KA. Social avoidance as a predictor of
analysis. 51st annual convention of the Association for Behavioral and Cognitive
Therapies. San Diego, CA, 2017
234. Phillips KA, Ritzert T, Brodt M, Menard W, Kelly M. Social avoidance as a predictor of
analysis. 2018 ADAA Annual Conference. Washington, DC: Anxiety and Depression
Association of America, 2018
systems: Results from an American Society of Clinical Psychopharmacology
membership survey. Annual Meeting of the American Society of Clinical
Psychopharmacology (NCDEU). Miami, FL: ASCP, 2018:W69
67
systems: Results from an American Society of Clinical Psychopharmacology
membership survey. American College of Neuropsychopharmacology 57th Annual
Meeting. Hollywood, FL: ACNP, 2018:139
PRESENTATIONS
1. Body Dysmorphic Disorder. Workshop on Reflections on Body Image, American

Psychiatric Association 143rd Annual Meeting. New York, NY, May 14, 1990
2. The Depressive Personality: A Review. Symposium on Depressive Personality Disorder,

American Psychiatric Association 143rd Annual Meeting. New York, NY, May 15, 1990
3. The Depressive Personality. The Postgraduate Education Program on Personality

Disorders, McLean Hospital. Belmont, MA, April 4, 1991
4. Depressive Personality: A Critical Reappraisal. Etiologic and Therapeutic Issues in

Personality Disorders, The Psychiatric Society of Virginia Annual Meeting. Richmond,
VA, April 6, 1991
5. Body Dysmorphic Disorder. The Stanley Cobb Assembly, The Boston Society of
Neurology and Psychiatry. Boston, MA, May 23, 1991
6. Body Dysmorphic Disorder: 30 Cases of Imagined Ugliness. Academic Conference,

McLean Hospital. Belmont, MA, May 31, 1991
7. Controversies Surrounding the Diagnosis of Depressive Personality. Second

International Congress on the Disorders of the Personality. Oslo, Norway, August 30,
1991
8. Body Dysmorphic Disorder: 30 Cases of Imagined Ugliness. Columbia University

Anxiety Disorders Research Group. New York, NY, September 27, 1991
9. Body Dysmorphic Disorder: 30 Cases of Imagined Ugliness. Center for Mental Health
and Retardation Services. Waltham, MA, October 24, 1991
10. Body Dysmorphic Disorder: 30 Cases of Imagined Ugliness (poster presentation).

Scientific Advisory Committee Research Program, McLean Hospital. Belmont, MA,
November 18, 1991
11. Body Dysmorphic Disorder: The Distress of Imagined Ugliness. Grand Rounds,
University of Cincinnati College of Medicine. Cincinnati, OH, November 20, 1991
12. Body Dysmorphic Disorder. Friends of McLean Semi-Annual Lecture, McLean Hospital.
Belmont, MA, November 25, 1991
13. Body Dysmorphic Disorder: 50 Cases of Imagined Ugliness. Primary Care Psychiatry
Unit, Massachusetts General Hospital. Boston, MA, February 12, 1992
68
14. Body Dysmorphic Disorder: 50 Cases of Imagined Ugliness. Manic-Depressive

Depressive Association (MDDA), McLean Hospital. Belmont, MA, February 12, 1992
15. Body Dysmorphic Disorder: 50 Cases of Imagined Ugliness. Corrigan Mental Health
Center. Fall River, MA, February 27, 1992
16. Personality Disorders. Comprehensive Review and Update in Psychiatry, Department of

Postgraduate and Continuing Education, McLean Hospital. Cambridge, MA, March 14,
1992
17. Body Dysmorphic Disorder. Postgraduate Education Program, McLean Hospital.

Belmont, MA, April 16, 1992
18. Symposium on Depressive Personality: New Data and Perspectives (Chairperson).

American Psychiatric Association 145th Annual Meeting. Washington DC, May 5, 1992
19. An Empirical Study of Depressive Personality. Symposium on Depressive Personality:

New Data and Perspectives, American Psychiatric Association 145th Annual Meeting.
Washington DC, May 5, 1992
20. Pharmacotherapy, Psychiatric Disorders, and Suicide. Course on Suicide and Clinical
Practice, American Psychiatric Association 145th Annual Meeting. Washington DC, May
5, 1992
21. Body Dysmorphic Disorder: The Distress of Imagined Ugliness. Grand Rounds, Albert
Einstein College of Medicine. New York, NY, May 15, 1992
22. Body Dysmorphic Disorder. Obsessive Compulsive and Related Disorders Support
Network, McLean Hospital. Belmont, MA, July 14, 1992
23. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Dartmouth
Medical School. Hanover, NH, August 4, 1992
24. Personality Disorders and DSM. Harvard University Extension School. Cambridge, MA,
August 11, 1992
25. Mixed Disorders and Comorbidity in Personality Disorder Classification (Symposium

Discussant). American Psychological Association Annual Meeting. Washington DC,
August 16, 1992
26. Body Dysmorphic Disorder. Harvard University Health Services. Cambridge, MA,
September 10, 1992
27. The Treatment of Depression in Borderline Personality Disorder. California Pacific

Medical Center. San Francisco, CA, September 26, 1992
28. Body Dysmorphic Disorder. Obsessive Compulsive Disorder Clinic, Massachusetts

General Hospital. Boston, MA, November 19, 1992
69
29. Body Dysmorphic Disorder. Association for Advancement of Behavior Therapy 26th
Annual Convention. Boston, MA, November 21, 1992
30. Body Dysmorphic Disorder: 84 Cases of Imagined Ugliness. Grand Rounds, Brigham
and Women's Hospital. Boston, MA, December 1, 1992
31. Pharmacotherapy, Psychiatric Disorders, and Suicide. A Training Forum on Suicide,

McLean Hospital. Belmont, MA, January 9, 1993
32. Body Dysmorphic Disorder: Data on Imagined Ugliness. Psychopharmacology Lunch

Program, McLean Hospital. Belmont, MA, February 4, 1993
33. Genetic and Treatment Factors in Nonpsychotic Psychiatric Disorders (Discussant).

Sanibel Island Symposium. Sanibel Island, Florida, February 10-12, 1993
34. Body Dysmorphic Disorder. Brookline Mental Health Center. Brookline, MA, February
19, 1993
35. Body Dysmorphic Disorder: Data on Imagined Ugliness. Massachusetts Institute of

Technology Psychiatry Service. Cambridge, MA, February 24, 1993
36. Body Dysmorphic Disorder: 84 Cases of Imagined Ugliness. First International

Obsessive Compulsive Disorder Conference. Capri, Italy, March 13, 1993
37. Body Dysmorphic Disorder: 84 Cases of Imagined Ugliness. Obsessive Compulsive and
Related Disorders Support Network, McLean Hospital. Belmont, MA, March 15, 1993
38. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Massachusetts
General Hospital. Boston, MA, April 8, 1993
39. Psychopharmacology, Psychiatric Disorders, and Suicide. Corrigan Mental Health

Center. Fall River, MA, April 14, 1993
40. Body Dysmorphic Disorder: 100 Cases of Imagined Ugliness (poster presentation).
Harvard Research Day, Department of Psychiatry, Harvard Medical School. Boston, MA,
April 21, 1993
41. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Carrier
Foundation. Belle Mead, NJ, May 6, 1993
42. The Treatment of Body Dysmorphic Disorder. Symposium sponsored by the American
Society of Clinical Psychopharmacology, American Psychiatric Association Annual
Meeting. San Francisco, CA, May 23, 1993
43. The Assessment and Treatment of Refractory Depression. Symposium on New

Horizons in the Management of Complicated Anxiety and Depressive Disorders,
American Psychiatric Association Annual Meeting. San Francisco, CA, May 24, 1993
70
44. The Pharmacotherapy of Suicide. Course on Suicide and Clinical Practice, American
Psychiatric Association Annual Meeting. San Francisco, CA, May 24, 1993
45. If It Changes, Was It a Personality Disorder? Symposium on The Concept of Personality

Change, American Psychiatric Association Annual Meeting. San Francisco, CA, May 27,
1993
46. Body Dysmorphic Disorder: Can It Be Psychotic? (poster presentation). NCDEU (New
Clinical Drug Evaluation Unit Program) Annual Meeting. Boca Raton, FL, June 3, 1993
47. An Empirical Study of Depressive Personality Disorder. Third International Congress on

the Disorders of Personality. Cambridge, MA, September 10, 1993
48. Is Body Dysmorphic Disorder a Well-Defined Nosological Entity? Symposium on

Controversies on Dysmorphophobia. Badalona, Spain, October 1, 1993
49. The Assessment and Treatment of Refractory Depression. Symposium on The

Diagnosis and Treatment of Complicated Anxiety and Depression, American Psychiatric
Association 45th Institute on H&CP. Baltimore, MD, October 8, 1993
50. When Your Patient Doesn't Respond: Strategies in the Assessment and Treatment of
Refractory Depression. Teleconference and Outreach Education, California Pacific
Medical Center. San Francisco, CA, October 14, 1993
51. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Tenth
Annual Psychopharmacology Symposium, Consultation and Education Service Network
of the Fall River/New Bedford Site Office, Massachusetts Department of Mental Health.
Westport, MA, October 27, 1993
52. The Assessment and Treatment of Refractory Depression. Symposium on Treatment

Strategies for Complicated Depression and Agitation, 6th Annual U.S. Psychiatric
Congress. San Diego, CA, November 18, 1993
53. Body Dysmorphic Disorder. Psychopharmacology Program, Cambridge City Hospital.

Cambridge, MA, December 8, 1993
54. Body Dysmorphic Disorder: 100 Cases of Imagined Ugliness. Research Seminar,
Western Psychiatric Institute and Clinic. Pittsburgh, PA, December 20, 1993
55. Body Dysmorphic Disorder: Research Findings on Imagined Ugliness. Grand Rounds,
Medical University of South Carolina. Charleston, SC, January 4, 1994
56. Body Dysmorphic Disorder: Data on Imagined Ugliness. Psychopharmacology Seminar,

Westwood Lodge. Westwood, MA, January 24, 1994
57. Pharmacotherapy and Suicide. Clinical Update: A Forum on Suicide, Consolidated

Department of Psychiatry, Harvard Medical School. Boston, MA, January 29, 1994
71
58. Body Dysmorphic Disorder: Diagnosis and Treatment of an Underrecognized Disorder.

The American College of Psychiatrists Annual Meeting. Kona, Hawaii, February 11,
1994
59. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Duke University
School of Medicine. Durham, NC, March 10, 1994
60. A Comparison of Delusional and Nondelusional Body Dysmorphic Disorder in 100 Cases
(poster presentation). Harvard Research Day, Department of Psychiatry, Harvard
Medical School. Boston, MA, March 10, 1994
61. Personality Disorders. Comprehensive Review and Update in Psychiatry, Department of

Postgraduate and Continuing Education, McLean Hospital. Belmont, MA, March 12,
1994
62. Body Dysmorphic Disorder: Data on Imagined Ugliness. Metro-West Medical Center.
Natick, MA, March 22, 1994
63. Body Dysmorphic Disorder: Data on Imagined Ugliness. Child and Adolescent Program
Academic Conference, McLean Hospital. Belmont, MA, April 7, 1994
64. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, The Institute of
Pennsylvania Hospital. Philadelphia, PA, May 3, 1994
65. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, University of
Minnesota School of Medicine. Minneapolis, MN, May 9, 1994
66. Body Dysmorphic Disorder: Obsessive Compulsive or Affective Spectrum Disorder?

Symposium on Obsessive-Compulsive Spectrum Disorders, American Psychiatric
Association Annual Meeting. Philadelphia, PA, May 21, 1994
67. Body Dysmorphic Disorder: Data on Imagined Ugliness. Symposium on OCD Spectrum
Disorders: Theory and Treatment, American Psychiatric Association Annual Meeting.
Philadelphia, PA, May 22, 1994
68. The Pharmacotherapy of Suicide. Course on Suicide and Clinical Practice, American
Psychiatric Association Annual Meeting. Philadelphia, PA, May 23, 1994.
69. Symposium on Can Certain Nonpsychotic Disorders Be Psychotic (Chairperson).

American Psychiatric Association Annual Meeting. Philadelphia, PA, May 24, 1994
70. Body Dysmorphic Disorder: Can It Be Psychotic? Symposium on Can Certain

Nonpsychotic Disorders Be Psychotic, American Psychiatric Association Annual
Meeting. Philadelphia, PA, May 24, 1994
71. Paper Session on Treatment of Mood Disorders (Chairperson). American Psychiatric

Association Annual Meeting. Philadelphia, PA, May 25, 1994
72
72. Severe Personality Disorders and Course of Axis I Illness (Symposium Discussant).
American Psychiatric Association Annual Meeting. Philadelphia, PA, May 25, 1994
73. Depressive Personality: Current Status. Symposium on Affective Personalities and

DSM-IV, American Psychiatric Association Annual Meeting. Philadelphia, PA, May 26,
1994
74. An Empirical Study of Depressive Personality Disorder. Psychopharmacology Lecture

Series on the Origin and Treatment of Personality Disorders, Massachusetts General
Hospital. Boston, MA, June 17, 1994
75. Body Dysmorphic Disorder: The Relationship of an Obsessive Compulsive Disorder to

the Medical Setting. The American Association of General Hospital Psychiatrists Fifth
Annual Meeting. Washington, DC, June 25, 1994
76. Body Dysmorphic Disorder: Data on Imagined Ugliness. Obsessive-Compulsive

Spectrum Disorders, McLean Hospital. Cambridge, MA, November 4, 1994
77. Delusional and Nondelusional Variants of Body Dysmorphic Disorder: Implications for
Classification and Treatment. American Psychiatric Association New York State Capital
District Branch Annual Meeting. Albany, NY, November 8, 1994
78. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, The Albany
Medical College. Albany, NY, November 9, 1994
79. Developmental Implications of Body Dysmorphic Disorder. The Albany Medical College.
Albany, NY, November 9, 1994
80. Body Dysmorphic Disorder: Diagnosis and Treatment of an OCD-Spectrum Disorder.

Conference on Setting a New Standard in OCD. Chicago, Ill, November 12, 1994
81. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Beth Israel
Medical Center, Albert Einstein College of Medicine. New York, NY, November 17, 1994
82. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Difficult
Case Conference, Mental Health Services of Cranston. Johnston, RI, November 18,
1994
83. Body Dysmorphic Disorder and Olfactory Reference Syndrome: Diagnosis and
Treatment of Under-recognized Somatic Delusional Syndromes. Practical
Psychopharmacology '95, CME Inc. Las Vegas, Nevada, January 14, 1995
84. Body Dysmorphic Disorder: The Ugly Duckling Revisited. Grand Rounds, Jefferson
Medical College. Philadelphia, PA, January 18, 1995
85. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Conference
on OCD-Spectrum Disorders, Butler Hospital. Providence, RI, January 25, 1995
73
86. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Butler
Hospital Staff Association, Butler Hospital. Providence, RI, March 2, 1995
87. Body Dysmorphic Disorder in a Surgical Setting. Plastic Surgery Conference, Rhode
Island Hospital. Providence, RI, March 8, 1995
88. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Maisonneuve-
Rosemont Hospital, University of Montréal. Montréal, Canada, March 9, 1995
89. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Jewish General
Hospital, McGill University School of Medicine. Montréal, Canada, March 9, 1995
90. Body Dysmorphic Disorder: Data on Imagined Ugliness. Quebec City, Canada, March 9,
1995
91. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Montréal
General Hospital, McGill University School of Medicine. Montréal, Canada, March 10,
1995
92. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Medical College
of Georgia. Augusta, GA, March 16, 1995
93. Body Dysmorphic Disorder: Data on Imagined Ugliness. Eisenhower Medical Center.
Fort Gordon, GA, March 16, 1995
94. Body Dysmorphic Disorder: Data on Imagined Ugliness. Grand Rounds, Mount Sinai
School of Medicine. New York, NY, March 21, 1995

Grand Rounds, The University of Kansas Medical Center School of Medicine-Wichita.
Wichita, KA, March 28, 1995
96. Body Dysmorphic Disorder: Data on Imagined Ugliness. Anxiety Disorders Association
of America Annual Meeting. Pittsburgh, PA, April 8, 1995

Northern California Psychiatric Society Annual Meeting. Monterey, CA, April 9, 1995
98. Dysmorphophobia: Clinical Features and the Use of Serotonin-Reuptake Inhibitors in

Treatment. 6th International Congress on Dermatology and Psychiatry. Amsterdam,
Netherlands, April 22, 1995
99. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Butler
Hospital Professional Lecture Series. Providence, RI, April 26, 1995
100. Body Dysmorphic Disorder and Social Phobia. Anxiety Disorders Screening Day Panel
Presentation. Providence, RI, May 3, 1995
74
101. Body Dysmorphic Disorder. Western Missouri Mental Health Center, University of
Missouri School of Medicine. Kansas City, MO, May 11, 1995
102. Imagined Ugliness: Body Dysmorphic Disorder. Grand Rounds, University of Kansas
Medical Center. Kansas City, KS, May 12, 1995
103. Body Dysmorphic Disorder. Grand Rounds, Norwood Hospital. Norwood, MA, May 16,
1995
104. Body Dysmorphic Disorder: The Delusionality Controversy. Symposium on New Insights
in Body Dysmorphic Disorder, American Psychiatric Association Annual Meeting. Miami,
FL, May 24, 1995
105. Body Dysmorphic Disorder in a Medical Setting. Symposium on OCD-Spectrum

Disorders in a Medical Setting, American Psychiatric Association Annual Meeting.
Miami, FL, May 26, 1995
106. Symposium on OCD-Spectrum Disorders in a Medical Setting (Chairperson). American

Psychiatric Association Annual Meeting. Miami, FL, May 26, 1995
107. Body Dysmorphic Disorder: Diagnosis and Treatment. Symposium on The Treatment of
Depression, Alpert Medical School of Brown University. Providence, RI, June 2, 1995
108. Diagnosis and Treatment of Olfactory Reference Syndrome. Professional Lecture

Series. Butler Hospital. Providence, RI, June 14, 1995
109. Personality Measures in Depressive Personality Disorder. 4th International Congress on

the Disorders of Personality, International Society for the Study of Personality Disorders.
Dublin, Ireland, June 22, 1995
110. Body Dysmorphic Disorder: Diagnosis and Treatment. New Frontiers in OCD Spectrum
Research for Psychiatry and Primary Care. Augusta, MI, September 21, 1995
111. Depression Screening Day Panel Presentation, Butler Hospital. Providence, RI, October
5, 1995
112. Somatoform Disorders. The Role of Social Approaches in the Concept of Psychiatric
Management, American Psychiatric Association Institute on Psychiatric Services.
Boston, MA, October 7, 1995
113. Pharmacotherapy and Suicide. Course on Suicide and Clinical Practice, American
Psychiatric Association Institute on Psychiatric Services. Boston, MA, October 10, 1995
114. Body Dysmorphic Disorder: Recognition and Treatment. Psychiatric Update 1995,
University of Wisconsin Medical School. Madison, WI, November 10, 1995
115. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. U.S.
Psychiatric and Mental Health Congress. New York, NY, November 19, 1995
75
116. Olfactory Reference Syndrome: Clinical Features of an Underrecognized Disorder. U.S.

Psychiatric and Mental Health Congress. New York, NY, November 19, 1995
117. Body Dysmorphic Disorder. Grand Rounds, Montefiore Medical Center, Albert Einstein
College of Medicine. New York, NY, November 22, 1995
118. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Symposium
on New Research in Obsessive Compulsive Spectrum Disorders. Madrid, Spain,
January 22, 1996
119. Recognition, Diagnosis, and Treatment of Body Dysmorphic Disorder. Psychiatry

Lecture Series, Rhode Island Hospital. Providence, RI, January 31, 1996
120. How Long Should We Treat OCD? (Symposium Discussant) Second International
Obsessive Compulsive Disorder Conference. Saint Francis, Guadeloupe, February 16,
1996
121. Is There a Distinct OCD Spectrum? (Symposium Discussant). Second International

Obsessive Compulsive Disorder Conference. Saint Francis, Guadeloupe, February 17,
1996
122. Body Dysmorphic Disorder: Diagnosis and Treatment. Grand Rounds, Friends Hospital,
The University of Pennsylvania School of Medicine. Philadelphia, PA, February 28, 1996
123. Body Dysmorphic Disorder: Diagnosis and Treatment. Grand Rounds, School of
Osteopathic Medicine, University of Medicine and Dentistry of New Jersey. Cherry Hill,
NJ, February 28, 1996
124. Body Dysmorphic Disorder and Dermatology. The College of Physicians of Philadelphia.
Philadelphia, PA, February 28, 1996
125. Body Dysmorphic Disorder: Diagnosis and Treatment. Psychopharmacology Lecture

Series, Massachusetts Mental Health Center. Boston, MA, March 1, 1996
126. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Grand
Rounds, St. Vincent’s Hospital, University of Massachusetts School of Medicine.
Worcester, MA, March 5, 1996
127. Body Dysmorphic Disorder. Grand Rounds, Westchester County Medical Center, New
York Medical College. Valhalla, NY, April 11, 1996
128. Body Dysmorphic Disorder. OCD Spectrum Disorders, Stanford University School of
Medicine. Palo Alto, CA, April 13, 1996
129. Body Dysmorphic Disorder and Anorexia Nervosa. Family Medicine Conference,
Memorial Hospital. Pawtucket, RI, April 18, 1996
130. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. American
College of Obstetrics and Gynecology Annual Meeting. Denver, CO, April 29, 1996
76
131. Social Phobia and Body Dysmorphic Disorder. Anxiety Disorders Screening Day Panel
Presentation. Providence, RI, May 1, 1996
132. Body Dysmorphic Disorder and Olfactory Reference Syndrome: Are They OCD-
Spectrum Disorders? American Psychiatric Association Annual Meeting. New York, NY,
May 8, 1996
133. Pharmacologic Treatment of Body Dysmorphic Disorder. NCDEU 36th Annual Meeting,
National Institute of Mental Health. Boca Raton, FL, May 29, 1996
134. Recognizing and Treating Body Dysmorphic Disorder. OC Foundation Lecture Series.
Belmont, MA, June 4, 1996
135. In the Mind’s Eye: Body Dysmorphic Disorder and the Plastic Surgeon. Grand Rounds,
Department of Plastic Surgery, Brigham and Women’s Hospital. Boston, MA, June 7,
1996
136. Body Dysmorphic Disorder. Consultation-Liaison Lecture Series, Massachusetts

General Hospital. Boston, MA, June 7, 1996
137. Body Dysmorphic Disorder and Somatic Delusional Disorders. CME, Inc. Santa Fe, NM,
June 14, 1996
138. Body Dysmorphic Disorder. University of Cincinnati College of Medicine. Cincinnati, OH,
September 7, 1996
139. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Academic
Conference, Pembroke Hospital. Pembroke, MA, October 2, 1996
140. Body Dysmorphic Disorder. Exploring the Spectrum of Obsessive-Compulsive

Disorders, Canadian Psychiatric Association. Quebec City, Canada, October 3, 1996
141. Body Dysmorphic Disorder. 8th Annual NARSAD Scientific Symposium. New York, NY,
October 11, 1996
142. Evaluation and Treatment of Somatoform Disorders. American College of Psychiatrists

Psychiatric Update Audiotape Program. October 17, 1996
143. New Clinical Strategies in Diagnosing and Managing Body Dysmorphic Disorder. The
State of the Art in the Clinical Management of Anxiety Disorders and ADHD, University
of California, Davis. Sacramento, CA, October 19, 1996
144. Recognizing and Treating Body Dysmorphic Disorder. Providence Center. Providence,
RI, October 30, 1996
145. Body Dysmorphic Disorder: Research on Imagined Ugliness. First Annual Research
Symposium on Mental Health Sciences, Department of Psychiatry, Brown Medical
School. Providence, RI, November 7, 1996
77
146. Body Dysmorphic Disorder and the OCD Spectrum. University of Pittsburgh Medical
Center. Pittsburgh, PA, November 8, 1996
147. Body Dysmorphic Disorder: Diagnosis and Management of Imagined Ugliness. Western
New York Psychiatry Update, SUNY at Buffalo. Buffalo, NY, November 9, 1996
148. Body Dysmorphic Disorder. Providence VA Medical Center. Providence, RI, November
13, 1996
149. Diagnosing and Treating Body Dysmorphic Disorder. Boston, MA, November 13, 1996
150. Body Dysmorphic Disorder and Comorbidity: An OCD Spectrum Disorder. Grand
Rounds, Causeway VA Medical Center, Boston University School of Medicine. Boston,
MA, November 15, 1996
151. Body Dysmorphic Disorder. Better Treatments for Children and Adolescents, CME Inc.
Atlanta, GA, December 6, 1996
152. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Grand
Rounds, St. Luke’s Hospital. North Dartmouth, MA, January 7, 1997
153. Body Obsession: Understanding Body Dysmorphic Disorder. Alpert Medical School of
Brown University. Providence, RI, March 4, 1997
154. Body Dysmorphic Disorder, OCD, and Psychosis. Advanced Psychopharmacology

Seminar, Cambridge Hospital. Cambridge, MA, March 12, 1997
155. Body Dysmorphic Disorder: Diagnosis and Treatment. Grand Rounds, Mayo Clinic.
Rochester, MN, April 1, 1997
156. Body Dysmorphic Disorder: Diagnosis and Treatment. Grand Rounds, University of Utah
School of Medicine. Salt Lake City, UT, April 21, 1997
157. Recognizing and Treating Body Dysmorphic Disorder. American College of Obstetrics
and Gynecology Annual Meeting. Las Vegas, NV, April 26, 1997
158. Development of a Screening Instrument for Body Dysmorphic Disorder (poster

presentation). Annual Meeting of the American Society of Dermatologic Surgery. Boston,
MA, May 9, 1997
159. Panel on Strategies for Treating Sexual Side Effects of Psychotropic Medications
(Chairperson). NCDEU 37th Annual Meeting, National Institute of Mental Health. Boca
Raton, FL, May 28, 1997
160. Relationship Between Comorbid Personality Disorders and Treatment Received in

Patients with Anxiety Disorders. 5th International Congress on the Disorders of
Personality. Vancouver, Canada, June 26, 1997
78
161. Paper Session on Personality, Axis I Disorders, and Epidemiology (Chairperson). 5th
International Congress on the Disorders of Personality. Vancouver, Canada, June 26,
1997
162. Body Dysmorphic Disorder and the OCD Spectrum: Phenomenology and Prevention.
105th Convention of the American Psychological Association. Chicago, IL, August 18,
1997
163. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. The
American Osteopathic Association 102 Annual Convention and Scientific Seminar. San
Antonio, TX, October 23, 1997
164. Recognizing and Treating Body Dysmorphic Disorder. Pittsburgh, PA, October 29, 1997
Rounds, St. Francis Medical Center. Pittsburgh, PA, October 30, 1997
166. Visiting Professor Workshop, St. Francis Medical Center. Pittsburgh, PA, October 30,
1997
167. Body Dysmorphic Disorder: When Appearance Becomes an Obsession. Mental Health
Awareness Series, Brown University. Providence, RI, November 6, 1997
168. The OCD Spectrum and Body Dysmorphic Disorder. Methodist Hospitals of Memphis.
Memphis, TN, November 15, 1997
169. Body Dysmorphic Disorder. Grand Rounds, Charter Behavioral Health System of
Brookside/New England. Nashua, NH, November 18, 1997
170. Body Dysmorphic Disorder and Its Relationship to Obsessive Compulsive Disorder.
McLean Hospital. Belmont, MA, November 21, 1997
171. Body Dysmorphic Disorder. Behavioral Health Specialists. Warwick, RI, January 6, 1998
172. Body Dysmorphic Disorder. Grand Rounds, University at Buffalo School of Medicine.
Buffalo, NY, January 9, 1998
173. Body Dysmorphic Disorder. Family Medicine Conference, Memorial Hospital of Rhode
Island, Alpert Medical School of Brown University. Pawtucket, RI, January 15, 1998
174. Body Dysmorphic Disorder. Psychopharmacology Grand Rounds, McLean Hospital.

Belmont, MA, March 5, 1998
175. Perceived Stress in Body Dysmorphic Disorder (poster presentation). Anxiety Disorders
Association of America 18th National Conference. Boston, MA, March 25, 1998
176. The Elephant Man: Treating a Patient with Long-Standing Body Dysmorphic Disorder.
Anxiety Disorders Association of America 18th National Conference. Boston, MA, March
27, 1998
79
177. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Second
Annual Life Span Mental Health Conference, The University of Utah Neuropsychiatric
Institute. Salt Lake City, UT, March 28, 1998
178. The OCD Spectrum and Body Dysmorphic Disorder. University of Brescia Medical
School. Brescia, Italy, April 18, 1998
179. Body Dysmorphic Disorder: Diagnosis and Treatment of Imagined Ugliness. Grand
Rounds, Morristown Memorial Hospital, University of Medicine and Dentistry of New
Jersey. Morristown, NJ, April 22, 1998
180. Retrospective Follow-Up Study of Body Dysmorphic Disorder (poster presentation).

Alpert Medical School of Brown University. Providence, RI, May 1, 1998
181. Office Treatment of Body Dysmorphic Disorder: Recognizing and Treating Imagined
Ugliness. Silver Hill Hospital and New York University Medical School Department of
Psychiatry. New Canaan, CT, May 2, 1998
182. Body Dysmorphic Disorder. The 1998 Global Summit on Aesthetic Surgery, The
American Society for Aesthetic Plastic Surgery. Los Angeles, CA, May 6, 1998
183. Body Dysmorphic Disorder. Rhode Island Medical Women’s Association Annual
Meeting. Warwick, RI, May 12, 1998
184. Antidepressants. Dermatology Resident Conference, Alpert Medical School of Brown

University. Providence, RI, May 15, 1998
185. Body Dysmorphic Disorder. Grand Rounds, Royal Ottawa Hospital, University of Ottawa
School of Medicine. Ottawa, Canada, May 20, 1998
186. A Clinician’s Guide to Body Dysmorphic Disorder. Ottawa, Canada, May 20, 1998
187. Case Conference (Discussant), Butler Hospital. Providence, RI, May 21, 1998

Medical Education Collaborative teleconference series. June 15, 16, 18, 25, 1998
189. Body Dysmorphic Disorder: When Appearance Becomes an Obsession. Staff

Development Day, Brown University. Providence, RI, June 16, 1998
190. Body Dysmorphic Disorder. Massachusetts Psychiatric Society. Sandwich, MA, June 24,
1998
191. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. CME, Inc.
Hilton Head, SC, June 27, 1998
192. Understanding and Treating Body Dysmorphic Disorder. Grand Rounds, Foothills
Hospital, University of Calgary School of Medicine. Calgary, Canada, August 25, 1998
80
193. The Broken Mirror: A Clinician’s Guide to Body Dysmorphic Disorder. Calgary, Canada,
August 25, 1998
194. Understanding and Treating Body Dysmorphic Disorder. Psychiatry Luncheon Rounds.
Grey Nuns Hospital, University of Edmonton School of Medicine. Edmonton, Canada,
August 26, 1998
195. The Broken Mirror: A Clinician’s Guide to Body Dysmorphic Disorder. Edmonton,
Canada, August 26, 1998
196. Body Dysmorphic Disorder: Clinical Features and Relationship to OCD. 10th Bienniel
Congress, Society of Psychiatrists of South Africa (Regional Meeting of the World
Psychiatric Association). Johannesburg, South Africa, September 10, 1998
197. Diagnosis and Treatment Issues in Body Dysmorphic Disorder. 10th Bienniel Congress,
Society of Psychiatrists of South Africa (Regional Meeting of the World Psychiatric
Association). Johannesburg, South Africa, September 10, 1998
198. Body Dysmorphic Disorder. Symposium on Recent Advances and the Future of
Research in Psychiatry, McLean Hospital. Belmont, MA, September 12, 1998
199. Body Dysmorphic Disorder. Grand Rounds, McMaster University. Hamilton, Canada,
September 23, 1998
200. Diagnosing and Treating Body Dysmorphic Disorder. Grand Rounds, Newton Wellesley
Hospital. Newton, MA, October 1, 1998
201. Body Dysmorphic Disorder: Identifying and Understanding the Psychologically Disturbed
Aesthetic Surgery Patient. Association of Plastic Surgery Assistants Annual Meeting.

Medical Education Collaborative teleconference series. October 7, 15, 19, 26, 1998
203. Recognizing and Treating Body Dysmorphic Disorder. Obsessive Compulsive

Foundation, Greater Boston Affiliate, McLean Hospital. Belmont, MA, November 3, 1998
204. Advances in Body Dysmorphic Disorder. Audioconference sponsored by the University

of South Dakota School of Medicine. November 5 and 19, 1998
205. Perceptual Training, Visual Organization, and Memory in Body Dysmorphic Disorder
(poster presentation). Association for Advancement of Behavior Therapy 32nd Annual
Convention. Washington, DC, November 14, 1998
206. Recognizing and Treating Body Dysmorphic Disorder in Depressed Patients. 11th
Annual New York State Office of Mental Health Research Conference. Albany, NY,
December 3, 1998
81
207. Body Dysmorphic Disorder: When Appearance Becomes an Obsession. Women and
Infants Hospital, Alpert Medical School of Brown University. Providence, RI, December
4, 1998
208. Faculty Development Workshop (Panel Participant). Alpert Medical School of Brown
University. Providence, RI, January 21, 1999
209. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Western
Psychiatric Institute and Clinic Symposium on Women and Mental Health. Pittsburgh,
PA, January 29, 1999
Rounds, Harvard Medical School. Boston, MA, March 2, 1999
Rounds, University of Medicine and Dentistry of New Jersey. Newark, NJ, March 3, 1999
Rounds, University of Pennsylvania School of Medicine. Philadelphia, PA, March 11,
1999
213. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. The 21st
Winter Psychiatry Conference, Karl Menninger School of Psychiatry and Mental Health
Sciences. Park City, UT, March 15, 1999
214. Controversies and Treatment Challenges in Body Dysmorphic Disorder. The 21st Winter
Psychiatry Conference, Karl Menninger School of Psychiatry and Mental Health
Sciences. Park City, UT, March 15, 1999
Rounds, UCLA. Los Angeles, CA, March 16, 1999
Rounds, New Hampshire Hospital, Dartmouth Medical School. Concord, NH, April 1,
1999
217. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Karolinska
Institute. Stockholm, Sweden, April 13, 1999
218. Muscle Dysmorphia: When Muscles Become an Obsession. Eastern Psychological

Association Annual Meeting. Providence, RI, April 17, 1999
219. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. University of
Massachusetts School of Medicine. Worcester, MA, April 29, 1999
220. Controversies in the Treatment of Body Dysmorphic Disorder. Brea, CA, May 7, 1999
82
221. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. Obsessive
Compulsive and Spectrum Disorders Association Biannual Conference. Universal City,
CA, May 8, 1999
222. Forum on the Practice Guidelines for Borderline Personality Disorder. American
Psychiatric Association Annual Meeting. Washington, DC, May 19, 1999
223. Symposium on Body Dysmorphic Disorder (Chairperson). American Psychiatric

Association Annual Meeting. Washington, DC, May 19, 1999
224. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Connecticut
Mental Health Center, Yale University School of Medicine. New Haven, CT, May 25,
1999
225. Body Dysmorphic Disorder: Controversies and Treatment Strategies. Fairfield, CT, May
25, 1999
226. The Broken Mirror: When Appearance Becomes an Obsession. 29th Annual
Commencement Forums, Brown University. Providence, RI, May 29, 1999
227. Body Dysmorphic Disorder: When Appearance Becomes an Obsession. Staff

Development Day, Brown University. Providence, RI, June 8, 1999
228. Update on Body Dysmorphic Disorder. Holyoke Hospital Dinner Meeting. Holyoke, MA,
June 10, 1999
Rounds, Holyoke Hospital. Holyoke, MA, June 11, 1999
230. Body Dysmorphic Disorder: Diagnosing and Treating an OCD-Spectrum Disorder.

Philadelphia, PA, June 23, 1999
231. Body Dysmorphic Disorder: Diagnostic and Treatment Controversies. Grand Rounds,
Friends Hospital. Philadelphia, PA, June 24, 1999
232. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Vestra, NY,
June 30, 1999
233. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Albany, NY,
June 30, 1999
234. Efficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder. Teleconference,

August 3, 1999
235. Perceived Stress in Body Dysmorphic Disorder (poster presentation). American

Psychological Association Annual Meeting. Chicago, IL, August 22, 1999
236. Body Dysmorphic Disorder. European College of Neuropsychopharmacology. London,

England, September 21, 1999
83
237. OCD and Anxiety Spectrum Disorders: A Focus on Body Dysmorphic Disorder. South
Barrington, IL, October 12, 1999
238. The OCD Spectrum: A Focus on Body Dysmorphic Disorder. Grand Rounds, Forest
Hospital. Des Plaines, IL, October 13, 1999
239. The Broken Mirror: When Appearance Becomes an Obsession. Parents’ Weekend,
Brown University. Providence, RI, October 16, 1999
240. Diagnosing and Treating Body Dysmorphic Disorder. Grand Rounds, SUNY Stony Brook
University. Stony Brook, NY, October 21, 1999
241. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Stony Brook,
NY, October 21, 1999
Rounds, University of Colorado School of Medicine. Denver, CO, October 27, 1999
Rounds, University of Connecticut School of Medicine. Farmington, CT, November 5,
1999
244. Pharmacotherapy of Body Dysmorphic Disorder. Fourth Annual Psychopharmacology

Conference, SUNY Health Science Center. Syracuse, NY, November 11, 1999
Rounds, Medical College of Virginia Hospitals, Virginia Commonwealth University.
Richmond, VA, November 12, 1999
Rounds, Jefferson Medical College. Philadelphia, PA, December 1, 1999
247. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Science
Lecture Series in Psychiatry, Tufts University School of Medicine. Boston, MA,
December 20, 1999
Rounds, Payne Whitney Clinic, Weill Medical College of Cornell University. New York,
NY, January 5, 2000
249. Obsessive Compulsive Spectrum Disorders. American Academy of Clinical Psychiatrists

Psychiatric Update Audiotape Program. January 12, 2000
250. Body Dysmorphic Disorder in Children and Adolescents: Recognizing and Treating
Imagined Ugliness. Child and Adolescent Psychiatry Grand Rounds, Alpert Medical
School of Brown University. Providence, RI, January 19, 2000
84
251. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Clinical Lunch
Series, Department of Psychology, Yale University. New Haven, CT, February 3, 2000
252. Body Dysmorphic Disorder. Closed Roundtable Forum, Fourth International Obsessive
Compulsive Disorder Conference. St. Thomas, US Virgin Islands, February 13, 2000
253. Body Dysmorphic Disorder: New Research Findings. Center for Clinical Research for
Anxiety Disorders. Sydney, Australia, March 15, 2000
254. Body Dysmorphic Disorder. Feast of Psychiatry, Fremantle Hospital and Health Service.
Fremantle, Australia, March 17, 2000
255. Body Dysmorphic Disorder. CME Weekend Conference 2000, Western Australia Branch
of the Royal Australia and New Zealand College of Psychiatrists. Rottnest Island,
Australia, March 18, 2000
256. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. New York,
NY, March 23, 2000
Rounds, St. Vincent’s Hospital, New York Medical College. Staten Island, NY, March 24,
2000
258. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Garden City,
NY, March 24, 2000
259. New Research Findings on Body Dysmorphic Disorder. Psychopharmacology Lecture

Series, Massachusetts General Hospital. Boston, MA, March 31, 2000
Rounds, Baylor College of Medicine. Houston, TX, April 5, 2000
261. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. Clinical
Update 2000, CME Inc. Kona, Hawaii, April 9, 2000
Rounds, Dorthea Dix Hospital, The University of North Carolina. Durham, NC, April 28,
2000
Rounds, The University of North Carolina at Chapel Hill. Chapel Hill, NC, April 28, 2000
264. Body Image in Adolescents: Context and Curricula. American Psychiatric Association
Annual Meeting. Chicago, IL, May 17, 2000
265. Update on the Practice Guideline on Borderline Personality Disorder. American

Psychiatric Association Annual Meeting. Chicago, IL, May 18, 2000
85
266. Methodological Challenges in Pediatric Clinical Trials (Chairperson). NCDEU 40th

Annual Meeting, National Institute of Mental Health. Boca Raton, FL, May 30, 2000
267. Body Dysmorphic Disorder in Children and Adolescents. Adolescent Medicine Update of
Issues in Health Care, Rhode Island Hospital, Alpert Medical School of Brown
University. Providence, RI, June 12, 2000
268. Body Dysmorphic Disorder. Symposium on Serotonin Spectrum Disorders, McLean

Hospital. Bedford, MA, June 16, 2000
269. Body Dysmorphic Disorder: Research on Imagined Ugliness. Cambridge, MA, June 25,
2000
270. Diagnosis and Treatment of Body Dysmorphic Disorder. 6th Annual Santa Fe Psychiatric
Symposium. Santa Fe, NM, June 29, 2000
271. Grantsmanship Strategies and Study Design. Cambridge, MA, July 25, 2000
272. Efficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder. Teleconference,

August 10, 2000
Rounds, The University of Rochester School of Medicine. Rochester, NY, September 27,
2000
274. Body Dysmorphic Disorder: The Disease of Imagined Ugliness. First Annual
International Neuroscience and Mental Health Fair. New York, NY, November 5, 2000
275. Workshop on Body Dysmorphic Disorder. First Annual International Neuroscience and
Mental Health Fair. New York, NY, November 5, 2000
276. Body Dysmorphic Disorder. Grand Rounds, Regions Hospital. St. Paul, MN, November
21, 2000
277. Body Dysmorphic Disorder. Grand Rounds, University of Minnesota School of Medicine.
Minneapolis, MN, November 22, 2000
278. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Clinical
Update Series, Duke University Medical Center. Durham, NC, December 9, 2000
Rounds, The University of Chicago. Chicago, IL, January 8, 2001
Rounds, The University of Virginia School of Medicine. Charlottesville, VA, January 16,
2001
Rounds, Western State Hospital. Staunton, VA, January 17, 2001
86
282. Body Dysmorphic Disorder: Diagnosis and Treatment. 31st Annual Colorado Psychiatric
Society Mid-Winter Meeting. Keystone, CO, January 27, 2001
283. Body Dysmorphic Disorder. Grand Rounds, Montefiore Medical Center, Albert Einstein
College of Medicine. New York, NY, March 8, 2001
284. Body Dysmorphic Disorder. Grand Rounds, Oregon Health Sciences University School
of Medicine. Portland, OR, March 13, 2001
285. Body Dysmorphic Disorder in Adolescents. Symposium on Adolescence, McLean

Hospital. Cambridge, MA, March 24, 2001
286. Body Dysmorphic Disorder: What Every Surgeon Needs to Know. 2001 National Plastic
Surgery Senior Residents Conference, Alpert Medical School of Brown University.
Providence, RI, March 29, 2001
287. Women, Body Image, and Body Dysmorphic Disorder. Symposium on Self-Destructive
Behaviors in Women, Cambridge Hospital. Boston, MA, March 31, 2001
288. Body Dysmorphic Disorder. Grand Rounds, Hillside Hospital, Albert Einstein College of
Medicine. Glen Oaks, New York, April 11, 2001
289. Body Dysmorphic Disorder. Grand Rounds, Stanford University Medical Center.
Stanford, CA, April 19, 2001
290. Body Dysmorphic Disorder in Men. American Psychiatric Association 2001 Annual
Meeting. New Orleans, LA, May 8, 2001
291. Symposium on Body Image Disorders in Men (Chairperson). American Psychiatric

Association 2001 Annual Meeting. New Orleans, LA, May 8, 2001
292. Update on the Practice Guideline on Borderline Personality Disorder. American

Psychiatric Association 2001 Annual Meeting. New Orleans, LA, May 9, 2001
293. Update on Body Dysmorphic Disorder. American Psychiatric Association 2001 Annual
294. Psychiatry Update: Somatoform and Factitious Disorder (Chairperson). American

Psychiatric Association 2001 Annual Meeting. New Orleans, LA, May 9, 2001
295. The Breadth of the OCD Spectrum and Some Treatment Considerations. NCDEU 41st
Annual Meeting, National Institute of Mental Health. Phoenix, AZ, May 29, 2001
296. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. The 7th
World Congress of Biological Psychiatry. Berlin, Germany, July 4, 2001
297. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. CME, Inc.
Vancouver, Canada, July 13, 2001
87
298. Body Dysmorphic Disorder. The American Medical Women's Association Advanced
Curriculum on Women's Health Second International Conference. Cleveland, OH,
August 4, 2001
Rounds, Harvard University Health Services. Cambridge, MA, October 11, 2001
300. An Update on Treatment Strategies for Body Dysmorphic Disorder. The Melbourne
Clinic. Melbourne, Australia, November 21, 2001
301. When the Mind Distorts the Body: The Psychiatry of Body Dysmorphic Disorder. Mental
Health Research Institute, University of Melbourne. Melbourne, Australia, November 22,
2001
302. Update on BDD: Recognizing and Treating Imagined Ugliness. Butler Hospital Staff
Association Meeting, Butler Hospital. Providence, RI, December 6, 2001
303. Psychosis in Body Dysmorphic Disorder. Symposium on Non-Schizophrenic Psychoses.

Stanford University School of Medicine. Stanford, CA, January 21, 2002
304. Hyperawareness and Unawareness in Body Dysmorphic Disorder. 13th Annual Meeting
of the American Neuropsychiatric Association. La Jolla, CA, March 11, 2002
305. Body Dysmorphic Disorder. Grand Rounds, University of Texas Medical Branch at
Galveston. Galveston, TX, March 12, 2002
306. Body Dysmorphic Disorder. University of Melbourne. Melbourne, Australia, March 25,
2002
307. Body Dysmorphic Disorder in Men: Not Just a Women's Problem. 2002 International
Conference on Eating Disorders, Academy for Eating Disorders. Boston, MA, April 26,
2002
308. "My Face is My Fate": Biological and Psychological Approaches to the Treatment of a
Woman with Obsessions and Delusions. Semi-Annual Case Conference, Massachusetts
General Hospital and McLean Hospital. Boston, MA, May 1, 2002
309. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Washington
Psychiatric Society. Washington, DC, June 3, 2002
310. The Study and Treatment of Nonschizophrenic Psychoses (Chairperson). NCDEU 42nd
Annual Meeting, National Institute of Mental Health. Boca Raton, FL, June 12, 2002
311. The Significance of Psychosis in Body Dysmorphic Disorder. NCDEU 42nd Annual
Meeting, National Institute of Mental Health. Boca Raton, FL, June 12, 2002
312. Body Dysmorphic Disorder. Women and Infants Hospital, Alpert Medical School of
Brown University. Providence, RI, August 2, 2002
88
Rounds, Roanoke Memorial Hospital, University of Virginia. Roanoke, VA, September 5,
2002
314. Body Dysmorphic Disorder in Children and Adolescents. Grand Rounds, Division of
Child and Adolescent Psychiatry, Alpert Medical School of Brown University.
Providence, RI, September 25, 2002
315. Body Dysmorphic Disorder: Update on an OCD Spectrum Disorder. Rockford Health
System, University of Illinois College of Medicine at Rockford. Rockford, IL, October 10,
2002
316. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Psychiatric
Update, University of Wisconsin Medical School and the Madison Institute of Medicine.
Madison, WI, November 8, 2002
317. Body Image: Distortion to Dysmorphia. Eating Disorder Professionals of Colorado.

Denver, CO, January 25, 2003
318. Treatment of Syndromes with Overvalued Ideas. Tenth International Symposium on

Controversies in Psychiatry. Barcelona, Spain, April 4, 2003
319. Update on Clinical Features and Pharmacotherapy of Body Dysmorphic Disorder. The
Priory Hospital. North London, England, May 7, 2003
320. Body Dysmorphic Disorder. 10th International Congress of the European Society for
Dermatology and Psychiatry. Brussels, Belgium, May 9, 2003
321. Body Dysmorphic Disorder Questionnaires. 10th International Congress of the European
Society for Dermatology and Psychiatry. Brussels, Belgium, May 9, 2003
322. Obsessions and Compulsions in Adults. New York, NY, June 18, 2003
323. Obsessions and Compulsions in Adults. Grand Rounds, Northern Westchester Hospital.
Mount Kisco, NY, June 19, 2003
324. Body Dysmorphic Disorder: Current Clinical and Therapeutic Features. Université Victor
Segalen. Bordeaux, France, September 27, 2003
325. Women, Body Image, and Body Dysmorphic Disorder. 2003 Illinois Women’s Health
Conference, Illinois Department of Public Health. Rosemont, Ill, October 29, 2003
326. Body Dysmorphic Disorder: Update on Imagined Ugliness. American Psychiatric

Association 55th Institute on Psychiatric Services. Boston, MA, October 30, 2003
327. OCD Spectrum—The Importance of Collaboration (Symposium Discussant). 6th

International Obsessive Compulsive Disorder Conference. Lanzarote, Spain, November
14, 2003
89
328. Insight in Body Dysmorphic Disorder. American Association of Behavior Therapy Annual
Meeting. Boston, MA, November 21, 2003
Rounds, Northwestern University Medical School. Chicago, IL, January 14, 2004
Rounds, University of Florida. Gainsville, FL, March 12, 2004
331. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Unity Health
System Ninth Annual Spring Conference. Rochester, NY, April 23, 2004
332. Update on the Clinical Features and Treatment of Body Dysmorphic Disorder. American
Psychiatric Association 2004 Annual Meeting. New York, NY, May 4, 2004
333. Update on Pharmacotherapy for Body Dysmorphic Disorder. American Psychiatric

Association 2004 Annual Meeting. New York, NY, May 6, 2004
334. Body Dysmorphic Disorder. NIMH NCDEU 44th Annual Meeting. Phoenix, AZ, June 2,
2004
335. Body Dysmorphic Disorder and Other OC-Spectrum Disorders: Clinical and Therapeutic
Perspectives. Collegium Internationale Neuropsychopharmacologicum (CINP). Paris,
France, June 24, 2004
336. Body Dysmorphic Disorder: What Every Plastic Surgeon Should Know. Grand Rounds,
Harvard Medical School Department of Plastic Surgery. Boston, MA, November 17,
2004
337. Opportunities for Professional Writing. Office of Women in Medicine, Alpert Medical
School of Brown University. Providence, RI, December 8, 2004
Rounds, The Cooper Health System, Robert Wood Johnson Medical School (University
of Medicine and Dentistry of New Jersey). Camden, NJ, March 8, 2005
Rounds, Cedars-Sinai Medical Center, University of California at Los Angeles. Los
Angeles, CA, April 7, 2005
340. Body Dysmorphic Disorder: Overview of Clinical Features, Surgical and Dermatologic
Treatment, and Pharmacotherapy, UCLA Body Dysmorphic Disorder Conference. Los
Angeles, CA, April 23, 2005
341. Symposium on A Sex/Gender Research Agenda for DSM-V (Chairperson). American

Psychiatric Association Annual Meeting. Atlanta, GA, May 23, 2005
90
342. Publishing Research. Workshop on Practical Tips on How to Be a Successful Author.

American Psychiatric Association Annual Meeting. Atlanta, GA, May 23, 2005
343. A Mock Grant Review. NCDEU (National Institute of Mental Health) 45th Annual
Meeting. Boca Raton, FL, June 8, 2005
344. Body Dysmorphic Disorder: Identifying and Understanding a Severe Body Image
Problem. American Medical Association and PTA Media Briefing. New York, NY, August
11, 2005
Rounds, New York-Presbyterian, Westchester Division, Weill Cornell Medical College of
Cornell University. White Plains, NY, September 6, 2005
Rounds, Payne Whitney at New York-Presbyterian/Weill Cornell Medical Center, Weill
Cornell Medical College of Cornell University. New York, NY, September 7, 2005
347. How To Get Published (workshop for residents). Fall Components Meeting, American
Psychiatric Association. Washington, DC, September 7, 2005
Rounds, Lenox Hill Hospital, New York University. New York, NY, November 9, 2005
349. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Rhode Island
College. North Providence, RI, April 13, 2006
Rounds, Boston University School of Medicine. Boston, MA, May 11, 2006
351. Body Dysmorphic Disorder. Obsessive Compulsive Behavior Spectrum. The Future of
Psychiatric Diagnosis: Refining the Research Agenda, American Psychiatric Institute for
Research and Education, American Psychiatric Association. Arlington, VA, June 22,
2006
352. Body Dysmorphic Disorder: Recognizing and Treating Imagined Ugliness. Professional
Education Program, Butler Hospital. Providence, RI, July 28, 2006
353. An Update on Clinical Features and Medication Treatment of Body Dysmorphic

Disorder. 2nd Annual Body Dysmorphic Disorder Conference. Hempstead, NY, October
21, 2006
354. Help, Education, and Resources for Treating Body Dysmorphic Disorder. 2nd Annual
Body Dysmorphic Disorder Conference. Hempstead, NY, October 21, 2006
355. How to Recognize and Manage Body Dysmorphic Disorder. 2nd Annual Body
Dysmorphic Disorder Conference. Hempstead, NY, October 22, 2006
91
Rounds, Dartmouth Medical School. Lebanon, NH, January 9, 2007
357. Women in Medicine Fireside Chat. Dartmouth Medical School. Hanover, NH, January 9,
2007
Rounds, Emory University School of Medicine. Atlanta, GA, March 14, 2007
359. Perspectives on DSM-V. 10th Annual Scientific Research Symposium, Anxiety Disorders
Association of America Annual Meeting. St. Louis, MO, March 29, 2007
360. Body Dysmorphic Disorder. Grand Rounds, Department of Surgery, The Warren Alpert
Medical School of Brown University. Providence, RI, April 24, 2007
361. Faculty Workshop on Research with Underserved Populations (Panel Member).

Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of
Brown University. Providence, RI, April 27, 2007
362. Body Dysmorphic Disorder. Symposium on Advances in Treatments of Psychiatric

Disorders. American Psychiatric Association 2007 Annual Meeting. San Diego, CA, May
21, 2007
363. Symposium on DSM-V: Obsessive-Compulsive Related Disorders (Symposium

Discussant). American Psychiatric Association 2007 Annual Meeting. San Diego, CA,
May 22, 2007
364. Body Dysmorphic Disorder. Neuroscience Seminar Series, McLean Hospital. Belmont,
MA, June 5, 2007
365. The Broken Mirror: An Update on Body Dysmorphic Disorder. Grand Rounds, Tufts
University School of Medicine. Boston, MA, October 15, 2007
Rounds, Baylor College of Medicine. Houston, TX, November 7, 2007
367. How Can Translational Neuroscience Inform DSM-V? The Example of the OCD
Spectrum. Study Group Chair and Presenter, American College of
Neuropsychopharmacology 46th Annual Meeting. Boca Raton, FL, December 10, 2007
368. Perspectives and Controversies: Rethinking Anxiety and Mood Disorders for DSM-V.
Association of America Annual Meeting. Savannah, GA, March 7, 2008
369. Are Body Dysmorphic Disorder and Hypochondriasis Anxiety Disorders? Anxiety
Disorders Association of America Annual Meeting. Savannah, GA, March 7, 2008
370. Body Dysmorphic Disorder: Clinical Features and Therapeutic Approaches. Symposium
on Affective Disorders (“Affektive Erkrankungen – was gibt es Neues?”), Klinik Schlossli
AG. Zurich, Switzerland, March 15, 2008
92
371. The Broken Mirror: An Update on Body Dysmorphic Disorder. Butler Hospital Staff
Association Meeting, Butler Hospital. Providence, RI, April 3, 2008
372. Publishing Research. Workshop on Practical Tips on How to Be a Successful Author,

American Psychiatric Association Annual Meeting. Washington, DC, May 5, 2008
373. Body Dysmorphic Disorder. Symposium on Impulsive-Compulsive Spectrum Disorders:

Recognition and Clinical Management, American Psychiatric Association Annual
Meeting. Washington, DC, May 8, 2008
374. Assessment and Treatment of Body Dysmorphic Disorder. Tenth Annual Future Leaders
in Psychiatry Symposium, Emory University School of Medicine. Orlando, FL, May 24,
2008
375. Mock Grant Review Participant. Workshop on How an Idea Becomes an NIMH-Funded
Grant, NCDEU (National Institute of Mental Health) 48th Annual Meeting. Phoenix, AZ,
May 27, 2008
376. OCD Classification in DSM-V. 15th Annual Obsessive Compulsive Foundation

Conference. Boston, MA, August 1, 2008
377. Body Dysmorphic Disorder. Grand Rounds, University of Virginia School of Medicine.
Charlottesville, VA, September 9, 2008
378. Body Dysmorphic Disorder: What Every Dermatologist Needs to Know. Grand Rounds,
Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Boston
University School of Medicine. Providence, RI, September 24, 2008
379. An Update on the DSM-V Development Process. 24th International Society for Traumatic
Stress Studies Annual Meeting. Chicago, IL, November 14, 2008
Rounds, University of Massachusetts Medical School. Worcester, MA, November 20,
2008
381. An Update on Body Dysmorphic Disorder. Division of Clinical Therapeutics, Columbia

University Department of Psychiatry. New York, NY, January 7, 2009
382. Body Dysmorphic Disorder: An Underrecognized Disorder of Youth. Grand Rounds,

Bradley Hospital, Alpert Medical School of Brown University. East Providence, RI,
January 14, 2009
383. Recognizing and Treating a Hidden Obsession: An Update on Body Dysmorphic

Disorder. Professional Lecture Series, Butler Hospital. Providence, RI, February 17,
2009
93
384. Body Dysmorphic Disorder: Clinical Features and Pharmacotherapy. 29th Annual
Conference, Anxiety Disorders Association of America. Albuquerque, NM, March 14,
2009
385. Distorted Body Image: Clinical Features, Diagnosis, and Treatment of Body Dysmorphic
Disorder. National Institute of Mental Health. Rockville, MD, April 2, 2009
386. Body Dysmorphic Disorder. Grand Rounds, Keck School of Medicine, University of
Southern California. Los Angeles, CA, April 14, 2009
387. DSM-V: Progress in Research and Development. American Psychiatric Association

Annual Meeting. San Francisco, CA, May 18, 2009
388. An Update on DSM-V. International Anxiety Disorders Symposium. Amsterdam, The

Netherlands, May 27, 2009
389. Distorted Body Image: Recognizing and Treating Body Dysmorphic Disorder. Friends of
Butler Hospital Lecture Series, Butler Hospital. Providence, RI, September 10, 2009
390. Body Dysmorphic Disorder. Presented at the Festschrift in Honor of Martin B. Keller,
M.D. Butler Hospital/Warren Alpert Medical School of Brown University. Providence, RI,
October 8, 2009
391. Olfactory Reference Syndrome. Bench to Bedside Presentation: Unraveling Diseases of

the Nervous System. Brown University Division of Biology and Medicine. Providence, RI,
October 14, 2009
392. An Update from the Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic, and

Dissociative Disorders DSM-V Work Group. American College of
Neuropsychopharmacology Annual Meeting. Hollywood, FL, December 9, 2009
393. Distorted Body Image: Clinical Features and Treatment of Body Dysmorphic Disorder.
14th Congress of the Italian Society of Psychopathology. Rome, Italy, February 17, 2010
394. Recognizing and Treating Body Dysmorphic Disorder in the Ambulatory Setting. Grand
Rounds, Weill Medical College of Cornell University. New York, NY, March 3, 2010
395. DSM-V: Its Impact on Practice and Research (Panel Participant). 30th Annual
Conference of the Anxiety Disorders Association of America. Baltimore, MD, March 5,
2010
396. The Clinical Course of Body Dysmorphic Disorder in the Harvard/Brown Anxiety
Research Project (HARP) (poster presentation). 30th Annual Conference of the Anxiety
Disorders Association of America. Baltimore, MD, March 5, 2010
397. Panic Attacks in Individuals with Body Dysmorphic Disorder (poster presentation). 30th
Annual Conference of the Anxiety Disorders Association of America. Baltimore, MD,
March 5, 2010
94
398. Two Comparison Studies of Body Dysmorphic Disorder Versus Social Phobia (poster
presentation). 30th Annual Conference of the Anxiety Disorders Association of America.
Baltimore, MD, March 5, 2010
399. Body Dysmorphic Disorder: What Physicians Need to Know. Grand Rounds, Department
of Medicine, Rhode Island Hospital/Warren Alpert Medical School of Brown University.
Providence, RI, March 9, 2010
400. Everything You Need to Know About Body Dysmorphic Disorder. Psychiatric Update,
University of Wisconsin School of Medicine and Public Health, and the Madison Institute
of Medicine. Madison, WI, March 19, 2010
401. Body Dysmorphic Disorder: What Clinicians Need to Know. Grand Rounds, Boston
Medical Center, Boston University School of Medicine. Boston, MA, April 1, 2010
402. Delusions in OCD-Spectrum Disorders. XVII International Symposium on Current Issues

and Controversies in Psychiatry, Hospital Universitari Germans Trias i Pujol and Hospital
Universitari de Bellvitge. Barcelona, Spain, April 16, 2010
403. Psychotherapy of Body Dysmorphic Disorder. American Psychiatric Association Annual

404. DSM-5 Update on Anxiety Disorders and Obsessive-Compulsive Spectrum Disorders.

American Psychiatric Association Annual Meeting. New Orleans, LA, May 25, 2010
405. New Findings on the Clinical Features of Body Dysmorphic Disorder. 6th World
Congress of Behavioral and Cognitive Therapies. Boston, MA, June 3, 2010
406. DSM-5 and Anxiety (Panel Participant). 6th World Congress of Behavioral and Cognitive
Therapies. Boston, MA, June 3, 2010
407. Cultural Variations in Social Anxiety and Taijin Kyofusho (Symposium Discussant). 6th
World Congress of Behavioral and Cognitive Therapies. Boston, MA, June 5, 2010
408. Body Dysmorphic Disorder. 6th Comprehensive Review of Psychiatry Conference,

University of Buffalo. Buffalo, NY, September 24, 2010
409. Body Dysmorphic Disorder and Its Management. OCD Master Class, Karolinska
Institute. Stockholm, Sweden, October 6, 2010
410. How DSM-5 Will Change Your Clinical Practice. Karolinska Institute. Stockholm,
Sweden, October 7, 2010
411. An Update on DSM-5: Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and

Dissociative Disorders. Grand Rounds, McLean Hospital. Belmont, MA, February 3,
2011
412. Case Study: Body Dysmorphic Disorder. 2011 Annual Meeting, American College of
Psychiatrists. San Francisco, CA, February 23, 2011
95
413. Body Dysmorphic Disorder and Personality. 2011 Annual Meeting, American College of
Psychiatrists. San Francisco, CA, February 25, 2011
414. Rejection Sensitivity in Body Dysmorphic Disorder (poster presentation). 31st Annual
Conference, Anxiety Disorders Association of America. New Orleans, LA, March 25,
2011
415. New Developments in the Conceptualization and Cognitive-Behavioral Therapy of

Obsessive-Compulsive Spectrum Disorders (Symposium Discussant). 31st Annual
Conference, Anxiety Disorders Association of America. New Orleans, LA, March 26,
2011
416. Research Symposium: Update on Body Dysmorphic Disorder: Research Findings and
Treatment Approaches (Chairperson). 31st Annual Conference, Anxiety Disorders
Association of America. New Orleans, LA, March 26, 2011
417. Phenomenology and Pharmacotherapy of Body Dysmorphic Disorder: Key Features and
New Findings. 31st Annual Conference, Anxiety Disorders Association of America. New
Orleans, LA, March 26, 2011
418. Body Dysmorphic Disorder. Grand Rounds, Newport Hospital. Newport, RI, April 15,
2011
419. DSM-5 Update: Obsessive-Compulsive Spectrum Disorders. 18th Annual Conference,

International OCD Foundation. San Diego, CA, July 29, 2011
420. Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic, and Dissociative Disorders:

Metastructure and Other Proposals for DSM-5. 63rd Institute on Psychiatric Services,
American Psychiatric Association. San Francisco, CA, October 30, 2011
421. Body Dysmorphic Disorder. Psychopharmacology and Neuroscience Course: Update

2011. Sponsored by the National Institutes of Health and George Washington University
Medical Center. Bethesda, MD, November 11, 2011
422. Update on DSM-5: Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and

Dissociative Disorders. Grand Rounds, Warren Alpert Medical School of Brown
University. Providence, RI, January 4, 2012
423. Body Dysmorphic Disorder: What Clinicians Need to Know. Grand Rounds, Sheppard
Pratt Health System. Towson, MD, January 11, 2012
424. Body Dysmorphic Disorder: What Clinicians Need to Know. Grand Rounds, University of
Connecticut Health Center. Farmington, CT, January 20, 2012
425. Body Dysmorphic Disorder: Diagnosis and Treatment. Grand Rounds and Visiting
Professor, University of Florida. Gainesville, FL, February 10, 2012
96
426. Body Dysmorphic Disorder. 17th Annual Psychopharmacology Conference, Nevada

Psychiatric Association. Las Vegas, NV, February 16, 2012
427. Body Dysmorphic Disorder: What Every Clinician Needs to Know. Grand Rounds,
Harvard University Health Services. Cambridge, MA, March 22, 2012
428. Understanding and Treating Body Dysmorphic Disorder. Grand Rounds, Dartmouth
Medical School. Hanover, NH, April 10, 2012
429. DSM-5 Update on Anxiety, Depressive, Obsessive-Compulsive Spectrum, and Trauma-

Related Disorders (Chair and Panelist). 32nd Anxiety Disorders Association of America
Annual Conference. Arlington, VA, April 12, 2012
430. Clinical Workshop: Cognitive-Behavioral Therapy for Body Dysmorphic Disorder. 32nd
Anxiety Disorders Association of America Annual Conference. Arlington, VA, April 13,
2012
431. Modular CBT for Body Dysmorphic Disorder: Predictors of Change in Body Dysmorphic
Disorder Symptom Severity. 32nd Anxiety Disorders Association of America Annual
Conference. Arlington, VA, April 13, 2012
432. Research Symposium on Initial Reports from the Harvard/Brown Anxiety Research
Project Phase II: A Study on the Nature, Course, and Treatment of Anxiety Disorders in
African American, Latino, and Caucasian Samples (Discussant). 32nd Anxiety Disorders
Association of America Annual Conference. Arlington, VA, April 14, 2012
433. Body Dysmorphic Disorder. North American Society for Psychosocial Obstetrics and
Gynecology 2012 Annual Meeting. Providence, RI, April 23, 2012
434. Update on Proposed Changes for DSM-5 Anxiety Disorders and Obsessive-Compulsive
and Related Disorders. American Psychiatric Association 165th Annual Meeting.
Philadelphia, PA, May 6, 2012
435. Symposium on Update on Body Dysmorphic Disorder (Chair). American Psychiatric

Association 165th Annual Meeting. Philadelphia, PA, May 8, 2012
436. Body Dysmorphic Disorder: Clinical Features, Assessment, and Proposed Changes for
DSM-5. American Psychiatric Association 165th Annual Meeting. Philadelphia, PA, May
8, 2012
437. Ask the Experts: Questions and Answers on Body Dysmorphic Disorder. 19th Annual
OCD Conference, International OCD Foundation. Chicago, IL, July 28, 2012
438. Phenomenology and Treatment of Body Dysmorphic Disorder: Key Features and New
Data. 19th Annual OCD Conference, International OCD Foundation. Chicago, IL, July 28,
2012
439. New Developments in DSM-5. Conference on Depression, Anxiety, and Stress in 2012.
McLean Hospital/Harvard Medical School. Boston, MA, September 7, 2012
97
440. Understanding and Treating Body Dysmorphic Disorder. Grand Rounds, Department of
Psychiatry, University of Wisconsin School of Medicine. Madison, WI, October 12, 2012
441. Body Dysmorphic Disorder: What Plastic Surgeons Need to Know. Grand Rounds,
Division of Plastic Surgery, University of Wisconsin School of Medicine. Madison, WI,
October 12, 2012
442. Body Dysmorphic Disorder: What Clinicians Need to Know. Grand Rounds, Department
of Psychiatry, Tufts University School of Medicine. Boston, MA, November 20, 2012
443. Body Dysmorphic Disorder: Understanding and Treating an Underrecognized Disorder.

2013 Annual Meeting of the South Carolina Psychiatric Association. Charleston, SC,
February 3, 2013
444. What’s New for DSM-5. Signature Seminar Series, Duke-National University of
Singapore Graduate Medical School. Singapore, Singapore, February 26, 2013
445. What’s New for DSM-5. Dinner lecture sponsored by Duke-National University of
Singapore Graduate Medical School. Singapore, Singapore, February 26, 2013
446. Discussant. General Psychiatry Combined Grand Ward Rounds, Institute of Mental
Health. Buangkok, Singapore, February 27, 2013
447. Body Dysmorphic Disorder. Continuing Psychiatric Education Session, Institute of

Mental Health. Buangkok, Singapore, February 27, 2013

Voice Annotated Presentation, Duke-National University of Singapore Graduate Medical
School. Singapore, Singapore, February 27, 2013
449. DSM-5. Voice Annotated Presentation, Duke-National University of Singapore Graduate

Medical School. Singapore, Singapore, February 27, 2013
450. DSM-5: What’s New and Different. KK Women’s and Children’s Hospital. Little India,
Singapore, February 28, 2013
451. Body Dysmorphic Disorder: Clinical Features and Management. KK Women’s and
Children’s Hospital. Little India, Singapore, February 28, 2013
452. Starting a Research Career. Discussion with Medical Students, Duke-National University
of Singapore Graduate Medical School. Singapore, Singapore, March 1, 2013
453. How to Develop a Research Career. Discussion with Khoo Scholars, Duke-National
University of Singapore Graduate Medical School. Singapore, Singapore, March 1, 2013
454. How to Develop a Research Career. Research Rounds, KK Women’s and Children’s
Hospital. Little India, Singapore, March 1, 2013
98
455. What’s New for DSM-5: Anxiety and Obsessive-Compulsive and Related Disorders.
Grand Rounds, University of Texas Medical Branch at Galveston. Galveston, TX, March
12, 2013
456. Body Dysmorphic Disorder: Update on an Underrecognized Disorder. Grand Rounds,

New York-Presbyterian Hospital and Weill Cornell Medical College - Westchester
Division. White Plains, NY, March 19, 2013

New York-Presbyterian Hospital and Weill Cornell Medical College - Manhattan Division.
New York, NY, March 20, 2013

Department of Psychiatry Research Conference, Johns Hopkins University School of
Medicine. Baltimore, MD, April 9, 2013
459. Body Dysmorphic Disorder. Presentation for undergraduate students, Brown University.
Providence, RI, April 18, 2013
460. Body Dysmorphic Disorder: Clinical and Translational Research Findings. Brown
Institute for Brain Science Lunch. Providence, RI, April 25, 2013
461. Body Dysmorphic Disorder. 2nd Annual Course on the Treatment of Obsessive-
Compulsive Disorder and Related Conditions, Yale University School of Medicine. New
Haven, CT, April 30, 2013
462. Anxiety Disorders and Obsessive-Compulsive and Related Disorders. Master Course
on DSM-5. American Psychiatric Association 166th Annual Meeting. San Francisco, CA,
May 18, 2013
463. Introduction and Co-Chair. Symposium on Anxiety Disorders in DSM-5. American

Psychiatric Association 166th Annual Meeting. San Francisco, CA, May 18, 2013
464. Body Dysmorphic Disorder. American Psychiatric Association 166th Annual Meeting. San
Francisco, CA, May 19, 2013
465. Symposium on Trauma and Stress-Related and Dissociative Disorders in DSM-5 (Co-
Chair). American Psychiatric Association 166th Annual Meeting. San Francisco, CA, May
20, 2013
466. Symposium on Obsessive-Compulsive and Related Disorders in DSM-5 (Chair).

American Psychiatric Association 166th Annual Meeting. San Francisco, CA, May 20,
2013
467. Changes for Obsessive-Compulsive and Related Disorders in DSM-5: The

Metastructure, Insight Specifiers, and Criteria for Body Dysmorphic Disorder. American
Psychiatric Association 166th Annual Meeting. San Francisco, CA, May 20, 2013
468. Panel Discussion: Extramural Perspective. 2013 New Investigators’ Workshop. Annual
99
Meeting of the American Society of Clinical Psychopharmacology. Hollywood, FL, May

27, 2013
469. DSM-5. Psychiatry in 2013 Conference, Harvard Medical School and McLean Hospital.
Boston, MA, June 13, 2013
470. What’s New for DSM-5. The Mental Health Center of Greater Manchester. Bedford, NH,
June 14, 2013
471. Body Dysmorphic Disorder. Department of Social Work, Rhode Island Hospital.
Providence, RI, June 19, 2013
472. Symposium on Recent Research Findings on Body Dysmorphic Disorder (Chair). 20th
Annual OCD Conference, International OCD Foundation. Atlanta, GA, July 19, 2013
473. Suicidality in Body Dysmorphic Disorder. 20th Annual OCD Conference, International
OCD Foundation. Atlanta, GA, July 19, 2013
474. DSM-5 Has Arrived: How Revisions to OCD and Related Disorders May Impact
Clinicians, Patients, and Families (Professional Plenary). 20th Annual OCD Conference,
International OCD Foundation. Atlanta, GA, July 19, 2013
475. Ask the Experts: Question and Answer Session on Body Dysmorphic Disorder. 20th
Annual OCD Conference, International OCD Foundation. Atlanta, GA, July 20, 2013
476. Anxiety Disorders and Obsessive-Compulsive and Related Disorders: What’s New for
DSM-5. Webinar sponsored by Global Medical Education. August 22, 2013
477. DSM-5: What’s New for Anxiety Disorders, Obsessive-Compulsive and Related
Disorders, and PTSD. Webinar sponsored by the Anxiety and Depression Association of
America (ADAA). August 29, 2013
478. Highlights of Changes for DSM-5: Anxiety Disorders, Obsessive-Compulsive and

Related Disorders, and PTSD. Conference on DSM-5: Implications for Child and
Adolescent Diagnoses, Bradley Hospital, Alpert Medical School of Brown University.
Riverside, RI, September 12, 2013
479. What’s New for DSM-5: Overview and Changes for Anxiety Disorders, Obsessive-
Compulsive and Related Disorders, and Trauma- and Stressor-Related Disorders.
Grand Rounds, Silver Hill Hospital. New Canaan, CT, September 19, 2013
480. Body Dysmorphic Disorder: Clinical Features, Diagnosis, Treatment, and Neurobiology.
Smith College Colloquium. Northampton, MA, October 3, 2013
481. Obsessive-Compulsive and Related Disorders in DSM-5. University of Wisconsin Annual

Update and Advances in Psychiatry Conference. Madison, WI, October 12, 2013
482. Body Dysmorphic Disorder. Grand Rounds, Beth Israel Medical Center. New York, NY,
October 17, 2013
100
483. DSM-5 Has Arrived: Major Changes and Their Implications for Clinical Practice. Quality
Behavioral Health and South Coast Educational Collaborative. Providence, RI, October
25, 2013

New York University School of Medicine. New York, NY, November 14, 2013
485. Changes for DSM-5: Anxiety Disorders, Obsessive-Compulsive and Related Disorders,
and Trauma- and Stressor-Related Disorders. Grand Rounds (Visiting Scholar Series),
McLean Hospital. Belmont, MA, February 27, 2014
486. Anger, Aggression, and Violent Behavior in Individuals with Body Dysmorphic Disorder.
2nd Annual New England OCD Research Symposium, Yale University. New Haven, CT,
March 7, 2014
487. Workshop on Key Changes for Obsessive-Compulsive and Related Disorders and Their
Relevance to Clinical Practice (Chair). Anxiety and Depression Association of America
Annual Conference. Chicago, IL, March 28, 2014
488. DSM-5 Chapter Structure and Key Changes for Body Dysmorphic Disorder. Anxiety and
Depression Association of America Annual Conference. Chicago, IL, March 28, 2014
489. Workshop on Key Changes for DSM-5 and Their Relevance to Clinical Practice:
Depressive Disorders, Anxiety Disorders, Obsessive-Compulsive and Related Disorders,
and Trauma- and Stressor-Related Disorders (Chair). Anxiety and Depression
Association of America Annual Conference. Chicago, IL, March 29, 2014
490. DSM-5 Chapter Structure, Measures, and Key Changes for Obsessive-Compulsive and
Related Disorders. Anxiety and Depression Association of America Annual Conference.
Chicago, IL, March 29, 2014
491. Suicidal Ideation, Suicide Attempts, and Completed Suicide in Patients with Body
Dysmorphic Disorder: Research Findings and a Suggested Treatment Approach.
Anxiety and Depression Association of America Annual Conference. Chicago, IL, March
29, 2014
and Trauma- and Stressor-Related Disorders. Department of Social Work, Rhode Island
Hospital. Providence, RI, April 16, 2014
493. Anxiety Disorders and Obsessive-Compulsive and Related Disorders. Master Course on
“DSM-5: What You Need to Know.” American Psychiatric Association 167th Annual
Meeting. New York, NY, May 3, 2014
494. Body Dysmorphic Disorder and the DSM-5 Reorganization of Disorders of Anxiety.
Advances in Psychiatry Series. American Psychiatric Association 167th Annual Meeting.
New York, NY, May 3, 2014
101
495. Body Dysmorphic Disorder: Update on a Common, Impairing, and Often Under-
recognized Disorder. American Psychiatric Association 167th Annual Meeting. New York,
NY, May 4, 2014
496. Symposium on Trauma- and Stressor-Related and Dissociative Disorders in DSM-

5 (Chair). American Psychiatric Association 167th Annual Meeting. New York, NY, May 5,
2014
497. Symposium on Obsessive-Compulsive and Related Disorders in DSM-5 (Chair).

American Psychiatric Association 167th Annual Meeting. New York, NY, May 6, 2014
498. The Meta-structure, Insight Specifier, and Criteria for Body Dysmorphic Disorder.
Symposium on Obsessive-Compulsive and Related Disorders in DSM-5. American
Psychiatric Association 167th Annual Meeting. New York, NY, May 6, 2014
499. Body Dysmorphic Disorder: Update on a Severe Yet Under-recognized Disorder. Grand
Rounds, Yale University School of Medicine. New Haven, CT, May 16, 2014
500. Big Changes in Diagnostic Categories: What Does It Mean for Me? Public Education
Webinar Series, Anxiety and Depression Association of America (ADAA). June 4, 2014
and Trauma- and Stressor-Related Disorders. Psychiatry in 2014 Conference, Harvard
Medical School and McLean Hospital. Boston, MA, June 12, 2014
502. Career Trajectories (Panel Member). New Investigators’ Workshop. Annual Meeting of
the American Society of Clinical Psychopharmacology. Hollywood, FL, June 15, 2014
and Trauma- and Stressor-Related Disorders. International Symposium of Psychiatry,
Psychopathology, and Neurosciences. RED Internacional de Psicopatología. Santiago,
Chile, July 3, 2014
504. Body Dysmorphic Disorder: Clinical Features and Management. International

Symposium of Psychiatry, Psychopathology, and Neurosciences. RED Internacional de
Psicopatología. Santiago, Chile, July 4, 2014
505. Obsessions, Overvalued Ideas, and Delusions. International Symposium of Psychiatry,

Psychopathology, and Neurosciences. RED Internacional de Psicopatología. Santiago,
Chile, July 4, 2014
506. Ask the Experts: Question and Answer Session on Body Dysmorphic Disorder. 21st
Annual OCD Conference, International OCD Foundation. Los Angeles, CA, July 19,
2014
507. Symposium on New Research Findings on Body Dysmorphic Disorder (Chair). 21st
Annual OCD Conference, International OCD Foundation. Los Angeles, CA, July 19,
2104
102
508. Anger, Aggression, and Violent Behavior in Individuals with Body Dysmorphic Disorder.
21st Annual OCD Conference, International OCD Foundation. Los Angeles, CA, July 19,
2104
509. Update on Body Dysmorphic Disorder: Clinical Features, Classification, Neurobiology,

Assessment, and Treatment. Grand Rounds, Elmhurst Hospital Center, Mount Sinai
School of Medicine. Elmhurst, NY, September 17, 2014
510. Update on Body Dysmorphic Disorder: Clinical Features, Classification, Neurobiology,

Assessment, and Treatment. Grand Rounds, Lenox Hill Hospital. New York, NY,
October 9, 2014
511. Body Dysmorphic Disorder. Fifth Annual Women’s Health Council Conference, Women’s
Health Council of Rhode Island. Providence, RI, October 23, 2014
512. Obsessive-Compulsive and Related Disorders in DSM-5. Conference on The Spectrum

of Compulsivity. Amsterdam, the Netherlands, November 6, 2014 (via webcam)
513. Visual Processing in Body Dysmorphic Disorder. Bench to Bedside Presentation, Brown
University Division of Biology and Medicine. Providence, RI, February 26, 2015
514. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: Double-Blind

Placebo-Controlled Trial (Phase 2). 3rd Annual New England OCD Research
Symposium, Yale University. Orange, CT, March 27, 2015
515. Body Dysmorphic Disorder: Clinical Features, Classification, Neurobiology, Assessment,

and Treatment. Presentation for undergraduate students, Brown University. Providence,
RI, April 8, 2015
516. Update on Treatment for Body Dysmorphic Disorder. 2015 Anxiety and Depression
Association of America Annual Conference. Miami, FL, April 10, 2015
517. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: Phase 2 Results.

2015 Anxiety and Depression Association of America Annual Conference. Miami, FL,
April 12, 2015
518. NIMH Relapse Prevention Study of BDD. International College of Obsessive-Compulsive

Spectrum Disorders 10th Scientific Meeting. Miami, FL, April 12, 2105
519. Obsessive-Compulsive and Related Disorders in DSM-5. Master Course on “DSM-5:

What You Need to Know.” American Psychiatric Association 168th Annual Meeting.
Toronto, Canada, May 18, 2015
520. Update on Pharmacotherapy and CBT for Body Dysmorphic Disorder. Symposium on
Evidence-Based Specialty Treatments for Obsessive-Compulsive and Related
Disorders: Updates and Issues on Dissemination of Expertise. American Psychiatric
Association 168th Annual Meeting. Toronto, Canada, May 18, 2015
521. Workshop on Body Dysmorphic Disorder: Clinical Features, Neurobiology, and
103
Treatment (Chair). American Psychiatric Association 168th Annual Meeting. Toronto,

Canada, May 19, 2015
522. Body Dysmorphic Disorder: Clinical Features and Treatment Approaches. Workshop on
Body Dysmorphic Disorder: Clinical Features, Neurobiology, and Treatment. American
Psychiatric Association 168th Annual Meeting. Toronto, Canada, May 19, 2015
523. Body Dysmorphic Disorder: What Surgeons Need to Know (Keynote Speaker).
Conference on Orthognathic Surgery, The Royal College of Surgeons of England.
London, England, May 28, 2015
524. Treatment Planning Panel. Conference on Orthognathic Surgery, The Royal College of
Surgeons of England. London, England, May 28, 2015
525. Motives to Drink Alcohol in Body Dysmorphic Disorder. BDD Research Day, Institute of
Psychiatry, Psychology and Neurosciences, King’s College London. London, England,
May 29, 2015
526. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind

Placebo-Controlled Trial. BDD Research Day, Institute of Psychiatry, Psychology and
Neurosciences, King’s College London. London, England, May 29, 2015
527. Body Dysmorphic Disorder (Keynote Speaker). The First International Conference on
BDD, The Body Dysmorphic Disorder Foundation. London, England, May 30, 2015
528. Medication for Body Dysmorphic Disorder. The First International Conference on BDD,
The Body Dysmorphic Disorder Foundation. London, England, May 30, 2015
529. Panel Discussion: Career Trajectories Featuring New Investigator Awardee Alumni. New
Investigators’ Workshop. Annual Meeting of the American Society of Clinical
Psychopharmacology. Miami, FL, June 21, 2015
530. Key Ingredients of Developing a Successful Research Career. New Investigators’

Workshop. Annual Meeting of the American Society of Clinical Psychopharmacology.
Miami, FL, June 21, 2015
531. Psychopharmacology Roundtable: The Pharmacologic Treatment of Resistant OCD and

Related Disorders. 22nd Annual OCD Conference, International OCD Foundation.
Boston, MA, July 31, 2015
532. Ask the Experts: Question and Answer Session on Body Dysmorphic Disorder. 22nd
Annual OCD Conference, International OCD Foundation. Boston, MA, August 1, 2015
533. Chair, Symposium on New Research Findings on Body Dysmorphic Disorder. 22nd
Annual OCD Conference, International OCD Foundation. Boston, MA, August 1, 2015
534. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: Double-Blind

Placebo-Controlled Trial (Phase 2). Symposium on New Research Findings on Body
104
Dysmorphic Disorder. 22nd Annual OCD Conference, International OCD Foundation.

Boston, MA, August 1, 2015
535. Body Dysmorphic Disorder: Clinical Features, Classification, Neurobiology, Assessment,

and Treatment. Grand Rounds, McGill University. Montréal, Canada, September 25,
2015
536. Body Dysmorphic Disorder: Diagnosis, Clinical Features, Neurobiology, and Treatment
of an Underrecognized Disorder in Children and Adolescents. Grand Rounds, Bradley
Hospital, Alpert Medical School of Brown University. East Providence, RI, October 14,
2015
537. Modification of Perception in Body Dysmorphic Disorder and Its Neural

Correlates. DEANS Award Translational Research Seminar Series, Alpert Medical
School of Brown University. Providence, RI, February 9, 2016
538. Strategies for Success in Preparing Grant Applications. 2016 Anxiety and Depression
Association of America Annual Conference. Philadelphia, PA, April 1, 2016
539. Update on Treatment for Body Dysmorphic Disorder. 2016 Anxiety and Depression
Association of America Annual Conference. Philadelphia, PA, April 2, 2016
540. Body Dysmorphic Disorder. Grand Rounds, New York Medical College. Valhalla, NY,
April 19, 2016
541. FOCUS LIVE! OCD and Related Disorders: Diagnosis to Treatment. American
Psychiatric Association Annual Meeting. Atlanta, GA, May 16, 2016
542. Update on Body Dysmorphic Disorder: Clinical Features, Neurobiology, and Treatment.
543. Developing and Running a Successful Research Track for Psychiatry Residents.
544. Panel Discussion: Career Trajectories Featuring New Investigator Awardee Alumni. New
Investigators’ Workshop. Annual Meeting of the American Society of Clinical
Psychopharmacology. Phoenix, AZ, May 29, 2016
545. Key Ingredients of Developing a Successful Research Career. New Investigators’

Workshop. Annual Meeting of the American Society of Clinical Psychopharmacology.
Phoenix, AZ, May 29, 2016
546. Body Dysmorphic Disorder (BDD): What Dermatologists and Surgeons Need to Know.
Santiago, Chile, July 13, 2016
547. Olfactory Reference Syndrome: Clinical Features, Diagnosis, and Treatment. III
Simposio Internacional RIPDES. Santiago, Chile, July 14, 2016
105
548. Update on Pharmacotherapy and Cognitive-Behavioral Therapy for Body Dysmorphic

Disorder. III Simposio Internacional RIPDES. Santiago, Chile, July 14, 2016
549. Motives to Use Drugs in Body Dysmorphic Disorder. 23rd Annual OCD Conference,
International OCD Foundation. Chicago, IL, July 29, 2016
550. Pharmacotherapy for Body Dysmorphic Disorder. 23rd Annual OCD Conference,
551. Update on Treatment for Body Dysmorphic Disorder. 23rd Annual OCD Conference,
552. Pharmacology Roundtable: The Pharmacologic Treatment of Resistant OCD and

Related Disorders. 23rd Annual OCD Conference, International OCD Foundation.
Chicago, IL, July 30, 2016
553. Pharmacotherapy for Body Dysmorphic Disorder. 2016 Annual Fall Meeting, American
Society of Clinical Psychopharmacology. New York, NY, October 30, 2016
554. Body Dysmorphic Disorder: Clinical Features, Neurobiology, and Treatment. Grand
Rounds, St. Elizabeth’s Medical Center, Tufts University School of Medicine. Brighton,
MA, November 3, 2016
555. Body Dysmorphic Disorder. Clinical Features, Neurobiology, Assessment, and

Treatment. 22nd Annual National Psychopharmacology Update, Nevada Psychiatric
Association. Las Vegas, NV, February 18, 2017
556. Trichotillomania (Hair-Pulling Disorder) and Excoriation (Skin-Picking) Disorder. 22nd

Annual National Psychopharmacology Update, Nevada Psychiatric Association. Las
Vegas, NV, February 18, 2017
557. Body Dysmorphic Disorder in the Aesthetic Surgery Patient. Grand Rounds and Visiting
Professor, Department of Surgery, Yale University School of Medicine. New Haven, CT,
September 6, 2017
558. Body Dysmorphic Disorder: Clinical Features, Neurobiology, and Treatment of an

Underrecognized Disorder. Grand Rounds, University of Miami School of Medicine.
Miami, FL, September 20, 2017
559. Body Dysmorphic Disorder: Clinical Features, Assessment, Neurobiology, and

Treatment. Advanced Forum on OCD-Related Disorders, International OCD Foundation.
560. Psychiatric Evaluation of Patients Seeking Cosmetic Treatment. IMCAS Annual World
Congress 2018 (international conference for plastic surgeons and cosmetic
dermatologists). Paris, France, February 2, 2018
106
561. Body Dysmorphic Disorder: What Plastic Surgeons and Dermatologists Need to Know.
Keynote speaker, IMCAS Annual World Congress 2018 (international conference for
plastic surgeons and cosmetic dermatologists). Paris, France, February 2, 2018
562. Predictors of Symptom Change During Cognitive-Behavioral Therapy or Supportive

Psychotherapy for Body Dysmorphic Disorder. Anxiety and Depression Association of
America Annual Conference. Washington, DC, April 6, 2018
563. Symposium on Common Challenges in Assessing and Treating Body Dysmorphic

Disorder (Chair). American Psychiatric Association Annual Meeting. New York, NY, May
5, 2018
564. Common Challenges in Assessing and Treating Body Dysmorphic Disorder. American
Psychiatric Association Annual Meeting. New York, NY, May 5, 2018
565. Work-Life Balance. Early Career Luncheon, Annual Meeting of the American Society of
Clinical Psychopharmacology. Miami, FL, May 29, 2018
566. Body Dysmorphic Disorder: What Orthognathic Clinicians Need to Know (Keynote
Presentation). Conference on Orthognathic Surgery: Principles, Planning, and Practice
III. London, England, June 14, 2018
567. Treatment Planning Panel. Conference on Orthognathic Surgery: Principles, Planning,

and Practice III. London, England, June 14, 2018
568. Predictors of Symptom Change During Cognitive-Behavioral Therapy or Supportive

Psychotherapy for Body Dysmorphic Disorder. Research Symposium, 25th Annual OCD
Conference, International OCD Foundation. Washington, D.C., July 26, 2018
569. Essential Components in the Treatment of Body Dysmorphic Disorder. 25th Annual OCD
570. Ask the Experts: Q and A Session on Body Dysmorphic Disorder. 25th Annual OCD
571. Severe OCD and Related Disorders: Therapeutic Models of Recovery (Presenter and
Chair). 25th Annual OCD Conference, International OCD Foundation. Washington, D.C.,
July 28, 2018
572. Body Dysmorphic Disorder. 27th Congress, European Academy of Dermatology and
Venerology. Paris, France, September 15, 2018
573. What’s New on Body Dysmorphic Disorder. 27th Congress, European Academy of
Dermatology and Venerology. Paris, France, September 15, 2018
574. Body Dysmorphic Disorder: Update on a Common, Impairing, and Underrecognized

Disorder. New York Psychiatric Society. New York, NY, October 1, 2018
107
Treatment. Grand Rounds, New York University School of Medicine. New York, NY,
October 18, 2018
576. Body Dysmorphic Disorder: What Pediatricians Need to Know. Pediatrics Grand
Rounds, New York-Presbyterian Hospital Queens, Weill Cornell Medical College, Cornell
University. Queens, NY, November 15, 2018
577. Body Dysmorphic Disorder: Clinical Features, Neurobiology, and Treatment. Virginia
Tarlow, M.D., Grand Rounds, Northwestern University Feinberg School of Medicine.
Chicago, IL, November 21, 2018

Treatment of an Underrecognized Disorder. Grand Rounds, New York-Presbyterian,
Westchester Division, Weill Cornell Medical College of Cornell University. White Plains,
NY, December 15, 2019

Treatment of an Underrecognized Disorder. Grand Rounds, Payne Whitney at New
York-Presbyterian/Weill Cornell Medical Center, Weill Cornell Medical College of Cornell
University. New York, NY, December 16, 2019

Treatment of an Underrecognized Disorder. Grand Rounds, Hackensack Meridian
Health, Jersey Shore University Medical Center. Neptune, NJ, January 30, 2019

Treatment of an Underrecognized Disorder. Grand Rounds, Tufts University School of
Medicine. Boston, MA, February 14, 2019
108

Terapias

Hochgeladen von

Dokumentinformationen

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Terapias

Hochgeladen von

Copyright:

Verfügbare Formate

Katharine A. Phillips, M.D.

Curriculum Vitae February 25, 2019

KATHARINE A. PHILLIPS, M.D.

Address: Weill Cornell Psychiatry Specialty Center

EDUCATION AND TRAINING

Dartmouth College, Hanover, N.H.

Dartmouth Medical School, Hanover, N.H.

Dartmouth-Hitchcock Medical Center, Hanover, N.H.

McLean Hospital/Harvard Medical School, Belmont, M.A.

Brown University, Providence, RI

Professor of Psychiatry, Weill Cornell Medical College, Cornell University, 2017-present

Instructor in Psychiatry, Harvard Medical School, 1991-1994

Clinical Fellow in Psychiatry, Harvard Medical School, 1988-1991

HOSPITAL AND DEPARTMENTAL APPOINTMENTS

Senior Research Scientist, Rhode Island Hospital, Providence, RI, 2010-2017

Director of Research Training, General Psychiatry Residency Training Program, Department of

Chief, Outpatient Services, Butler Hospital, Providence, RI, 1994-1999

Research Affiliate in Psychiatry, McLean Hospital, Belmont, MA, 1994-1998

Assistant Psychiatrist, McLean Hospital, Belmont, MA, 1992-1994

Assistant in Psychiatry, McLean Hospital, Belmont, MA, 1991-1992

CERTIFICATION AND LICENSURE (CURRENT)

Licensed physician in New York state

HONORS AND AWARDS

Summa Cum Laude, Dartmouth College, 1977

Phi Beta Kappa National Honor Society, Dartmouth College, 1977

Rufus Choate Scholar, Dartmouth College, 1977

Outstanding Resident Award, National Institute of Mental Health, 1989

American Psychiatric Association/Burroughs-Wellcome Fellow, American Psychiatric

Honorable Mention, Psychiatric Research Fellowship, American Psychiatric Association, 1991

Resident Research Award, American Psychiatric Association, 1991

The Paul M. Howard Prize, McLean Hospital, 1991

Marquis Who’s Who Among Human Services Professionals, 1991

NCDEU New Investigators' Award, National Institute of Mental Health, 1993

Travel Award, American College of Neuropsychopharmacology, 1995

Best Doctors in America (National Edition), 2001-2003, 2005-2006, 2007-2008, 2009-2010,

Dorfman Journal Paper Award, Academy of Psychosomatic Medicine, 2002

Distinguished Fellow, American Psychiatric Association, 2003-present

Special Presidential Commendation (for research on body dysmorphic disorder), American

America’s Top Doctors (National Edition), Castle Connolly, 2006-2019

American Men and Women of Science, 26th Edition, 2009

Marquis Who’s Who in America, 2009-2016

Marquis Who’s Who of American Women, 2010

Fellow, American College of Neuropsychopharmacology, 2010-present

Marquis Who’s Who in Medicine and Healthcare, 2011

US News and World Report Best Doctors, 2011-2013

Marquis Who’s Who in Science and Engineering, 2011-2012 and 2016-2017

Author Commendation (one of best authors in Psychiatry), UpToDate, 2017

Exceptional Women in Medicine (National Edition), Castle Connolly, 2017, 2018

Marquis Who’s Who Lifetime Achievement Award, 2017, 2018

Who’s Who Top Doctors Honors Edition, 2017-present

Regional Top Doctor, Castle Connolly, 2017

Marquis Who’s Who in the World, 2017, 2018, 2019

1. Livingston Research Fellowship

2. Development of Diagnostic Instruments and Prevalence of Body Dysmorphic Disorder in

3. An Open-Label Flexible Dose Study of Fluvoxamine in Body Dysmorphic Disorder

4. A Prospective, Multicenter, Open-Label Study of Serzone (Nefazodone) in the

5. Pharmacotherapy of Body Dysmorphic Disorder

6. Pimozide Augmentation of Fluoxetine in Body Dysmorphic Disorder

7. Retrospective Follow-up Study of Body Dysmorphic Disorder

8. Weekly Enteric-Coated Fluoxetine Hydrochloride Versus Daily Fluoxetine or Placebo in

9. Phenomenology of Body Dysmorphic Disorder in Children and Adolescents

10. Harvard/Brown Anxiety Research Program

11. Citalopram Treatment of Body Dysmorphic Disorder